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Brief overview of membrane trafficking
Coordinated vesicular trafficking is necessary for internal communication between organelles, for
targeting of proteins, lipids and other biomolecules to their cellular destinations, and for 
regulating organellar morphology and the spatiotemporal organization of cells (Fig. 1). Many 
cell types have specialized membrane trafficking, such as for the release of neurotransmitter at 
the chemical synapse between neurons [1], the delivery of granzyme B and perforin by natural 
killer cells and cytolytic T cells at the immunological synapse with target cells [2, 3]. Membrane 
trafficking is responsible for orchestrating endosomal and phagosomal maturation and for 
transporting cargoes and molecules from within the cell to be secreted or presented on the cell 
surface.
The protein machinery responsible for membrane trafficking is well understood. Cage proteins 
such as clathrin, caveolin, COP-I and COP-II [4-6] are responsible for the formation of trafficking 
vesicles at the donor compartment or at the plasma membrane for endocytosis. Some cell types 
are also capable of uptake of large material by phagocytosis, which does not rely on specific 
cage proteins, but can depend on the actin cytoskeleton. Cage proteins can interact directly 
with cargo molecules, or indirectly via so-called adapter proteins [5]. Many trafficking vesicles 
and whole organelles are transported within the cell by the microtubular cytoskeleton. The 
molecular identity of organelles is governed by several factors, including small GTPases of the 
RAB family, N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) [7] and 
phosphoinositides [8, 9]. Combinations of these factors determine the site of membrane fission 
and fusion and are recognized by tethering factors, which are large multiprotein complexes that 
can span over long distances up to 200 nm [10, 11]. SNARE proteins are the engines of membrane 
fusion, and the interactions of cognate SNAREs present in both the donor and acceptor membrane 
drive membrane fusion. The lipid membrane composition of organelles itself is a dynamic factor 
governing trafficking with many trafficking proteins being recruited to specific lipid species [9, 
12]. Membrane trafficking is a large area of research focusing on resolving the mechanisms and 
pathways of intracellular transport. 
In our work we focused on the aspects of membrane trafficking by dendritic cells (DCs) – important 
phagocytes of the innate immunity actively engaged into antigen sampling via endocytosis or 
phagocytosis, antigen degradation and presentation. Cancer-antigens and pathogens can be 
engulfed by DCs into a vacuole by endocytosis or phagocytosis (for small solutes and larger 
particles (> 0.5 µm), respectively). In our work we aim to focus on events guiding endo/phagosomal 
remodeling during early moments of internalization and later phagosomal maturation. Then, we 
focus on an important class of lipid species at the vacuolar membrane upon antigen internalization 
– phosphoinositides. We aim to understand the importance of some phosphoinositide species 
phosphatidylinositol (3,4)-bisphosphate (PI(3,4)P2) and phosphatidylinositol (3,5)-bisphosphate 
(PI(3,5)P2) in early and late maturation events leading to antigen presentation by human and 
mouse
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DCs. Finally, we discuss a potentially new mechanism of antigen sampling by human and mouse 
DCs via protrusive podosomes.
(PI(3,5)P2) in early and late maturation events leading to antigen presentation by human and mouse 
DCs. Finally, we discuss a potentially new mechanism of antigen sampling by human and mouse DCs 
via protrusive podosomes.  
 
Figure 1. Schematic overview of the main topics in membrane trafficking field (summary of [6, 9, 
13]). Transport vesicles can dissociate from donor membrane compartments via membrane 
deformation and tubulation facilitated by BAR superfamily proteins (e.g. F-BAR and I-BAR domains) 
and be enclosed into scaffolds formed by cage proteins (e.g. COPI, COPII, clathrin, caveolin). 
Transport vesicles can move along the cytoskeleton utilizing motor proteins and eventually fuse with 
target membrane compartments utilizing tethering complexes (e.g. TRAPP, COG, exocyst, GARP, 
Dsl1) and SNAREs. SNAREs can facilitate membrane fusion via formation of four-helix complex 
between vesicle-associated (v-SNAREs) and target membrane-associate (t-SNAREs). Structurally, v-
SNAREs are often called R-SNAREs due to a presence of arginine (R) in their SNARE domain. t-SNARES 
most often have glutamine residue (Q) in the SNARE domain and are subdivided into three types: Qa-, 
Qb-, and Qc-SNARE. Rab GTPases cycle between “active” GTP-bound and “inactive” GDP-bound forms 
that interact with multiple effector targets promoting vesicle formation, uncoating, fusion, movement 
and maturation (e.g. Rab5, Rab7, Rab27, Rab11a). Maturing endosomes rely on the ESCRT family 
(e.g. ESCRT-0, I, II or III) of proteins for membrane deformations leading to multivesicular body 
formation preceding the degradative lysosomes. The ESCRT machinery can also recognize vesicular 
proteins targeted for degradation via ubiquitylation. Elements of autophagy pathway can be used for 
vesicle fusion with lysosomes  (e.g. Atg5, Atg7, LC3).  Membrane traffic does not only rely on proteins, 
but also on the lipid composition of membranes such as cholesterol, charged lipids (phosphoinositides 
(PIPs)) or lipid degradation/hydrolysis products (inositol phosphate (IP3)). The lipid composition may 
control membrane curvature, direct recruitment of lipid-interacting proteins, the creating of an 
environment for protein clustering, ion-transport channels, kinase activation, etc.  
Role of phagocytes in immune response.  
The immune system of higher organisms has been evolving to attack malicious cancerous cells or 
pathogens encountered by the body. The central mechanism of antigen uptake by immune cells in 
multicellular organisms appeared  initially in lower unicellular organisms and are used  for nutrient 
uptake (well studied in the protozoan amoebae Entamoeba histolytica, Amoeba proteus and 
Dictyostelium discoideum [14-16]) which evolved into endocytic  and phagocytic pathways in higher 
species [17].  
^ Fig. 1: Schematic overview of the main topics in membrane trafficking field (summary of [6, 9,13]). Transport vesicles 
can dissociate from d nor membrane comp rtments via membrane deformation and tubulation facilitated by BAR 
superfamily proteins (e.g. F-BAR and I-BAR domains) and be enclosed into scaffolds formed by cage proteins (e.g. COPI, 
COPII, clathrin, caveolin). Transport vesicles can move along the cytoskeleton utilizing motor proteins and eventually fuse 
with target membrane compartments utilizing tethering complexes (e.g. TRAPP, COG, exocyst, GARP, Dsl1) and SNAREs. 
SNAREs can facilitate membrane fusion via formation of four-helix complex between vesicle-associated (v-SNAREs) and 
target membrane-associate (t-SNAREs). Structurally, vSNAREs are often called R-SNAREs due to a presence of arginine (R) 
in their SNARE domain. t-SNARES most often have glutamine residue (Q) in the SNARE domain and are subdivided into 
three types: Qa-, Qb-, and Qc-SNARE. Rab GTPases cycle between “active” GTP-bound and “inactive” GDP-bound forms 
that interact with multiple effector targets promoting vesicle formation, uncoating, fusion, movement and maturation (e.g. 
Rab5, Rab7, Rab27, Rab11a). Maturing endosomes rely on the ESCRT family (e.g. ESCRT-0, I, II or III) of proteins for membrane 
deformations leading to multivesicular body formation preceding the degradative lysosomes. The ESCRT machinery can 
also recognize vesicular proteins targeted for degradation via ubiquitylation. Elements of autophagy pathway can be used 
for vesicle fusion with lysosomes (e.g. Atg5, Atg7, LC3). Membrane traffic does not only rely on proteins, but also on the lipid 
composition of membranes such as cholesterol, charged lipids (phosphoinositides (PIPs)) or lipid degradation/hydrolysis 
products (inositol phosphate (IP3)). The lipid composition may control membrane curvature, direct recruitment of lipid-
interacting proteins, the creating of an environment for protein clustering, ion-transport channels, kinase activation, etc. 
Role of phagocytes in immune response
The immune system of higher organisms has been evolving to attack malicious cancerous cells 
or pathogens encountered by the body. The central mechanism of antigen uptake by immune 
cells in multicellular organisms appeared initially in lower unicellular organisms and are used for 
nutrient uptake (well studie  in the tozoan amoebae Entamoeba histolytica, A oeba proteus 
and Dictyostelium discoideum [14-17]) which evolved into endocytic and phagocytic pathways 
in higher species [18].
Cargo of smaller size is internalized via endocytosis and can utilize clathrin coated piths or caveolin 
for formation of endocytic vesicles. Cellular drinking is called pinocytosis and used for non-receptor 
dependent internalization of liquids. Larger solid components are internalized via phagocytosis, a 
term first coined by Élie Metchnikoff [19], and currently defined as a clathrin-indep nde t uptake 
mechan s of particles > 0.5 µm in diamet r requiri g F-actin polymerization. Phagocytes can
be subdivided into professional (macrophages, DCs, neutrophils) and non-professional cell 
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types (epithelial cells and fibroblast) [20-23]. Endocytosis and phagocytosis are important steps 
towards constituting the first line of immune defense – called innate immunity – involving antigen 
recognition, killing and degradation of infectious microbes. Immune phagocytes continuously 
patrol the body for potential infections, this leads to formation of unique niches were phagocytes 
may reside. The major phagocytic leukocytes that provide innate immunity are granulocytes, 
macrophages and DCs.
Granulocytes, which include neutrophils, are believed to be the most efficient phagocytes 
capable of rapid and productive phagocytosis for intracellular killing of the pathogens or being 
able to kill pathogens via extracellular mechanisms [24]. Macrophages mainly play homeostatic 
roles and are tuned for killing pathogens and apoptotic cells, although they can also present 
peptides derived from ingested antigens in major-histocompatibility complex to T-cells. Tissue-
resident macrophages are distributed within the most tissues of the body where they can be 
either replenished from blood recruited monocytes or accrued from embryonic sources in the 
tissue [25, 26]. Tissue-resident macrophages can be classified into inflammatory M1 and anti-
inflammatory M2 phenotypes [26]. It has been shown that anti-inflammatory macrophages are 
engaged into a vigorous pinocytosis while pro-inflammatory macrophages are virtually inactive 
[27].
DCs create the link between innate and adaptive immunity. DCs orchestrate immunity against 
a wide range of pathogens as well as tolerance to self and harmless environmental pathogens 
[28]. DCs do not only patrol for pathogens but also are highly specialized antigen-presenting cells 
that internalize exogenous peptides derived from cancer cells or pathogens and present them 
within MHC-class I or II on the DC’s surface. Antigen presented on the surface of MHC-I can trigger 
adaptive immune system via activation of cytolytic CD8+ T-cells, whereas antigen presented 
within MHC-II can trigger helper CD4+ T-helper cells [29, 30]. Antigen processing and presentation 
between DCs and macrophages has differences and similarities [31]. Macrophages are tuned for 
faster antigen uptake leading to degradation and clearance of pathogens. DCs are known for 
higher activity of NOX2 associated with higher levels of ROS leading to alkalinized pH in their 
endo-/phagosomes. This leads to a delay in antigen processing due to inhibition of proteases 
in suboptimal pH or inhibition of lysosomal thiol reductases due to excess of ROS. This causes a 
delay in antigen processing, resulting in more diverse repertoire of antigens for presentation and 
allows for sustained presentation of antigens following DC’s migration to lymph nodes which can 
take days, but is necessary for encountering naive T-cells by DCs [32-40]. The recent work suggests 
that monocyte-derived DCs (moDC) and monocyte-derived macrophages can cross-present 
efficiently exclusively through vacuolar pathway, but only moDCs specialize on the producing of 
co-stimulatory signals for activation of effector cytotoxic CD8+ T-cells [41]. 
DCs consist of multiple subsets [22, 29, 30, 42] showing high inter individual variation and tissue
specialization [19]. Understanding the properties of different DC subsets is a current focus for
11
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optimizing anti-tumor DC-based immunetherapies [26]. Depending on the lineage origin, 
type of transcription factors and surface markers expressed and cell specialization, naturally 
occurring DCs currently are classified into the following subsets: plasmacytoid DC (pDC), myeloid/
conventional DC1 (cDC1) and myeloid/conventional DC2 (cDC2) [43]. DCs can also originate 
from monocytes and have a phenotype that can be placed between cDC2 and macrophages. 
Monocyte-derived DCs (moDCs) were initially used in immunotherapies until it was understood 
that they do not efficiently migrate to the lymph nodes [24] in contrast to other subtypes of DCs 
such as plasmacytoid (pDCs) and myeloid DCs (mDC). In our work, we mainly used primary human 
moDCs as it allows as to acquire substantial quantities of cells from healthy donor blood ex vivo 
from CD14+ blood monocytes with granulocyte monocyte colony stimulating factor (GM-CSF) 
and interleukin-4 (IL-4) [25, 44], and they can be transfected with plasmids and siRNA with high 
efficiency.
Bridging receptors and ligands as a first step towards phagocytosis
Co-evolution of phagotrophic protozoans and bacteria led to the emergence of phagocytic 
receptors binding pathogen-derived ligands [45]. Phagocytic receptors fall into two main 
categories: integrins [46-48] and lectins [44]. Phagocytosis in innate immunity is triggered through 
recognition of antigen ligands by the pathogen recognition receptors (PRR) that recognize 
pathogen-associated molecular patterns (PAMPs) [14, 31, 49, 50] and scavenger receptors that 
recognize signs of cell stress called danger-associated molecular patterns (DAMPs) [51] (apoptotic 
cell recognition is beyond the scope of this thesis). The best characterized PRRs are Toll-like 
receptors (TLRs) (Fig. 2) which are type I transmembrane receptors involved in recognition of a 
variety of microbial pathogens, orchestrating innate immune responses [52]. DCs that encounter 
pathogens [28] via PRRs [18] can engulf them via endocytosis or phagocytosis [53]. Phagocytosis 
is utilized for clearance of infections such as bacteria (~0.5–3 µm) or yeast (~3–4 µm) [53] or 
even larger apoptotic cells (~5-50 µm) [47, 53]. Pathogens can be directly ingested by PRRs or by 
scavenger receptors after opsonization [54]. PRRs (Fig. 2) can directly recognize ligands on the 
surface of a pathogen [49]. Pathogens can be also decorated by serum proteins called opsonins, 
which can be serum-derived antibodies recognized by Fc-receptors (FcR) (Fig. 2) or components 
of the complement system such as C3bi recognized by complement receptors (CR) (Fig. 2) [55]. 
Some pathogens developed efficient mechanisms of interfering with opsonization [56, 57], 
or avoiding the complement pathway by inactivating C4b [58]. In contrast, some pathogens 
hijack receptors for their survival and for instance the intracellular pathogen. Mycobacterium 
tuberculosis triggers scavenger receptor overexpression on the cell surface of macrophages to 
foster continuous uptake of the bacteria [59].  
 
Pathogenic ligands engaging PRRs and scavenger receptors not only trigger cellular programs 
facilitating antigen uptake, but also downstream signaling cascades that lead to expression of 
costimulatory molecules, cytokines and chemokines. Although the uptake and killing of ingested 
microbes by DCs contributes to innate immunity [60], this eventually triggers the second line of 
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defense called adaptive immunity. Adaptive immunity is activated when antigens are presented 
by phagocytes to T lymphocytes. 
In our studies we researched the roles of integrins, FcR, TLR2 and Dectin-1 receptors into 
phagosomal formation as well as mannose receptor antigen uptake of OVA-antigens.
 
Figure 2. Antigen recognition via receptors expressed by DCs. Top panel: Molecular structures of the 
different microorganisms called pathogen associated molecular pattern (PAMPs) that can be 
recognized by phagocytes. Bottom panel: strategic surface/intracellular localization and molecular 
targets of non-opsonic pathogen recognition receptors (PRR) (CLR, NLR, RLR, TLR; see figure for 
explanations) and opsonic Fc (FcR) and complement (CR) receptors (adapted from Rossana Zaru). 
Pathogenic ligands engaging PRRs and scavenger receptors not only trigger cellular programs 
facilitating antigen uptake, but also downstream signaling cascades that lead to expression of co-
stimulatory molecules, cytokines and chemokines. Although the uptake and killing of ingested 
microbes by DCs contributes to innate immunity [59], this eventually triggers the second line of 
defense called adaptive immunity. Adaptive immunity is activated when antigens are presented by 
phagocytes to T lymphocytes 
 
 
^ Fig. 2: Antigen recogniti n via receptors xpressed by DCs. Top panel: Molecular structures of the different micro r-
ganisms called pathogen associated molecular pattern (PAMPs) that can be recognized by phagocytes. Bottom panel: 
strategic surface/intracellular localization and molecular targets of non-opsonic pathogen recognition receptors (PRR) 
(CLR, NLR, RLR, TLR; see figure for explanations) and opsonic Fc (FcR) and complement (CR) receptors (adapted from 
Rossana Zaru [52]).
 
Figure 3. Schematic signaling programs initiated by TLRs, opsonic receptors (e.g. FcR) or direct 
phagocytic cargo binding by cell-surface integrins. Left-hand panel: Upon recognition of microbial 
ligands, TLRs initiate signaling via cytoplasmic tails by direct recruitment of adaptor molecules such 
as TRIF or MYD88 and by secondary adaptors such as TIRAP (for MYD88) and TRAM (for TRIF). 
Adaptor molecules can initiate the following pathways: MAP kinase (JNK, p38 and ERK), NFκB and 
IRF. Translocation of transcription factors leads to different immune response programs such as 
altered cytokine or chemokine production, expression of anti-microbial components and enhancing 
the antigen uptake and presentation. Middle panel: antigens on the surface of pathogens or tumor 
cells can be opsonised via immunoglobulins (antibodies) of the humoral immune defense. The 
antibody Fc-region of the heavy chain can be recognized by Fc-receptors (FcR) triggering 
phosphorylation of the cytoplasmic tail, leading to the docking of Syk, activating multiple targets 
including phosphoinositide 3-kinase (PI3K). PI3K generates PIP3 from PIP2 and creates a platform for 
Rac recruitment. Rac requires active guanine nucleotide exchange (GEFs) to trigger WAVE activation. 
After that, Cdc42 GTPase can be recruited to phago/endosomes and activate WASP. WAVE and WASP 
are essential for Arp2/3 activation orchestrating F-actin nucleation and branching, triggering 
membrane rearrangements and providing pulling forces for endo/phagocytosis. Syk and PI3K can also 
trigger phospholipase Cγ (PLCγ) recruitment, which activates downstream kinases or leads to Ca2+ 
release from the endoplasmic reticulum (ER), triggering calcium-dependent fusion of endomembranes 
with endo/phagosomes. Right-hand panel: interaction of integrins (e.g. αMβ2 integrin recognizing 
C3bi opsonins or fibrinogen) with extracellular targets can lead to recruitment of focal adhesion 
kinase (FAK) and scaffold proteins, such as talin, kindling, ILK, PINCH, parvin and paxillin, leading to 
actin polymerization. Syk activating signals from other receptors (FcR) can contribute to integrin-
mediated phagocytosis.  
In our studies we researched the roles of integrins, FcR, TLR2 and Dectin-1 receptors into 
phagosomal formation as well as mannose receptor antigen uptake of OVA-antigens.  
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^ Fig. 3: Schematic signaling programs initiated by TLRs, opsonic receptors (e.g. FcR) or direct phagocytic cargo binding by 
cell-surface integrins. Left-hand panel: Upon recognition of microbial ligands, TLRs initiate signaling via cytoplasmic tails 
by direct recruitment of adaptor molecules such as TRIF or MYD88 and by secondary adaptors such as TIRAP (for MYD88) 
and TRAM (for TRIF). Adaptor molecules can initiate the following pathways: MAP kinase (JNK, p38 and ERK), NFκB and IRF. 
Translocation of transcription factors leads to different immune response programs such as altered cytokine or chemokine 
production, expression of anti-microbial components and enhancing the antigen uptake and presentation. Middle panel: 
antigens on the surface of pathogens or tumor cells can be opsonised via immunoglobulins (antibodies) of the humor-
al immune defense. The antibody Fc-region of the heavy chain can be recognized by Fc-receptors (FcR) triggering phos-
phorylation of the cytoplasmic tail, leading to the docking of Syk, activating multiple targets including phosphoinositide 
3-kinase (PI3K). PI3K generates phosphatidylinositol 3,4,5-phosphate (PI(3,4,5)P3) from phosphatidylinositol 4,5-phosphate 
(PI(4,5)P2) and creates a platform for Rac recruitment. Rac requires active guanine nucleotide exchange (GEFs) to trigger 
WAVE activation. After that, Cdc42 GTPase can be recruited to phago/endosomes and activate WASP. WAVE and WASP are 
essential for Arp2/3 activation orchestrating F-actin nucleation and branching, triggering membrane rearrangements and 
providing pulling forces for endo/phagocytosis. Syk and PI3K can also trigger phospholipase Cγ (PLCγ) recruitment, which 
activates downstream kinases or leads to Ca2+ release from the endoplasmic reticulum (ER), triggering calcium-dependent 
fusion of endomembranes with endo/phagosomes. Right-hand panel: interaction of integrins (e.g. αMβ2 integrin recogniz-
ing C3bi opsonins or fibrinogen) with extracellular targets can lead to recruitment of focal adhesion kinase (FAK) and scaf-
fold proteins, such as talin, kindling, ILK, PINCH, parvin and paxillin, leading to actin polymerization. Syk activating signals 
from other receptors (FcR) can contribute to integrin-mediated phagocytosis. 
Phagocytic cup formation for antigen uptake
The engagement of pathogens by DCs leads to phagocytic cup formation for antigen uptake. 
The first moments of particle engulfment relies on the deformations of the plasma membrane 
of the DC and on the formation of pseudopod-like extensions leading to the creation of the 
phagocytic cup [61-63]. This leads to engulfment of the microbe, eventually followed by the 
closure of the growing cup triggering movement of the phagosome into an intracellular space. 
During microbial cargo engagement, the membrane receptors undergo rapid rearrangements 
for creating necessary mechanical forces for cargo uptake [8, 64, 65]. 
The lipid content at the plasma membrane of the DC interface with the pathogen can 
drive internalization events. In has been shown that an increase of anionic lipids such as 
phosphatidylserine (PtdSer) in the membrane may drive a spontaneous curvature promoting 
endocytosis [66]. The membrane composition is also important for phagocytosis, as it undergoes 
multiple changes during microbe uptake [12]. Phagosomal lipid composition might differ 
between opsonic and non-opsonic type of receptors engaged with phagocytic cargo. One factor 
contributing to this change in lipid composition is the focal fusion of intracellular vesicles at the 
phagocytic cup, which provides a source of membrane for internalization of large cargo, although 
the source of these vesicles is still debated and might be either of recycling or late endosomal 
or even lysosomal origin [67]. A second factor contribution to the changing lipid composition 
are phosphoinositide kinases and phosphatases, and for instance phosphatidylinositol 3-kinase 
is essential for large cargo ingestion (≥ 0.5 µm) [68] but is dispensable for smaller particles [69, 
70]. The dynamic changes of phosphoinositide content on phagosomes and pinosomes are 
well-described [9]. Many pathogens developed virulence factors targeting phosphatidylinositol 
metabolism in the host [71].
14
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Another important component of phagocytic cup formation is F-actin polymerization driving the 
formation of membranous extensions of the phagocytic cup. The cascade of actin polymerization 
into filamentous F-actin can differ depending on the type of receptor involved and is tightly 
linked to phosphoinositide metabolism. F-actin polymerization is also targeted by pathogens 
that developed specific toxins interfering with F-actin polymerization pathways for enhancing 
intracellular invasion [72]. The phagosomal phosphoinositide content and F-actin rearrangements 
in relation to antigen uptake and maturation are summarized in (Fig. 4).
 
Figure 4. Scheme of phosphoinositide metabolism during phagocytosis (based on [9, 72]). From 
left- to right-hand panel: Upon recognition of phagocytic cargo (e.g. via engagement of FcR or C-type 
lectin receptors), the concentration of PI(4,5)P2 present in the inner monolayer of the plasmalemma 
(PM) will increase at the base of the phagocytic cup and triggers initial steps of Rac1 and Cdc42 
activation. Receptor clustering at the target interface can lead to a burst of tyrosine kinase activity, 
activating PI3K and displacing PI(4,5)P2 with PI(3,4,5)P3 at the basis of the phagocytic cup. This leads 
to further activation of lipid kinases and recruitment of adaptors and GEFs capable of activating Rac, 
promoting the further remodeling of the cytoskeleton, eventually driving F-actin-dependent 
pseudopod extension engulfing the prey. Vesicle secretion at the phagocytic cup provides the material 
for membrane extension. Shortly before closure of the phagocytic cup, the phagosome will acquire 
PI(3,4)P2, a signaling lipid capable of recruiting the F-actin adaptor SWAP70 which further anchors F-
actin to the phagosomal membrane. Lastly, after cup sealing and complete internalization, the 
phagosome is detached from the PM via various lipid phosphatases and GAPs. Early 
endo/phagosomes are characterized by the presence of PI(3)P guiding assembly of the NADPH 
oxidase NOX2 and acquisition of early markers such as EEA1 and Rab5. Endo/phagosomal PI3P is 
converted into PI(3,5)P2 by the kinase PIKfyve, which is a necessary step for cation channel TRPML1-
activation promoting fusion with lysosomes and acidification.  
NOX2 is a large multiprotein complex which transfers electrons from the cytosolic electron donor 
NADPH to O2, thereby generating reactive oxygen species (ROS) which create a microbicidal 
environment within the phagosome [73] and control the activation status of proteases [41]. 
Phagosomal acidification is triggered by v-ATPase recruitment (reviewed [75]).Pro-inflammatory M1 
and anti-inflammatory M2 macrophages have significant differences in NOX2 recruitment and 
phagosomal acidification rates [74]. The M1 phenotype is promoted in a pro-inflammatory 
environment such as upon infection, i.e. the presence of TLR stimuli or interferon(INF)- γ secretion. 
M1 macrophages are destined to quickly clear infections and have an enhanced antigen 
presentation. The M2 phenotype serves homeostatic function such as apoptotic cell clearance, 
inflammation suppression and tissue repair. The differentiation of M2 phenotype macrophages is 
triggered via activation of the STAT6 signaling pathway through interleukin(IL)-4 and IL-13.  
Phago/endosomal maturation  
^ Fig. 4: Scheme of phosphoinositide metabolism during phagocytosis (based on [9, 72]). From left- to right-hand panel: 
Upon recognition of phagocytic cargo (e.g. via engagement of FcR or C-type lectin receptors), the concentration of PI(4,5)P2 
present in the inner monolayer of the plasmalemma (PM) will increase at the base of the phagocytic cup and triggers initial 
steps of Rac1 and Cdc42 activation. Receptor clustering at the target interface can lead to a burst of tyrosine kinase activity, 
activating PI3K and displacing PI(4,5)P2 with PI(3,4,5)P3 at the basis of the phagocytic cup. This leads to further activation 
of lipid kinases and recruitment of adaptors and GEFs capable of activating Rac, promoting th  further remodeling of 
the cytoskeleton, eventually driving F-actin-dependent pseudopod extension engulfing the prey. Vesicle secretion at 
the phagocytic cup provides the material for membrane extension. Shortly before closure of the phagocytic cup, the 
phagosome will acquire PI(3,4)P2, a signaling lipid capable of recruiting the F-actin adaptor SWAP70 which further anchors 
F-actin to the phagosomal membrane. Lastly, after cup sealing and complete internalization, the phagosome is detached 
from the PM via various lipid phosphatases and GAPs. Early endo/phagosomes are chara terized by the pres nce of PI(3)P 
guiding assembly of the NADPH oxidase NOX2 and acquisition of early markers such as EEA1 and Rab5. Endo/phagosomal 
PI3P is converted into PI(3,5)P2 by the kinase PIKfyve, which is a necessary step for cation channel TRPML1- activation 
promoting fusion with lysosomes and acidification. 
 
NOX2 is a large multiprotein complex which transfers electrons from the cytosolic electron donor
NADPH to O2, thereby ge erating re ctive oxygen species (ROS) which create a microbicidal 
environme t within the phagosome [73] and control the activati n s atus of proteases [42]. 
Phagosomal acidification is triggered by v-ATPase recruitment (reviewed [74]). Pro-inflammatory 
M1 and anti-inflammatory M2 macrophages have significant differences in NOX2 recruitment and
phagosomal acidification rates [75]. The M1 phenotype is promoted in a pro-inflammatory 
ent such as u on infection, i.e. the presenc of TLR stimuli or interferon(INF)-γ secretion 
M1 macrophages are destined to quickly clear infections and have an enhanced antigen 
presentation. The M2 phenotype serves homeostatic function such as apoptotic cell clearance 
inflammation suppression, tissue repair and immunity to helminths [75, 76]. The differentiation of 
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M2 phenotype macrophages is triggered via activation of the STAT6 signaling pathway through 
interleukin(IL)-4 and IL-13.
Phago/endosomal maturation
Similarly to the endocytic pathway, phagosomal maturation can be divided into early, late and 
lysomal stages. Rab GTPases facilitate this maturation process. Rab5 in a key marker of early 
phagocytosis that precedes the late Rab7-positive stage. Rab5 recruits endosomal early antigen 
1 (EEA1) and Vps34 type III phosphatidylinositol 3-kinase, which generates PI(3)P. Later Rab5 
is replaced by Rab7 in a process that requires recruitment of Rab7-GEFs [77], but the precise 
mechanism of this process is not completely clear [61]. Rab7 can recruit many effectors that 
guide vesicular transport over microtubulae in both antero- and retrograde directions. PI(3)P 
can also recruit PIKfyve via its FYVE-domain, which leads to production of PI(3,5)P2 that activates 
the calcium-permeable cation channel TRPML1 and plays an essential role in phago/endosomal 
acidification and transport. Phago/lysosomal maturation is dependent on the presence of LAMP1 
and 2, as it has been shown that in knock-outs lacking LAMP1 and 2, the Rab5 positive phagosomes 
fail to recruit Rab7 and fuse with lysosomes [78]. It was shown that individual phagosomes in 
DCs and monocytes behave autonomously both in terms of cargo degradation and antigen 
presentation. It was shown that IgG-opsonization cause faster degradation and presentation of 
the cargo as opposed to phagosomes with non-opsonised cargo from the same cell [30].
Phagosomal maturation can utilize components of the autophagy machinery. Such phagosomes 
are called LAPosomes and they may mediate the fusion with lysosomes [79]. A hallmark of 
LAPosomes is the direct recruitment of the key autophagosomal regulator LC3 to the phagosome. 
It is believed that the autophagy pathway may mediate antigen presentation but is not universally 
required for phagosomal maturation [80]. Phagocytic uptake of fungal pathogens via Dectin-1 
was shown to cause LC3 recruitment to the phagosome and this was linked to fungal antigens 
presentation on the surface of MHCII but not MHCI [81], although mechanistic details of the 
LAPosome pathway can differ between bacterial, fungal and parasitic microorganisms [82]. On 
the other hand, autophagy can also prevent immune detection and facilitate pathogen survival, 
and for instance some microorganisms can escape phagosomes and reside in autophagocytic 
compartments [83].
Medical conditions and phagocytosis
Several mutations in phagosomal/endosomal proteins are related to human disease. X-linked 
Wiskott–Aldrich syndrome, caused by mutations in the protein WASP is characterized by an 
inability to trigger F-actin polymerization at the phagocytic cup. This disease is associated with 
eczema, low platelet count and immune deficiency [62, 63, 84]. In chronic obstructive pulmonary 
disease (COPD), macrophages are characterized by a significantly reduced phagocytic capacity 
of bacteria and apoptotic cells [85]. Mutations in synaptotagmin-11 (Syt11) were found to be 
associated with impaired cytokine secretion and phagocytosis in microglia, contributing to the 
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development of Parkinson disease and schizophrenia [86]. Retinal pigment epithelium (RPE) cells 
are cells supporting homeostasis of the retina within the eye by phagocytosing photoreceptor 
outer segments (POS), and this is important for photoreceptor renewal and regeneration of 
photobleached visual pigments. It is suggested that deregulation of this process may result in 
a disease age-related macular degeneration (AMD) which can manifest into blindness [87]. Fc-
independent phagocytosis of platelets by macrophages and neutrophils was shown to be crucial 
at thrombocytopenia prevention [88].
Phagocytosis is an important target in medicine development, as nano-particle drug carriers can 
be ingested by cells to combat a range of diseases such as HIV [89], tuberculosis [90] and cancer 
[91, 92]. A challenge is the controlled targeting of such drug carriers to affected cell types, as a 
possible culprit is that nano-particles can be cleared via phagocytosis as foreign particles [93, 
94]. Overall, in recent years nano-particle therapy approaches have experienced unprecedented 
growth. Understanding the mechanisms of their uptake and processing may provide new ways to 
improve these therapies and allow insights in the adverse effects of nano-particle formulations, 
such as toxicity or inefficiency at triggering immune responses.
Podosomal protrusions: novel role in antigen uptake
Podosomes are mechanosensitive structures found in many cells types.  In microscopy experiments 
in DCs and macrophages, podosomes were identified as solid cores of F-actin surrounded by 
a ring of adaptor proteins [95]. However, when placed on soft 3D surfaces, podosomes were 
shown to have the ability to protrude and degrade extracellular matrix [96]. The function of 
such protrusions was not completely understood. We utilized confocal and EM microscopy to 
demonstrate that DCs retain endocytic activity at the tip of the podosomal protrusions allowing 
them to sample antigens through endothelial and epithelial membranes [97, 98].
culprit is that nanoparticles can be cleared via phagocytosis as foreign particles [91, 92]. Overall, in 
recent years nanoparticle therapy approaches have experienced unprecedented growth and 
constiture. Understanding the mechanisms of their uptake and processing may provide new ways to 
i prove these therapies and allow insights in the adverse effects of nanoparticle formulations, such 
as toxicity or inefficiency at triggering immune responses.  
Podosomal protrusions: novel role in antigen uptake.  
Podosomes are mechanosensitive structures foun  in many cells types. In microscopy experiments in 
DCs and macrophages, podosomes were identified as solid cores of F-actin surrounded by a ring of 
adaptor proteins [93]. However, when placed on soft 3D surfaces, podosomes were shown to have 
the ability to protrude and degrade extracellular matrix [94]. The function of such protrusion  was 
not completely understood. We utilized confocal and EM microscopy to demonstrate that DCs retain 
endocytic activity at the tip of the podosomal protrusions allowing them to sample antigens through 
endothelial and epithelial membranes [95, 96].   
  
Figure 5. Human monocyte derived DCs can form solid-core podosomes when cultured on stiff 
substrates. Top right panel: podosomes consist of a solid F-actin core surrounded by a ring of 
adhesion proteins (vinculin, talin, paxilin)(pink) and integrins (blue) anchoring F-actin filaments to the 
plasma membrane. When encountering certain physiological cues or permissive substrate stiffness, 
podosomes can protrude and facilitate antigen sampling through epithelial and endothelial barriers. 
Antigen recognition receptors such as C-type lectin receptors (CLR; blue) can migrate to the tip of the 
protrusions and acquire antigens).    
Scope of this thesis.  
The work outlined in this thesis is dedicated to understanding the routes of antigen uptake and 
processing by DCs with the emphasis on the role of a particular class of signaling lipids – 
^ Fig. 5:  Human monocyte derived DCs can form solid-core podosomes when cultured on stiff substrates. Top right panel: 
podosomes consist of a solid F-actin core surrounded by a ring of adhesion proteins (vinculin, talin, paxillin)(pink) and inte-
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grins (blue) anchoring F-actin filaments to the plasma membrane. When encountering certain physiological cues or permis-
sive substrate stiffness, podosomes can protrude and facilitate antigen sampling through epithelial and endothelial barri-
ers. Antigen recognition receptors such as C-type lectin receptors (CLR; blue) can migrate to the tip of the protrusions and 
acquire antigens).
Scope of this thesis
The work outlined in this thesis is dedicated to understanding the routes of antigen uptake 
and processing by DCs with the emphasis on the role of a particular class of signaling lipids –
phosphoinositides – that tightly control phago/endosomal life from uptake to degradation as 
well as subsequent antigen presentation on the DC surface.
We first discuss the state-of-the-art knowledge on membrane trafficking in phagocytes based on
super-resolution microscopy techniques (such as STED, PALM, STORM). In chapter 2 we provide 
an overview on breakthrough discoveries in membrane trafficking encompassing topics 
from organization of the plasma membrane to cytoskeleton arrangement and dynamics in 
endocytosis, phagocytosis and immunological synapse formation. We focus on identifying key 
areas in organellar trafficking where super-resolution microscopy is a required approach for 
addressing long-standing questions.
In chapter 3 we addressed the role of the understudied and short-lived PI(3,4)P2 in antigen uptake
via phagocytosis by DCs. Initial quantitative mass-spectrometry data on phosphoinositide-
binding proteins published in [99] identified SWAP70 as a potential interaction partner of PI(3,4)P2. 
We confirmed with imaging experiments that SWAP70 is a strong binder to PI(3,4)P2 in phagocytic 
cups during early stages of phagocytosis. SWAP70 was not found in other F-actin-dense 
structures such as podosomes, confirming previous observations [100]. 3D super-resolution STED 
imaging revealed that SWAP70 aligns along parallel arches or rings of F-actin filaments together 
with the Rac1 GTPase at the phagocytic cup. Mutational analysis and knock-down of SWAP70 
or pharmacologically-induced perturbation of PI(3,4)P2 production in human moDCs revealed a 
key role for SWAP70 in Rac1 activation, F-actin formation and phagocytosis. Thus, we identified a 
novel PI(3,4)P2 binder which as an adaptor for F-actin tethering on the phagosome during a short 
time frame of phagocytic cup formation necessary for successful antigen uptake. 
In chapter 4 we extended our conclusions about the role of SWAP70, testing it not only in human
monocyte-derived DCs, but also in other DC subsets such as pDCs and mDCs. We also confirmed 
the universal role of SWAP70 in phagocytosis in mouse bone-marrow derived DCs (BMDCs) 
subsets generated with FLT3 and GM-CSF and in the mouse macrophage cell line RAW264.7. 
We present additional data demonstrating the role of SWAP70 in controlling F-actin at the 
phagosome, but not at the immunological synapse where DCs come in contact with T-cells [101]. 
We further validated the role of SWAP70 by inhibiting its function with the small molecule inhibitor 
sanguinarine, strengthening our findings observed with SWAP70 knock-down and mutational 
analysis in chapter 3. Additionally, we observed that active SWAP70 does not only sustain F-actin 
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formation, but also blocks activation of the F-actin severing factor cofilin.
In chapter 5 we looked into later maturation events of phagosome transitioning from early to late 
phagosomes and we addressed the role of the phosphoinositide kinase PIKfyve in this process 
PIKfyve is the only kinase in the cell capable of producing PI(3,5)P2. This is another understudied 
phosphoinositide species which is crucial for converting late phagosomes into phagolysosomes 
characterized by low pH and elevated protease activity such as cathepsins. We showed that 
pharmacological inhibition of PIKfyve resulted in blockage of phagosomal maturation and led to 
the prolonged presence and elevated activity of NOX2. This was accompanied by higher levels 
of ROS which resulted in reduced activity of cystein cathepsins. We investigated how blockage 
of PIKfyve and lower levels of cathepsin activity affect antigen degradation and presentation at 
MHC class II. Additionally, we developed an alternative bio-orthogonal MHC class II presentation 
assay to trace viral hemagglutinin presentation within MHCII directly at the DC surface. Our 
experiments reveal an important role of PIKfyve in antigen degradation within phago/endo-
lysosomes leading to antigen presentation within MCH class II triggering adaptive immunity.
In chapter 6 we identified a novel role of podosomes in antigen uptake. Podosomes are found 
in different cell types and are well-understood to perform mechanosensitive functions for 
guiding cell migration through the extracellular matrix and endo/epithelial barriers. Our study 
was inspired by observations that the dense cores of podosomes can form protrusive structures 
when encountering soft spots on substrates [80], raising the possibility of a potential role in 
antigen sampling. Indeed, our experiments revealed that DCs can utilize these podosome-
derived protrusions for receptor-mediated endocytosis and thereby sample for antigens across 
extracellular matrix, trans-epithelial and trans-endothelial membranes.
In a short study presented in chapter 7, we further strengthen the protrusive nature of podosomes,
and demonstrate the presence of various endocytic and exocytic markers at protrusive 
podosomes.
Finally, in chapter 8 we discuss our results and relate our observations to currently available data 
in the literature. We discuss possible new directions in phosphoinositide research with a focus 
on the possible applications of super-resolution microscopy and novel biorthogonal labeling 
techniques. Finally, findings outlined in this thesis are summarized in an overview figure allowing 
us to trace the unique and complex mechanisms of antigen uptake and processing by antigen-
presenting cells before presentation to T-cells. These fundamental discoveries allow a further 
understanding of what routes of phosphoinositide metabolism are crucial for endo/phagocytic 
functions of DCs and might provide a mechanistic explanation for the findings from several 
clinical trials that inhibitors of phosphoinositide-related proteins such as apilimod or YM201636 
have an overall toxic effect.
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Abstract
Since their invention about two decades ago, super-resolution microscopes have become a 
method of choice in cell biology. Owing to a spatial resolution below 50 nm, smaller than the size 
of most organelles, and an order of magnitude better than the diffraction limit of conventional 
light microscopes, super-resolution microscopy is a powerful technique for resolving intracellular 
trafficking. In this review we discuss discoveries in endocytosis and phagocytosis that have 
been made possible by super-resolution microscopy – from uptake at the plasma membrane, 
endocytic coat formation, and cytoskeletal rearrangements to endosomal maturation. The 
detailed visualization of the diverse molecular assemblies that mediate endocytic uptake will 
provide a better understanding of how cells ingest extracellular material.
Highlights
• Super-resolution microscopy is widely available to most cell biologists and has become the 
method of choice for studying endocytic and phagocytic trafficking. 
• Current live imaging techniques allow 3D super-resolution microscopy with a temporal 
resolution of seconds to visualize uptake and trafficking processes at the whole-cell level. 
• Quantification strategies combined with super-resolution microscopy have enabled a 
quantitative understanding of receptor clustering, the appearance of signaling lipids, and 
the dynamics of F-actin assembly on endosomes and phagosomes.
• Super-resolution microscopy is often combined with techniques such as electron microscopy 
and TIRF to enable more accurate localization of endocytic proteins in relation to stage of 
uptake, membrane curvature, and protein–protein interactions.
• Although generally of lower spatial resolution compared with other super-resolution 
microscopy techniques, structured illumination microscopy has at present yielded most 
new insights in endocytic trafficking because it combines improved spatial resolution 
with a reasonably high temporal resolution and can be readily used for live cell imaging 
applications.
Outstanding Questions
• How are receptors organized in the membranes of organelles to facilitate sorting of cargo and 
trafficking proteins for different intracellular destinations?
• What is the precise role of the F-actin cytoskeleton for different types of endocytosis?
• What is the role of calcium for membrane fusion and fission in organellar trafficking? How is 
membrane fusion and fission coupled in organellar trafficking?
• How do membranes bend in endocytosis and organellar trafficking processes that do not 
involve known cage proteins?
• How do lipid turnover and transfer at membrane contact sites between endosomes, the ER, 
and the plasma membrane contribute to endosomal maturation?
• Nearly three-quarters of the 70 members of the Rab family in humans are involved in 
endocytic trafficking, and they play a role in endosomal maturation, coordination of vesicle 
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budding and fusion, effector recruitment, and coordination of endosomal signaling. What are 
their precise localizations, interactions, and stoichiometries?
Early Visualization of the Cellular Trafficking System
The mystery of how cells organize endocytic trafficking system has been extensively studied 
[1–4]. Endocytosis and phagocytosis (reviewed in [5]) are evolutionarily conserved mechanisms 
of internalization of solutes or small particles (endocytosis) or large particles sized above ~0.5 
μm (phagocytosis). Insight into endocytic and phagocytic trafficking provides understanding 
of disease mechanisms because they are essential for many physiological processes, including 
nutrient uptake, immune clearance of pathogens, and the removal of apoptotic cells [3]. They 
are highly dynamic processes that begin with clustering of specialized membrane receptors at 
the site of uptake [6], followed by the assembly of coat proteins such as clathrin (endocytosis) 
or the engulfment of a particle by rapid actin rearrangements into protrusive pseudopodia 
(phagocytosis). Alternatively, many receptors are captured by pre-existing clathrin sites, thereby 
facilitating their uptake. Endocytosis and phagocytosis are orchestrated by the membrane 
composition, coat proteins, the F-actin (see Glossary) cytoskeleton, and membrane fission 
proteins such as dynamin [7]. After their formation, endosomes and phagosomes undergo a 
mechanistically similar maturation process in which they are transported via microtubules to the 
microtubule organizing center (MTOC) and gradually convert into late endo/phagosomes and 
finally into lysosomes [8]. 
Our current understanding of the nanoscale organization and morphology of endosomes and 
phagosomes stems mainly from electron microscopy (EM). From this technique, we know that 
cells are very crowded, containing organelles of sizes ranging from tens of nanometers for small 
trafficking vesicles to up to several micrometers for the nucleus and large phagosomes (Figure 
1A). Moreover, many organelles have a highly complex and dynamic morphology, such as the 
heterogeneous network of recycling endosomes. However, EM can only be used on fixed or frozen 
material and cannot follow dynamic processes in living cells, making this technique unsuitable for 
research questions related to dynamic alterations and stoichiometries of molecular assemblies. 
Live cell imaging is feasible with optical microscopy, but, owing to their small size, individual 
organelles are often impossible to resolve with conventional optical microscopy. Starting about 
two decades ago, the development of super-resolution microscopy techniques, including 
stimulated emission depletion (STED) (Figure 1B), single-molecule localization microscopy (SMLM), 
structured illumination microscopy (SIM), and lattice light sheet microscopy (LLSM), is helping to 
overcome this problem (Box 1 for more information on each super-resolution technique) [9–16]. 
It is therefore no surprise that these techniques have provided crucial information on trafficking, 
particularly on exocytosis in neurons, neuroendocrine cells, and immune cells [14,17,18]. This 
review aims to provide an overview of the breakthrough discoveries that have been enabled by 
super-resolution microscopy specifically in endocytosis and phagocytosis.
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Organization of Endocytic Receptors at the Plasma Membrane
The clustering of endocytic receptors in distinct regions of the plasma membrane allows the 
localized uptake of material. SIM microscopy revealed that receptor-mediated caveolar and 
clathrincoated vesicular uptake and nonspecific endocytosis occur at separate locations on 
the plasma membrane [19–21]. The spatial clustering and segregation of these different forms 
of endocytosis likely enable more efficient uptake and might facilitate the differential sorting 
of cargoes into different types of endosomes. In addition, receptor clustering can promote 
downstream signaling, for instance by oligomerization of kinase domains. Indeed, a SIM 
microscopy study in human macrophages showed that the Fc receptor FcγRIIA must diffuse 
laterally to become activated upon clustering by multivalent targets [22]. SMLM revealed that 
such clusters are approximately ~70 nm in size and contain ~100 Fc receptors [23], and that they 
locate adjacent to clusters enriched in the inhibitor of phagocytosis signal regulatory protein α 
(SIRPα) [24]. SMLM microscopy revealed that two other endocytic receptors, DC-SIGN and the 
mannose receptor CD206, both organize in similarly ~80 nm sized domains which, upon binding 
to fungal pathogens, merge into larger disc-shaped clusters of 150–175 nm in diameter, and this 
facilitates the ingestion of the pathogen [25–28] (Box 2). Toll-like receptor 4 (TLR4) is also present 
in nanodomains of 60–80 nm in size, and it was demonstrated by SMLM that its oligomeric state 
is controlled by its ligand endotoxin and its coreceptors MD2 and CD14 [29,30]. Finally, a SMLM 
study of endocytic cargo revealed that the vesicular acetylcholine transporter rapidly diffuses 
over the membrane until it is trapped for uptake by a membrane structure that contains clathrin 
and its adapter protein AP2 [31].
Role of Lipids in Receptor Clustering
The combination of SMLM and total internal reflection fluorescence (TIRF) microscopy 
enables the tracking of single molecules in time, and revealed that membrane clustering of 
glycosylphosphatidylinositol (GPI)-anchored receptors in the outer leaflet of the plasma membrane 
is promoted by transmembrane coupling to the long acyl-chain lipid phosphatidylserine in the 
inner leaflet [32,33]. Phosphatidylserine directly interacts with F-actin adaptors and thereby 
anchors the outer-leaflet receptors to the cortical actin cytoskeleton [32,33]. Several other 
lipid species can also contribute to receptor clustering. First, cholesterol-mediated lipid phase 
separation is involved in clustering of GPI-anchored proteins [33,34]. Second, domains with 
lactosylceramide (LacCer), a glycosphingolipid present in immune phagocytes that contributes 
to integrin-mediated phagocytosis, are separated from domains containing another abundant 
phosphatidylglucoside (PtdGlc) [35]. Finally, domain formation of the WNT receptor LNP6, clathrin, 
and its adaptor AP2 depend on coclustering with phosphatidylinositol 4,5-bisphosphate [PI(4,5)
P2] lipids [36]. Such clustering of phosphoinositides in membrane domains has been reported for 
several species. For instance, a SMLM study revealed that phosphatidylinositol 4-phosphate (PI4P), 
phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] and phosphatidylinositol 3,4,5-triphosphate 
[PI(3,4,5)P3] are all present in domains of about 350–400 nm diameter in the plasma membrane of 
insulin-secreting INS-1 cells [37]. Membrane domains of phosphoinositides can be highly specific 
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because plasma membrane domains containing PI(4,5)P2 can segregate from domains enriched 
in PI(3,4,5)P3 [38].
The lateral diffusion of uptake receptors can be obstructed by transmembrane proteins (so-called 
pickets), such as CD45 [22,39], that are immobilized by interactions with the cortical cytoskeleton. 
STED microscopy showed that the extracellular domain of CD45 can bind to hyaluronic acid 
which forms a pericellular coat and, together with the actin cytoskeleton, limits the mobility of 
phagocytic Fc receptors [22,39]. Such remodeling of the actin fence is necessary to enable Fc 
receptor clustering and the initiation of phagocytosis [22,39]. Remodeling of cortical actin is also 
essential for some forms of endocytosis [7] because a SIM study showed that actin rearrangements 
at the mammalian growth cone of neuronal axons by the F-actin bundling protein fascin are 
essential for endophilin-mediated endocytosis but not for clathrin-mediated endocytosis [20]. 
Thus, the clustering of endocytic receptors results from the interactions with various lipid species, 
the cortical cytoskeleton, and pericellular glycosylation. In this respect, it is similar to the clustering 
of proteins involved in exocytosis in distinct domains of the plasma membrane, particularly soluble 
The lateral diffusion of uptake receptors can be obstructed by transmembrane proteins (so-called
pickets), such as CD45 [22,39], that are immobilized by interactions with the cortical cytoskele-
ton. STED microscopy showed that the extracellular domain of CD45 can bind to hyaluronic
acid which forms a pericellular coat and, together with the actin cytoskeleton, limits the mobility
Glossary
BAR domain: named after three
proteins that contain this domain – bin/
amphiphysin/rvs. BAR domains facilitate
membrane curvature and/or bind to
curved membranes.
Correlative light-electron
microscopy (CLEM): overlapping
ﬂuorescence and electron microscopy
images of the same specimen.
Electron microscopy (EM): a
microscopy technique that uses electron
beams of much shorter wavelength than
visible light, allowing the ultrastructure of
frozen or chemically ﬁxed samples to be
resolved.
F-actin: ﬁlamentous actin, a
component of the cytoskeleton.
Fluorescence resonance energy
transfer (FRET): enables the detection
of small changes (nm) in distance
between two ﬂuorophores.
Glycosylphosphatidylinositol (GPI):
a glycolipid that can be post-
translationally coupled to the C-terminus
of proteins.
HaloTag: 33 kDa tag derived from the
bacterial enzyme haloalkane
dehalogenase that can bind ﬂuorescent
dyes via a ﬂuochloroalkane linker.
IgG: immunoglobulin G, a type of
antibody that can be ﬂuorescently
labeled, allowing the location of speciﬁc
proteins to be visualized.
Microtubule organizing center
(MTOC): a cellular structure from which
microtubules emerge.
Soluble N-ethylmaleimide-sensitive
factor (NSF) attachment protein
receptor (SNARE): a family of proteins
that facilitate intracellular vesicle docking
and fusion.
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Figure 1. The Advantage of High Spatial Resolution for Resolving Cellular Structures. (A) Human blood
monocyte-derived dendritic cell ultrastructure revealed by transmission electron microscopy (EM). Indicated are the
approximate diffraction limited spatial resolution (~200 nm lateral, x/y; and 1000 nm axial, z) and an example of the
50 nm spatial resolution attainable by super-resolution microscopy. (B) Maximum intensity z-projection and orthogonal
view of confocal, 2D stimulated emission depletion (STED), and 3D STED microscopy of dendritic cells with microtubules
stained with silicon rhodamine (SiR) tubulin [114]. Cross-sections of different colors correspond to intensity proﬁles. Image
courtesy of Alf Honigmann (Max Planck Institute for Cell Biology and Genetics, Dresden, Germany).
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N-ethylmaleimide-sensitive factor (NSF) attachment protein receptors (SNAREs) (reviewed in 
[17]). In the future, the increasing number of colors that can be simultaneously resolved by super-
resolution microscopy [40] will facilitate the characterization of the different types of membrane 
domains enriched in endocytic and phagocytic receptors. A largely unexplored question is 
how receptors are precisely organized in intracellular membranes of organelles such as early 
endosomes, where STED revealed cholesterol-dependent clustering of SNARE proteins [41].
Endocytosis
Clathrin Coat Formation
Many super-resolution microscopy studies have aimed to resolve the localization, shape, and 
time-dependent localization of clathrin and clathrin-associated proteins (Figure 2) [42–44]. For 
instance, SMLM in combination with TIRF was used to visualize the different topologies of curved 
clathrin-coated pits and flat clathrin plaques [44]. SIM microscopy revealed that mature clathrin-
coated pits assemble as rings of about ~100 nm in diameter that persist for seconds to minutes 
and are associated with the actin cytoskeleton [45]. Two correlative light-electron microscopy 
(CLEM) studies mapped the arrangement of multiple endocytic proteins during various assembly 
stages of the clathrin coat, and showed that many proteins are primarily located near the edge 
(e.g., FCHO1/2, Eps15, dynamin) or the center (epsin, CALM, receptor cargo) of the clathrin 
lattice (Figure 2) [46,47]. Pulse-chase approaches in yeast and mammalian cells also allowed 
the localization of endocytic proteins to be resolved during various stages of endocytosis, and 
revealed that the actin-recruiting protein N-WASP is organized radially in a ring-like pattern during 
the early stages of clathrin pit formation, and that interactions between the clathrin coat, N-BAR 
proteins, and phosphoinositides orchestrate F-actin positioning at the endocytic site (Figure 2) 
[48–51]. Nevertheless, the role of actin in clathrin-mediated endocytosis remains controversial. 
Although actin might only be necessary to limit the lateral movement of endocytic vesicles in 
yeast [48], F-actin is already present at the base of the forming clathrin-coated vesicle [49,51], and 
an F-actin peak can be observed following dynamin recruitment [7,52], arguing for a function 
in vesicle internalization. Accordingly, a high-throughput super-resolution SMLM study in yeast 
showed that WASP family proteins form a ring-shaped pattern on membranes for future F-actin 
nucleation, and that this drives membrane invagination [51]. The latter seems to be also the case 
in mammalian cells because a SIM microscopy study in murine fibroblasts showed that actin can 
accelerate endocytosis and that clathrin-coated pit internalization is aided by actin filaments in 
about half of the cases [45]. A combination of TIRF and CLEM was used to visualize how clathrin 
coat assembly produces membrane curvature, which is the rate-limiting step for vesicle formation 
(Figure 2) [47]. It was found that clathrin coat assembly is versatile and accommodates membrane 
bending concurrently with or after the assembly of the clathrin lattice, and this bendingmay be 
regulated by axillary proteins such as CALM [47].
The process following vesicle fission and shedding of the clathrin coat has been addressed by 
SMLM, where it was found in yeast that the levels of phosphatidylinositol 3-phosphate (PI3P) at 
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internalized endocytic vesicles increased 100-fold after clathrin coat shedding [53]. The yeast 
homolog of the early endosomal GTPase Rab5 (Vps21p) located to smaller endosomes (~80 nm-
sized) at the initial stages of PI3P production, whereas the homolog of late endosomal Rab7 
(Ypt7p) bound to larger endosomes (~170 nm) with more saturated PI3P levels [53]. Despite 
this increase in PI3P levels following endocytosis and during endosomal maturation, PI3P may 
already play a role during the uptake itself and in recruitment of endocytic cargo. SMLM on 
cultured mouse cortical neurons showed that the PI3 kinases ATM and ATR play a role in synaptic 
vesicle recycling and colocalize with the clathrin adaptor protein AP2, with ATR being recruited 
to nascent inhibitory (VGAT+) and ATM to excitatory (VGLUT+) vesicles [54]. Moreover, LLSM in 
SUM159 breast cancer cells expressing probes that bind clathrin and phosphoinositides revealed 
a new cascade of phosphoinositide lipids after fission of clathrin-coated vesicles. A pool of PI3P 
was already present before phosphatidylinositol (3,4)-bisphosphate (PI(3,4)P2) and Rab5, and this 
pool was distinct from the PI3P pool of early endosomes [55].
^ Fig. 2: Coupling Membrane Curvature to Nanoscale Localization of Endocytic Proteins. (Upper panel) Electron microscopy 
(EM) [46,47], atomic force microscopy (AFM) [47], or polarized total internal reflection fluorescence microscopy (pol-TIRF) 
[47] have been used to determine the curvature of endocytic membranes. (Lower panel) Super-resolution imaging using 
stimulated emission depletion (STED) [50], structured illumination microscopy (SIM) [46,50], or single-molecule localization 
microscopy (SMLM) [43,44,46] can be coupled to the membrane curvatures determined with the methods from the upper 
panel. This allowed the positions of endocytic proteins (EPS, CALM, BAR-proteins, dynamin, F-actin) to be mapped during 
various stages of endocytosis [46,47,50].
Caveolin Coat Formation
Super-resolution microscopy has also allowed new insights into another endocytic coat: caveolin. 
Although the structural organization of caveolar structures was already well understood from 
EM [56,57], super-resolution studies offered the possibility to image caveolae under various 
physiological challenges. For instance, SMLM revealed that caveolae under osmotic stress flatten 
and increase by ~30% in volume [58]. Although SIM and SMLM showed that caveolin oligomers 
vesicles [54]. Moreover, LLSM in SUM159 breast cancer cells expressing probes that bind
clathrin and phosphoinositides revealed a new cascade of phosphoinositide lipids after ﬁssion
of clathrin-coated vesicles. A pool of PI3P was already present before phosphatidylinositol
(3,4)-bisphosphate (PI(3,4)P2) nd Rab5, and this pool was distinct from the PI3P pool of arly
endosomes [55].
Caveolin Coat Formation
Super-resolutionmicroscopy has also allowed new insights into another endocytic coat: caveolin.
Although the structural organization of caveolar structures was already well understood from EM
[56,57], super-resolution studies offered the possibility to image caveolae under various physio-
logical challenges. For instance, SMLM revealed that caveolae under osmotic stress ﬂatten and
increase by ~30% in volume [58]. Although SIM and SMLM showed that caveolin oligomers
can assemble in structures with different shapes (~60–80 nm diameter) [59], individual caveolae
might be able to cluster in much larger (~300 nm) ribbon-like assemblies [45]. The shape and size
of these caveolar structures depend on the isoform of caveolin because ﬂask-shaped invaginat-
ing caveola are fourfold more densely packed with caveolin-1 than are ﬂat caveola, and the den-
sity of caveolin-1 is sensitive to osmotic tensions [60]. Super-resolution microscopy also revealed
signaling-mediated receptor rearrangements at caveolae, as shown by SIM for the purinergic
receptor P2X7R in osteoblasts [61], by CLEM and STED for the Ca2+ release channel ryanodine
receptor at the sarcoplasmic reticulum in muscles [62,63], and by STED for the inward rectiﬁer
potassium channel Kir2.1 in human cardiac ventricles [64].
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Figure 2. Coupling Membrane Curvature to Nanoscale Localization of Endocytic Proteins. (Upper panel) Electron
microscopy (EM) [46,47], atomic force microscopy (AFM) [47], or polarized total internal reﬂection ﬂuorescence icroscopy
(pol-TIRF) [47] have be n used to determine the curvature of endocytic membranes. (Lower panel) uper-resolution imaging
using stimulated emission depletion (STED) [50], structured illumination microscopy (SIM) [46,50], or single-molecule
localization microscopy (SMLM) [43,44,46] can be coupled to the membrane curvatures determined with the methods from
the upper panel. This allowed the positions of endocytic proteins (EPS, CALM, BAR-proteins, dynamin, F-actin) to be
mapped during various stages f endocytosis [46,47,50].
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can assemble in structures with different shapes (~60–80 nm diameter) [59], individual caveolae 
might be able to cluster in much larger (~300 nm) ribbon-like assemblies [45]. The shape and size 
of these caveolar structures depend on the isoform of caveolin because flask-shaped invaginating 
caveola are fourfold more densely packed with caveolin-1 than are flat caveola, and the density 
of caveolin-1 is sensitive to osmotic tensions [60]. Super-resolution microscopy also revealed 
signaling-mediated receptor rearrangements at caveolae, as shown by SIM for the purinergic 
receptor P2X7R in osteoblasts [61], by CLEM and STED for the Ca2+ release channel ryanodine 
receptor at the sarcoplasmic reticulum in muscles [62,63], and by STED for the inward rectifier 
potassium channel Kir2.1 in human cardiac ventricles [64].
Noncanonical Endocytosis
Endocytosis can also occur in unconventional pathways that do not depend on clathrin 
and caveolin. Endophilins are members of the BAR domain superfamily and are involved in 
noncanonical endocytosis in neuronal [20] and nonneuronal cells [65]. In the axon growth tips 
(cones) of neurons, SMLM revealed a novel form of clathrin-independent endocytosis that relies 
on endophilin-3 and dynamin-1, and that correlates with fascin-1-dependent F-actin bundling at 
the endocytic sites, and F-actin was required for retrograde trafficking of the presynaptic proteins 
VAMP2, SCAMP1, SV2, and synaptophysin [20]. Endophilins-A1 and A2 interact with several 
endocytic proteins, including dynamin, synaptojanin, and lamellipodin, and also with endocytic 
cargo proteins via their N-BAR or SH3 domains, leading to uptake of G protein-coupled protein 
receptors, receptor tyrosine kinases, and the interleukin-2 receptor [65]. Moreover, SIM revealed 
that endophilin-A2 reshapes membranes and, together with F-actin and dynamin, contributes to 
membrane scission during clathrin-independent uptake of Shiga and cholera toxins [66].
Endocytosis can be coupled to exocytosis, and this enables the rapid recycling of exocytic 
trafficking proteins and cellular homeostasis. STED revealed that hemifused intermediates (in 
which the membrane outer leaflet, but not the inner leaflet, is fused) and sometimes fully fused 
vesicles are able to fluctuate back to the fully separated or hemifused state [67]. This reversible 
transition likely resulted from a competition between membrane fusion and Ca2+/dynamin 
dependent membrane fission [67]. Other studies provided evidence for a role for dynamin in 
this coupling of endocytosis with exocytosis. By SIM, it was shown that dynamin controls fusion 
pore kinetics, promoting closure of the fusion pore, vesicle detachment from the plasmalemma, 
and internalization [68]. STED microscopy showed that dynamin in conjunction with the F-actin 
cytoskeleton led to the formation of transient fusion pores with sizes ranging up to 490 nm [69], 
much larger than was previously thought (<5 nm) [70,71].
Multivesicular Body Formation
Early endosomes mature to form multivesicular bodies where the membrane is bulged into 
the lumen of the endosomes by the endosomal sorting complex required for transport (ESCRT) 
complex. This results in the formation of intraluminal vesicles which play a role in the degradation 
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of integral membrane proteins [72]. By LLSM, it was shown that ESCRT-III subunits polymerize 
rapidly on yeast endosomes, together with the recruitment of at least two hexamers of the AAA 
ATPase Vps4 [73]. Intraluminal vesicle formation depended on ATPase activity of Vps4 and was 
associated with a continuous and stochastic exchange of Vps4 and ESCRT-III components [73].
Phagocytosis
After a cell encounters a particle, a phagocytic synapse is established by formation of F-actin 
rich filopodia-like extensions from the membrane which engulf the particle [4]. This structure 
is called the phagocytic cup and creates a physical barrier for organizing the signaling cascade 
induced by target binding [22]. Arp2/3 complex-mediated F-actin nucleation and branching 
at the nascent phagosome is triggered by the GTPases Rac1, Rac2, and Cdc42, although the 
contribution of this actin remodeling depends on the type of phagocytosis. In case of Fc receptor-
mediated phagocytosis, but not for complement C3bi receptor-mediated phagocytosis, a super-
resolution microscopy study showed that branching of F-actin within lamellipodia depends 
on Arp2/3 [74]. By SIM on macrophages derived from Cdc42 knockout mice, it was shown that 
Cdc42 is dispensable for the formation of filopodia (finger-like protrusions) upon uptake of yeast 
particles, but is necessary for the subsequent formation of lamellipodia (the F-actin meshwork at 
the leading edge of a migrating cell) with parallel actin bundles during cell spreading [75]. 
STED microscopy was used to resolve the organization of Rac1 and actin during phagocytosis of 
yeast cells by dendritic cells [76]. It was found that F-actin, Rac1, and their binding protein SWAP70 
align in parallel arches and sometimes in concentric rings on the surface of phagosomes [76]. In 
this case SWAP70 acted as an adapter, tethering the F-actin cytoskeleton to the phagocytic surface 
by interacting with Rac1 and phosphatidylinositol (3,4)-bisphosphate. Although structures such 
as actin rings or radial actin bundles for parasite internalization into host cells can already be 
visible by conventional confocal microscopy [77], the increased resolution of SMLM allowed the 
organization of such structures to be resolved and addressed the bundling of actin filaments, 
such as for the more accurate measurements of the dimensions of the 100 nm-sized F-actin ring 
during Salmonella typhimurium phagocytosis [78]. Although the nature of these actin rings is 
still unknown, they could be mediated by septins [79]. Septins control receptor and phospholipid 
dynamics and can form ring-like structures by bundling actin via anillin and myosin binding at the 
site of pathogen invasion in mammalian cells [79], structures that are reminiscent of the structures 
observed during phagocytosis [76]. Moreover, SMLM revealed that septins can form cables with 
a thickness of 20−30 nm in complex with Cdc42 and Gic1 in vitro [80]. However, in cells, high-
resolution microscopy data on septin collars are only available for prokaryotes and budding yeast, 
where septins are involved in cell division and budding [80], and it would be interesting to resolve 
potential septin rings in phagocytosing cells by super-resolution microscopy.
Future Technical Improvements Needed
Super-resolution microscopy has led to important new insights in endocytic trafficking, but some 
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technical improvements are highly desirable.
Improving Spatial Resolution
Most of the current super-resolution microscopy techniques that are widely used by biologists 
offer a spatial resolution between 20–60 nm lateral and about 100 nm axial, but this axial 
resolution is still too low to resolve complex organelle morphologies and individual endosomes. 
Isotropic imaging, with identical resolution in all dimensions, would be beneficial because it allows 
the shape and localization of 3D cellular structures to be resolved. To address this problem, new 
microscopy developments are increasingly improving the spatial resolution, such as MINFLUX 
that allows 1 nm lateral and axial resolution in live cells [81]. However, at such high microscope 
resolutions the size of the fluorescent probes becomes the limiting factor (Figure 3). Antibodies 
are several nm in size, and, although this has a negligible influence in conventional optical 
microscopy, it is becoming a major problem in super-resolution microscopy because it limits the 
spatial resolution (Figure 3) [82]. The same holds true for the ~3 nm-sized fluorescent proteins and 
protein tags that can specifically bind to organic fluorophores (e.g., HaloTag [11]). Nanobodies, that 
contain only a single antigen-binding fragment, may provide a partial solution to this problem 
because they are about twofold smaller than a full-size antibody, and the creation of a library of 
nanobodies with high specificities for mouse and rabbit IgGs is an important development [83]. 
Alternative approaches to replace the large fluorescent proteins are fluorescent non-natural amino 
acids (reviewed in [21,84,85]). The need for smaller probes has become evident in super-resolution 
imaging studies showing that the glutamate receptor AMPAR clusters in dynamic and transient 
membrane domains, instead of in the more stable domains previously observed by antibody-
based labeling [86–88]. However, even organic fluorophores have a minimum physical size limit 
and likely cannot be made much smaller, particularly for the conjugated ring systems needed for 
red fluorescent dyes. Therefore, in the long run, the size of the fluorophores will become limiting 
for the spatial resolution of fluorescence microscopy, and other (nonfluorescent) methods would 
need to be developed to reach even higher spatial resolutions.
Improving Spectral Resolution
Most current super-resolution microscopy techniques have typically only two colors that can 
be discerned simultaneously. One of the reasons for this is that, in SMLM and STED, one channel 
often requires more than one spectral input – the first for image acquisition and the second for 
fluorophore switching (localization techniques in SMLM) or because of the doughnut shape of 
the emission depletion beam (STED). However, resolving the nanostructure of complex molecular 
assemblies, such as protein complexes or organelles, requires more colors. Moreover, multiple 
colors would allow functional probes in super-resolution microscopy, such as ratiometric pH 
probes [89] or fluorescence resonance energy transfer (FRET) sensors for GTPases [90]. Three- and 
four-color STED microscopes have been developed, based on adjustable laser intensities [40] and 
spectral unmixing of fluorescence emission wavelengths and lifetimes [91]. SMLM can also be 
performed with multiple colors, for instance by careful selection of dyes and excitation schemes 
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[92] or by sequential exchange of antibodies or probes [93,94]. These new techniques will be 
important for the endocytic trafficking field because they will, for instance, enable the different 
types of early, recycling, and late endosomes and lysosomes to be resolved.
^ Fig. 3: Spatial Scale of Phagosomes, Clathrin-Coated Vesicles, Coat Proteins, Uptake Receptors, and Probes Commonly 
Used in Fluorescence Super-Resolution Microscopy (SRM). All molecules and models are displayed to scale. Structures are 
from the Protein Data Bank (PDB): 1xi4, 3zys, 6d8c, 3j2u, 1igt, 3mkq, 1fdl, 3ogo, 5dty, 3kzy, 3s05, 2cl8, 3wjj, 3vq2, 1a1o, 3qxa. 
For comparison, the diffraction-limited point spread function of confocal microscopy (blue mesh) and an example of the 
50 nm resolution attainable by SRM (blue ball) are shown. Abbreviations: B. taurus, Bos taurus; D. melanogaster, Drosophila 
melanogaster; G. gallus, Gallus gallus; H. sapiens, Homo sapiens; M. musculus, Mus musculus; S. cerevisiae, Saccharomyces 
cerevisiae.
Improving Temporal Resolution
The low speed of image acquisition is a third limitation of current super-resolution techniques 
because this precludes the visualization of endo/phagosomal maturation and cytoskeletal 
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transport (Figure 4). One issue that is apparent from this review is that most of the results discussed 
here have been obtained with SIM, even though this technique generally has a lower spatial 
resolution than either SMLM or STED. Indeed, SIM offers the advantage that it combines improved 
spatial resolution with a reasonably high temporal resolution (seconds), and thereby allows the 
dynamics of spatiotemporal recruitments, stoichiometries, and interactions between proteins 
and organelles to be resolved. SMLM and STED are intrinsically slow techniques because SMLM 
requires the acquisition of many (thousands) of images, and laser scanning in STED requires a very 
small pixel step to attain high spatial resolution. SIM is faster, but still requires the acquisition of 
multiple optical planes, and the spatial resolution of this technique is typically relatively modest 
compared with STED and SMLM. LLSM combines fast imaging with a high lateral and axial spatial 
resolution, has the additional advantage of low light exposure [10], and enables imaging of up 
to six colors [95], but this approach is not yet broadly available. For events at the proximity of 
the microscopy coverslip, SIM can be combined with TIRF, thereby enabling both high spatial 
and temporal resolution [45]. Very recently, deconvolution approaches in combination with low 
photon dose and submillisecond exposure times have been developed to improve applications 
of SIM in live cell imaging [96]. Many other developments in super-resolution microscopy also aim 
to increase the speed of image acquisition, and live cell SMLM is possible now with ~10 s temporal 
resolution [97], for instance by ‘moving-window binning’ [98,99]. In SMLM, improved optics, more 
sensitive and faster cameras, and improved image processing algorithms [96] allow not only faster 
acquisition of individual frames but also higher labeling densities, reducing the number of frames 
necessary to compute a high-resolution image in SMLM [100]. There also are ongoing technological 
developments in STED, where the image acquisition rate was substantially improved by so-called 
parallelization, which involves scanning with optical lattices of the excitation and depletion beams 
[101]. All techniques will benefit from machine-learning approaches for image evaluation that 
allow improved resolution and prediction of structures [39,102]. These developments will allow 
fast events in endocytic trafficking to be resolved with not only high spatial but also temporal 
resolution [67–69].
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Figure 4. Temporal Resolution for Imaging of Intracellular Trafﬁcking. (A) Confocal live cell imaging showing
intracellular transport of phagosomes containing yeast particles. Individual phagosomes (labeled with stars) are
transported by microtubules from the cell periphery towards the cell center over minutes after uptake. Scale bar, 10 μm.
(B) Time-dependent conversion of signaling lipid phosphoinositides (PIP) during phagosomal maturation (data from [76]).
Time 0 is the time of phagosomal cup sealing (i.e., complete particle ingestion). Abbreviation: min, minutes; MTOC, microtubule
organizing center.
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microtubules from the cell periphery towards the cell center over minutes after uptake. Scale bar, 10 μm. (B) Time-
dependent conversion of signaling lipid phosphoinositides (PIP) during phagosomal maturation (data from [76]). Time 0 
is the time of phagosomal cup sealing (i.e., complete particle ingestion). Abbreviation: min, minutes; MTOC,microtubule 
organizing center.
Concluding Remarks
In conclusion, super-resolution microscopy techniques have enabled the visualization of endosomal 
structures with nanoscale resolution, allowing membrane curvature and stages of endosome and 
phagosome formation to be linked with protein and lipid contents. There are still longstanding 
questions that will be addressable by these new techniques (see Outstanding Questions). Ongoing 
technological developments in super-resolution microscopy will lead to further improved spatial, 
temporal, and spectral resolution, enabling more applications in endocytic trafficking. Given 
the central role of membrane trafficking in eukaryotic cells, this will not only allow fundamental 
longstanding questions in cell biology to be resolved but will also lead to new understanding of 
the development and progression of diseases.
Box 1. Super-Resolution Microscopy Techniques
Several super-resolution microscopy techniques are now available with spatial resolutions well 
below the diffraction limit of conventional light microscopy. Total internal reflection fluorescence 
(TIRF) microscopy uses the evanescent wave of reflected light at the interface between the 
microscope cover glass and the specimen for excitation of fluorophores that are within ~100 
nm distance of the cover glass. TIRF thereby has a high axial (z) resolution, whereas the lateral 
(x,y) resolution remains diffraction-limited. TIRF is often combined with other super-resolution 
microscopy techniques to achieve super-resolution in all dimensions. Stimulated emission 
depletion (STED) microscopy uses two laser beams of different wavelengths, one surrounding the 
other and creating a ‘donut’ [16]. The outer beam brings fluorescent molecules into a dark state of 
emission depletion, leaving only the fluorescent molecules in the center to actively emit photons, 
thereby effectively reducing the size of the excitation spot to below the diffraction limit. A second 
de-excitation pattern can be superimposed on the first ‘donut’ for combined lateral and axial 
super-resolution [103]. The family of single-molecule localization microscopy (SMLM) techniques 
uses a completely different approach and differentiates fluorophores using time [104]. The 
principle is to sequentially image frames with limited numbers of molecules and fit the intensity 
profiles of individual fluorophores. This allows the positions of these fluorophores to be obtained 
with localization accuracies better than the diffraction limit. By recording a large number of 
frames, positional information of numerous fluorophores can be combined to reconstruct a high-
resolution image. High 3D resolution can be obtained by deforming the point spread function 
with an asymmetric lens or a deformable mirror in the emission light path. SMLM includes a 
range of techniques differing in the types of fluorophores used and in the methods for visualizing 
individual fluorophores, but the best known are photoactivatable localization microscopy (PALM) 
and stochastic optical reconstruction microscopy (STORM). In structured illumination microscopy 
(SIM), super-resolution is obtained using an overlapping pattern of excitation beams, followed by 
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computational deconvolution. For lattice light sheet microscopy (LLSM), a planar illumination array 
is created by multiple beams with tightly controlled spacing oriented perpendicular to the optical 
light path of the emission [10]. This list is not complete, and there are other techniques for imaging 
below diffraction-limited resolution, for instance based on mathematical reconstruction [105,106]. 
Finally, fluorescence (super-resolution) microscopy can be combined with EM, which facilitates 
determination of the cellular localization of fluorescently labeled molecules by a technique called 
correlative light and electron microscopy (CLEM). Several recent reviews describe in detail the 
technical breakthroughs of super-resolution microscopy [9–12,16,107].
Box 2. Pathogen Entry
Several super-resolution microscopy studies have explored the nanostructures of the interactions 
of pathogens with host cells. SIM revealed that neutrophils prestore Zn2+ in lysosomes and 
azurophilic granules, and utilize Zn2+-toxicity for combating streptococcal infections [108]. Another 
SIM study on phagosomes formed in mouse macrophages in response to Candida albicans 
infection showed enriched SEC5 and inositol (1,4,5)-trisphosphate receptor (InsP3R) colocalization 
at phagosomes, and this enhanced phagocytosis and promoted antifungal signaling events [109]. 
Moreover, by SMLM, it was revealed how Salmonella enterica employs its virulence factors SifA 
and SseJ for endosomal tubule formation, and can thereby survive the acidic vacuoles of host cells 
[110]. It was found that SseJ hijacks the host motor protein kinesin for force-driven invasion along 
microtubules [110]. SMLM was also used to show that Salmonella typhimurium is surrounded by a 
heterogeneous coat of ubiquitin in the cytosol of host cells, with different densities of ubiquitination 
and of the E3 ubiquitin ligase [111]. Knockdown experiments of the host deubiquitinase OTULIN 
resulted in increased methionine-ubiquitin observable by SMLM microscopy, and this in turn 
promoted NF-κB signaling, leading to restriction of bacterial proliferation [111]. A SIM study also 
revealed nonhomogeneous methionine-linked ubiquitination at the surface of S. typhimurium, 
and reported a role for the ubiquitin ligase LUBAC in restricting bacterial proliferation through 
xenophagy and NF-κB activation [112]. Thus, super-resolution microscopy has made it possible to 
resolve how host ubiquitination limits the growth of S. typhimurium. By contrast, Shigella flexneri, 
another intracellular pathogen, expresses a protein called IpaH1.4 to negate the effect of LUBAC 
and promote its escape into the cytosol for survival [112]. Super-resolution microscopy has also 
revealed roles of ESCRT in assembly of viral particles, especially for HIV-1, as recently reviewed 
elsewhere [113].
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Glossary
• BAR domain: named after three proteins that contain this domain – bin/amphiphysin/rvs. BAR 
domains facilitate membrane curvature and/or bind to curved membranes.
• Correlative light-electron microscopy (CLEM): overlapping fluorescence and electron 
microscopy images of the same specimen. 
• Electron microscopy (EM): a microscopy technique that uses electron beams ofmuch shorter 
wavelength than visible light, allowing the ultrastructure of frozen or chemically fixed 
samples to be resolved. 
• F-actin: filamentous actin, a component of the cytoskeleton. 
• Fluorescence resonance energy transfer (FRET): enables the detection of small changes (nm) 
in distance between two fluorophores. 
• Glycosylphosphatidylinositol (GPI): a glycolipid that can be posttranslationally coupled to the 
C-terminus of proteins.
• HaloTag: 33 kDa tag derived from the bacterial enzyme haloalkane dehalogenase that can 
bind fluorescent dyes via a fluochloroalkane linker.
• IgG: immunoglobulin G, a type of antibody that can be fluorescently labeled, allowing the 
location of specific proteins to be visualized.
• Microtubule organizing center (MTOC): a cellular structure from which microtubules emerge.
• Soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein receptor (SNARE): a 
family of proteins that facilitate intracellular vesicle docking and fusion.
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Abstract
Actin plays a critical role during the early stages of pathogenic microbe internalization by immune 
cells. In this study, we identified a key mechanism of actin filament tethering and stabilization to the 
surface of phagosomes in human dendritic cells. We found that the actin-binding protein SWAP70 
is specifically recruited to nascent phagosomes by binding to the lipid phosphatidylinositol 
(3,4)-bisphosphate. Multicolor super-resolution stimulated emission depletion (STED) microscopy 
revealed that the actin cage surrounding early phagosomes is formed by multiple concentric 
rings containing SWAP70. SWAP70 co-localized with and stimulated activation of RAC1, a known 
activator of actin polymerization, on phagosomes. Genetic ablation of SWAP70 impaired actin 
polymerization around phagosomes and resulted in a phagocytic defect. These data show a key 
role for SWAP70 as a scaffold for tethering the peripheral actin cage to phagosomes.
Introduction
Phagocytosis is an evolutionarily conserved mechanism by which immune cells take up foreign 
particles for degradation, such as microbial pathogens and tumor cells. Phagocytosis, thereby, 
plays an essential role in the defense against disease. Actin executes a pivotal function in 
phagocytosis with its precise role depending on the stimuli and receptors involved (Freeman 
and Grinstein, 2014; May et al., 2000; Rohatgi et al., 2001; Swanson, 2008). F-actin-rich protrusions 
facilitate the initial capture of phagocytic targets. Actin is polymerized around the nascent 
phagosome forming a cage that helps wrapping of the membrane for particle engulfment and 
membrane fission. The actin cytoskeleton also exerts physical forces for pulling the pathogen 
inside the cell from the outside environment (May et al., 2000). Although the precise course of 
actin cytoskeleton assembly varies for different receptors (Allen and Aderem, 1996; Caron and 
Hall, 1998; Kuiper et al., 2008), actin polymerization is mediated by small GTPases of the RHO 
family: CDC42, RHOA, and RAC1 (Caron and Hall, 1998; May et al., 2000; Swanson, 2008). Within 
minutes after internalization, actin is depolymerized, a step that is required for the unhindered 
fusion of the maturing phagosome with endomembranes (Ferrari et al., 1999; Liebl and Griffiths, 
2009). The maturation process that succeeds phagosome formation can be accompanied by 
successive waves of actin polymerization and depolymerization, which can facilitate or impede 
additional fusion events with endolysosomal compartments (Anes et al., 2003; Greenberg et 
al., 1991; Kjeken et al., 2004; Yam and Theriot, 2004). Despite phagocytosis being a well-studied 
phenomenon, the molecular mechanisms for F-actin cage tethering to the phagocytic surface 
are not clear. The structure of the phagosomal actin cage has also not been resolved, as F-actin is 
densely packed around the phagosome, and there is a lack of high resolution data. 
In this study, we report that the actin cage in dendritic cells is connected to phagosomes by the 
69 kDa scaffolding protein SWAP70. SWAP70 is expressed in many cell types, including mast 
cells (Gross et al., 2002), fibroblasts (Shinohara et al., 2002), dendritic cells (Oberbanscheidt et al., 
2007), monocytes, and macrophages (Hilpela et al., 2003). In these cells, the absence of SWAP70 
leads to defects in actin polymerization and impairs cell migration, adhesion, polarization, and 
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morphology Bahaie et al., 2012; Chopin et al., 2010; Garbe et al., 2012; Murugan et al., 2008; 
Ocana-Morgner et al., 2011; Pearce et al., 2006; Ripich and Jessberger, 2011; Shinohara et al., 2002; 
Sivalenka and Jessberger, 2004). SWAP70 can directly bind, bundle, and stabilize actin filaments by 
means of its C-terminal actin binding domain (Chacon-Martınez et al., 2013; Gomez-Cambronero, 
2012; Hilpela et al., 2003; Ihara et al., 2006; Murugan et al., 2008; Pearce et al., 2011; Shinohara et 
al., 2002). SWAP70 regulates cellular actin dynamics and organization via activation of RHOA and 
RAC1 (Dwyer et al., 2015; Oberbanscheidt et al., 2007; Ocana-Morgner et al., 2009; Ocana-Morgner 
et al., 2011; Shinohara et al., 2002; Sivalenka and Jessberger, 2004; Sivalenka et al., 2008). Binding of 
SWAP70 to phosphoinositides is required for this activation of RHO-GTPases (Murugan et al., 2008; 
Shinohara et al., 2002). We found that SWAP70 was transiently recruited to nascent phagosomes 
in human monocyte-derived dendritic cells. SWAP70 remained associated to these phagosomes 
shortly after phagocytic cup closure by specific binding of its Pleckstrin homology (PH-) domain to 
phosphatidylinositol (3,4)-bisphosphate (PI(3,4)P2) and to a lesser extent to phosphatidylinositol 
(3,4,5)-trisphosphate (PI(3,4,5)P3). Knockdown of SWAP70 by small interfering RNA (siRNA) 
significantly decreased RAC1 activation, actin polymerization, and phagocytic capability. Multi-
color super-resolution STED microscopy showed that SWAP70 overlapped with RAC1 and aligned 
with parallel F-actin filaments and concentric rings surrounding the phagosome. These F-actin 
structures were not observable upon siRNA knockdown of SWAP70. Our findings show that 
SWAP70 is a scaffolding protein that promotes particle internalization by enabling the formation 
of the phagosomal actin cage.
Results
SWAP70 Aligns with F-Actin Filaments on the Surface of Early Phagosomes
Because SWAP70 can bind directly to F-actin via its C-terminal region (Chacon-Martınez et al., 2013; 
Hilpela et al., 2003; Ihara et al., 2006) and can regulate cellular actin dynamics and organization via 
activation of RHOA and RAC1 (Dwyer et al., 2015; Oberbanscheidt et al., 2007; Ocana-Morgner et al., 
2009; Ocana-Morgner et al., 2011; Shinohara et al., 2002; Sivalenka and Jessberger, 2004; Sivalenka 
et al., 2008), we hypothesized that SWAP70 would have an important role in the formation of the 
phagocytic actin cage. To prove this hypothesis, we first investigated whether SWAP70 is recruited 
to phagosomes. Dendritic cells derived from monocytes isolated from blood of healthy volunteers 
were pulsed with zymosan particles, a cell wall preparation of the yeast Saccharomyces cerevisiae. 
Zymosan signals through a number of pattern recognition receptors, including Toll-like receptor 
2 and the C-type lectin CLEC7A (Dectin-1). Zymosan is taken up by CLEC7A, which is the main 
phagocytic receptor for live fungi (Goodridge et al., 2009). Cells were immunolabeled for SWAP70 
and F-actin was stained with fluorescently labeled phalloidin. A substantial portion of SWAP70 
localized to F-actin-rich phagosomes that often (35%–70%, depending on the donor) were positive 
for SWAP70 (Figures 1A and 1B). Live cell experiments with dendritic cells overexpressing SWAP70 
fused to GFP revealed transient recruitment of SWAP70 to phagosomes simultaneously with the 
F-actin binding probe LifeAct-RFP (Riedl et al., 2008) (Figures 1C and 1D; Movie S1). We performed 
three-dimensional super-resolution stimulated emission depletion (STED) microscopy to visualize 
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the ultrastructure of SWAP70 on the surface of the phagosomes. The cores of the zymosan 
particles were visualized by their auto-fluorescence in the GFP channel. Filamentous structures of 
SWAP70 were distinguishable by STED but not by conventional confocal microscopy (Figure 1E). 
Interestingly, we frequently observed that SWAP70 was arranged in parallel arched structures that 
aligned with the membrane of the phagosome (Figure 1F; Movies S2, S3, and S4). We also often 
observed concentric ring-like structures of SWAP70 (Figure 1G; Movies S5 and S6). This observation 
raised the possibility that SWAP70 would align with the F-actin filaments previously described to 
form around the phagocytic cup following uptake of non-opsonized zymosan (Goodridge et al., 
2012; Huang et al., 2014; Liebl and Griffiths, 2009). We performed multi-color STED microscopy 
to address this possibility and observed perfect alignment of the F-actin filaments with SWAP70 
(Figures 1H–1J; Movie S7). These results suggest a role for SWAP70 in the organization and/or 
formation of peripheral actin filaments on the phagosome. We next investigated when and under 
what conditions SWAP70 was recruited to phagosomes. 
The recruitment of SWAP70 to phagosomes was not dependent on the type of phagocytic 
receptor, as it was broadly observed for different phagocytic cargoes, such as IgG-opsonized and 
naked latex beads (taken up by integrin αMβ2) (Freeman and Grinstein, 2014) (Figures 2A and S1A). 
Remarkably, the recruitment of SWAP70 to phagosomes was much stronger than to other actin-
rich structures, such as podosomes (>5-fold based on fluorescence intensity; Figure 2B). SWAP70 
has been shown to locate to podosomes in mouse dendritic cells, but its role there is not clear, 
as it is not required for podosome formation or turnover (Goetz and Jessberger, 2013). Although 
SWAP70 has been detected in nuclear fractions of B cells (Borggrefe et al., 1999) and mouse 
dendritic cells (Ocana-Morgner et al., 2013), we did not detect endogenous for overexpressed 
SWAP70 in the nucleus of human monocyte-derived dendritic cells. In order to determine when 
SWAP70 was recruited to phagosomes, dendritic cells were pulsed with fluorescein isothiocyanate 
(FITC)-labeled zymosan followed by immunolabeling with an antibody directed against FITC (i.e., 
without permeabilization). Zymosan particles that were completely taken up by the dendritic 
cells are inaccessible to antibody, allowing for selective labeling of free zymosan and nascent 
phagocytic cups. SWAP70 was recruited to sealed phagosomes (i.e., no anti-FITC labeling) and 
to nascent cups (Figure 2C; Movie S8). SWAP70 was only transiently recruited to phagosomes, as 
the total fraction of all SWAP70-positive phagosomes readily decreased in time (Figure 2D). As 
expected, the fraction of nascent cups compared to total phagosomes also readily decreased in 
time as more and more zymosan particles were fully internalized (Figure 2E). Approximately 50% 
of all nascent cups were positive for SWAP70 at all time points tested (Figure 2F). SWAP70 resided 
on phagosomes for 1–3 min after zymosan uptake based on the time-lapse imaging of dendritic 
cells expressing SWAP70-GFP, although we sometimes observed considerable longer residence 
times (up to 10–15 min; Figure 2G). We performed co-immunofluorescence labeling experiments 
to determine whether SWAP70 was still present on early phagosomes defined by the presence of 
the early endosomal protein EEA1 (Figures S1B and S1C). We could not find a single phagosome 
positive for both EEA1 and SWAP70, indicating that SWAP70 dissociated from the phagosomes 
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prior to EEA1 recruitment. We also observed complete exclusion of SWAP70 with the late 
endosomal/lysosomal protein LAMP1 (Figures S1D and S1E). In agreement with these findings, 
live cell imaging revealed that SWAP70-GFP was recruited 3 min prior to mRFP-tagged RAB5A 
(Vonderheit and Helenius, 2005), an early endosomal small GTPase that binds EEA1 (Figures 2H 
and 2I; Movie S9). These results mirror the transient recruitment of SWAP70 to macropinosomes in 
mouse dendritic cells prior to RAB5A (Oberbanscheidt et al., 2007). Thus, in most cases, SWAP70 is 
already recruited to the nascent cup during phagosome formation and disappears within minutes 
after cup closure prior to the recruitment of EEA1.
^ Fig. 1: SWAP70 Aligns with Actin Filaments on the Phagosomal Surface. (A) Confocal micrograph of zymosan pulsed 
dendritic cells immunostained for SWAP70 (magenta in merge) and F-actin (green). Pink arrowheads, double-positive 
phagosomes; yellow arrowheads, phagosomes only positive for SWAP70; BF, bright field. (B) Quantification of (A). Aver., 
average ± SEM (100 cells/donor). (C) Live cell imaging of zymosan-pulsed dendritic cells expressing SWAP70-GFP (green 
in merge) and LifeAct-RFP (magenta). The inset shows a time series during zymosan uptake. See also Movie S1. (D) 
Quantification from (C). The histogram shows the time difference of peak recruitment of SWAP70-GFP and LifeAct-RFP 
based on fluorescence intensities (40 phagosomes). Negative values indicate that LifeAct was recruited prior to SWAP70 
and positive values later than SWAP70. (E) Confocal (top) and super-resolution 3D-STED (bottom) microscopy of dendritic 
cells pulsed with zymosan (blue) and immunostained for SWAP70 (magenta). (F and G) 3D-reconstructions of the STED from 
(E). Often, parallel arches (F) (yellow arrowheads and depicted in the insets) and rings (G) of SWAP70 were visible. This is 
more clear in the 3D-rotations (Movies S2, S3, S4, S5, and S6). (H–J) Same as (F) and (G) but now with co-staining for F-actin 
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(green).Shown are cross-section and orthogonal sections (H; indicated by dashed yellow lines), the maximum intensity 
surface projection (I), and maximum intensity height maps (J). Note the overlap of SWAP70 and F-actin on the surface of the 
phagosome (yellow arrowhead). Scale bars, 10 µm (A and C); 2 µm (E–H). See also Movie S7. 
Phagosomal Recruitment of SWAP70 Is Promoted by PI(3,4)P2
The phosphoinositide composition of phagosomes changes progressively during phagosome 
formation and maturation. Phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P2), which is the 
predominant phosphoinositide at the plasma membrane (van den Bogaart and ter Beest, 2014), 
converts into PI(3,4,5)P3 by the action of PI3-kinases (Greenberg and Grinstein, 2002; Gu et al., 
2003; Hoppe and Swanson, 2004; Terebiznik et al., 2002). PI(3,4,5)P3 is then dephosphorylated 
by SHIP1 (INPP5D) and SHIP2 (INPPL1), yielding PI(3,4)P2 (Brooks et al., 2010; Drobek et al., 2015; 
Fuhler et al., 2012), which in turn is converted into PI(3)P by PI 4-phosphatases. Both SHIP1 and 
2 are expressed by human monocyte-derived dendritic cells (Figure S2A). As EEA1 is known to 
be recruited to early phagosomes by binding to phosphatidylinositol 3-phosphate (PI(3)P) (Levin 
et al., 2015; Simonsen et al., 1998), we speculated that SWAP70 is recruited to the phagosome 
through its known binding partners PI(3,4)P2 and PI(3,4,5)P3 (Hilpela et al., 2003; Shinohara et al., 
2002). To assess this, we overexpressed in dendritic cells GFP-tagged probes with specificity for 
several phosphoinositide species: the PLCδ1 (PLCD1) PH-domain specific for PI(4,5)P2 (Lemmon 
et al., 1997; Stauffer et al., 1998), the PHdomain of AKT specific for PI(3,4,5)P3 and less for PI(3,4)P2 
(Klippel et al., 1997; Rosen et al., 2012), the PH-domain of TAPP2 (PLEKHA2) specific for PI(3,4)
P2 (Marshall et al., 2002), the PX domain of p40
phox (NCF4) specific for PI(3)P (Kanai et al., 2001), 
and the N-terminal sequence of MCOLN1 specific for PI(3,5)P2 (Li et al., 2013). We then tested the 
co-localization of endogenous SWAP70 (i.e., by immunostaining) with these phosphoinositide- 
probes (Figures 3A and 3B). Of all probes, co-localization of SWAP70 on phagosomes was 
strongest with the probe sensing PI(3,4)P2 (70% of all PI(3,4)P2 positive phagosomes). Live cell 
imaging of dendritic cells co-expressing the GFP-tagged probes together with SWAP70 fused to 
mCherry showed simultaneous recruitment of SWAP70 and the probe for PI(3,4)P2 to phagosomes 
(Figures S2B and S2C; Movie S10). The probes for PI(4,5)P2 and PI(3,4,5)P3 were mostly present 
on phagosomes before SWAP70-mCherry was recruited and the probe for PI(3)P was recruited 
later than SWAP70-mCherry (Figures S2D–S2I; Movies S11, S12, and S13). Experiments with co-
expression of the mCherry-tagged PH-domain of SWAP70 (amino acid residues 210–306) with 
our GFP-tagged phosphoinositide probes demonstrated that PI(3,4)P2 binding was mediated 
by the PH-domain of SWAP70 (Figures 3C, S3A, and S3B). Phagosome binding was not observed 
for the PH-domain carrying mutations R223E and R224E (Figure S3C), which is unable to bind to 
phosphoinositides in vitro (Hilpela et al., 2003).
To further validate the role of PI(3,4)P2 in SWAP70 recruitment, we cultured dendritic cells in the 
presence of the specific SHIP1 inhibitor 3-a-aminocholestane (3AC) or the specific SHIP2 inhibitor
AS1949490 (Brooks et al., 2010). We selected concentrations of 25 and 50 µM for 3AC and 10 
and 25 µM for AS1949490; just below and above the concentrations where cellular viability and 
phagocytosis capacity were affected (Figures 3D, 3E, S3D, and S3E). These concentrations of 3AC 
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and AS1949490 resulted in a lower recruitment of the PI(3,4)P2 probe to phagosomes compared 
to the solvent controls, indicating a reduced presence of PI(3,4)P2 at the phagosomes (Figures 
S3F–S3H). We also observed 50% reduction of phagosomes containing SWAP70 with 3AC or 
AS1949490 (Figures 3F–3H), supporting a role for PI(3,4)P2 in phagosomal recruitment of SWAP70. 
This reduced recruitment of SWAP70 was not due to a general trafficking defect, because the 
presence of gp91phox (CYBB, an integral membrane component of the NADPH oxidase NOX2) at 
the phagosome was not affected by 3AC nor AS1949490 (Figures S3I–S3K).
^ Fig. 2: SWAP70 Is Recruited to Nascent Phagosomes. (A) Human dendritic cells were pulsed with a combination of FITC-
labeled zymosan (zymosan-FITC; green in merge) and latex beads followed by immunostaining for SWAP70 (magenta). 
SWAP70 was recruited to both zymosan (pink arrowheads) and latex beads (yellow arrowhead). BF, bright field. See also 
Figure S1A. (B) Maximum intensity z projection of zymosan-pulsed dendritic cells immunostained for SWAP70 (magenta) 
and F-actin (green). F-actin and SWAP70 are shown in the fire look-up-table to emphasize the low recruitment of SWAP70 
to podosomes (podosome region encircled in yellow) compared to phagosomes (pink arrowheads). (C) Identification of 
nascent cups by labeling of zymosan-FITC (green) with an antibody (blue; anti-FITC) in absence of permeabilization. Only 
free zymosan particles (yellow arrowhead) and nascent cups (pink) were accessible to anti-FITC labeling. Inset: magnification 
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of a nascent cup. See also Movie S8. (D–F) Phagosomes in dendritic cells from three different donors over time of uptake 
(70 cells/donor/time point) were analyzed for the fraction of SWAP70-positive phagosomes (D), the fraction of nascent 
cups to total phagosomes (E), and the fraction of SWAP70-positive nascent cups to all SWAP70-positive phagosomes (F). 
(G) Residence time of SWAP70-GFP on phagosomes quantified based on live cell imaging (150 phagosomes). (H) Live cell 
imaging of dendritic cells expressing SWAP70-GFP (green in merge) and RAB5A-RFP (magenta). The inset shows a time series 
during zymosan uptake (arrowhead). See also Figures S1B–S1E and Movie S9. (I) Quantification from (H). The histogram shows 
the time difference of peak recruitment of SWAP70-GFP and RAB5A-RFP based on fluorescence intensity (50 phagosomes). 
Negative values indicate that RAB5A was recruited prior to SWAP70 and positive values later than SWAP70. Scale bars, 10 µm
PI(3,4)P2 is not the only factor recruiting SWAP70 to the phagosome, as the PH-domain alone 
showed considerably higher cytoplasmic background compared to endogenous SWAP70 (Figure 
S3a) and to overexpressed full-length SWAP70 fused to GFP (Figure S4). This is also indicated by the 
finding that a GFP-tagged full-length SWAP70 mutant unable to bind to phosphoinositides (R223E 
and R224E (Hilpela et al., 2003)) was still recruited to phagosomes, albeit less efficiently than wild-
type SWAP70 (Figure S4). We tested GFP-tagged N- and C-terminal truncation mutants of SWAP70 
to test which domains contribute to SWAP70 binding to phagosomes. Truncation mutants of 
SWAP70 lacking its N-terminal fragment containing the EF-hand motif or its C-terminal fragment 
containing the putative Dbl-homology domain (DH) (Shinohara et al., 2002) and actin-binding 
domain were recruited to phagosomes less efficiently compared to full-length SWAP70 (Figure 
S4), indicating that not only the PH-domain but also the N- and C-terminal regions contribute 
to phagosomal recruitment of SWAP70. These results compare well with the reported domain 
requirement for binding of SWAP70 to macropinosomes (Oberbanscheidt et al., 2007), except that 
the PH-domain alone is recruited to phagosomes (Figure S3a, S4) but not to macropinosomes 
(Oberbanscheidt et al., 2007). Possibly, phagosomes have prolonged presence and/or higher 
levels of PI(3,4)P2 than macropinosomes. F-actin is not a major contributor for phagosomal 
SWAP70 recruitment, as mutants lacking part of or the entire C-terminal actin-binding domain 
(Ihara et al., 2006) were recruited to phagosomes with similar efficiency as full-length SWAP70 
(Figure S4).
SWAP70 Controls Phagocytosis via F-Actin Polymerization
We then addressed the functional role of SWAP70 in phagocytosis. We first evaluated how siRNA 
knockdown of SWAP70 (80% knockdown efficiency; Figure 4A) affected uptake of FITC-labeled 
zymosan by flow cytometry (Figure S5A). For all donors tested, SWAP70 knockdown reduced the 
phagocytosis capacity of dendritic cells. The total fraction of cells that ingested zymosan was 
significantly reduced upon SWAP70 knockdown (Figures 4B and S5B). In this fraction of cells that 
took up zymosan, the total uptake was also significantly reduced (Figures 4C, S5C, and S5D). Lower 
zymosan uptake upon SWAP70 knockdown was also apparent from confocal imaging (Figures 4D 
and 4E). Zymosan uptake could be rescued by combining SWAP70 knockdown with overexpression 
of SWAP70-GFP with altered codon usage to protect it from siRNA targeting (Figures 4F, S5E, and 
S5F). These results contrast a study where TAT-mediated transduction of human granulocytes 
with a dominant-negative form of SWAP70 did not (or only somewhat) affect phagocytosis of 
gonococci via CEACAM3 (Schmitter et al., 2007). We also tested the effect of SWAP70 knockdown 
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on pinocytosis, because SWAP70 is recruited to pinosomes (Oberbanscheidt et al., 2007) and 
S1P-induced endocytosis is reduced in dendritic cells from SWAP70 -/-  mice (Ocana-Morgner et al., 
2011). Similar to our findings with zymosan particles, we observed a significant reduction (25%) in 
uptake of BSA labeled with Alexa Fluor 488 (Figure S5G). 
^ Fig. 3: Phagosomal SWAP70 Is Mainly Recruited by PI(3,4)P2. (A) Confocal images of zymosan-pulsed dendritic cells 
expressing GFP-tagged phosphoinositide-probes (PI probe; green in merge) and immunolabeled for SWAP70 (magenta). 
The following PI probes were used: the PH-domain of PLCδ1 for PI(4,5)P2, the PH-domain of AKT for PI(3,4,5)P3, the PH-
domain of TAPP2 for PI(3,4)P2, the PX-domain of NCF4 for PI(3)P, and the N-terminal sequence of MCOLN1 for PI(3,5)P2. Yellow 
arrowheads, phagosomes positive for SWAP70; BF, bright field. See also Figure S2 and Movies S10, S11, S12, and S13. (B) 
The percentages of phagosomes positive for the phosphoinositide biomarkers and endogenous SWAP70 (mean ± SEM for 
three donors; >60 phagosomes/condition). (C) Same as (B) but now with the mCherry-tagged PH-domain of SWAP70 (PH-
SWAP70; mean ± SEM for three donors). See also Figures S3A–S3C. (D) Phagocytosis capacity with the SHIP1 inhibitor 3AC by 
flow cytometry. MFI, mean fluorescence intensity of the zymosan-FITC signal (mean ± SEM for three donors). EtOH, ethanol 
solvent control. See also Figure S3D. (E) Same as (D) but now for the SHIP2 inhibitor AS1949490. DMSO, solvent control. 
See also Figure S3E. (F) Confocal micrographs of dendritic cells pulsed with zymosan in the presence or absence of 25 
µM 3AC. Yellow arrowheads, phagosomes positive for SWAP70. (G and H) Quantification of SWAP70-positive phagosomes 
52
Chapter 3
3
after 30 min internalization for the 3AC (G) and AS1949490 (H) concentrations indicated (mean ± SEM for three donors; >80 
phagosomes/donor/condition). Scale bars, 10 µm (A), 20 µm (F). See also Figures S3F–S3K and S4.
In our flow cytometry experiments, we stained F-actin with fluorescently labeled phalloidin. This 
allowed quantification of the amount of F-actin per cell. Knockdown of SWAP70 led to a small 
(10%–20%) but significant reduction of F-actin (Figures 4Gand S5H). This result is in line with 
the reduced F-actin levels in macrophages from SWAP70 -/- mice (Chacon-Martınez et al., 2013). 
Confocal imaging showed that the percentage of F-actin-positive phagosomes was reduced by 
50% upon SWAP70 knockdown and the phalloidin intensity at these F-actin-positive phagosomes 
was also reduced by 50% (Figures 4H and 4I). We no longer observed the parallel arches or rings 
of F-actin on the surface of the phagosomes by STED microscopy upon SWAP70 knockdown, 
whereas these structures were readily observable in the non-targeting siRNA control (Figures S6A 
and S6B). Phagosomes of SWAP70 knockdown dendritic cells still contained PI(4,5)P2, PI(3,4,5)P3, 
and PI(3,4)P2 based on experiments with the GFP-tagged phosphoinositide probes (Figure S6C). 
Thus, knockdown of SWAP70 leads to a phagocytotic defect and reduced actin filament formation 
around phagosomes. Our data suggest that SWAP70 acts as a scaffolding protein, coordinating 
the tethering and stabilization of actin filaments on the phagosome surface. We then investigated 
the role of RAC1 in this process.
SWAP70 Promotes Phagosomal RAC1 Activity
SWAP70 can bind to RHO-GTPases, including the activated form of RAC1 (Ihara et al., 2006; 
Oberbanscheidt et al., 2007; Ocana-Morgner et al., 2009; Sivalenka and Jessberger, 2004). RAC1 
activity is promoted by its binding to SWAP70 (Dwyer et al., 2015; Murugan et al., 2008; Shinohara 
et al., 2002; Sivalenka et al., 2008). RAC1 stimulates actin polymerization on phagosomes by 
Arp2/3 through activation of WAVE (Swanson, 2008). In its inactive state, RAC1 is associated to 
RHO-GDI that keeps the protein in the cytosol. Dissociation of RHO-GDI from RAC1 results in 
membrane association of RAC1 via insertion of its geranyl-geranyl moiety (Bustelo et al., 2007; 
van de Donk et al., 2005). RAC1 is transiently recruited to phagosomes and disappears within 
minutes after phagocytic cup closure (Hoppe and Swanson, 2004; Oberbanscheidt et al., 2007). 
By confocal microscopy, we estimated that the majority (60%–90%, depending on the donor) of 
SWAP70-positive zymosan phagosomes contained RAC1 and 70% of these also contained F-actin 
(Figures 5A and 5B). RAC1 not only localized to phagosomes but also to the plasma membrane, 
as reported previously for lymphocytes (Cernuda-Morollo´ n et al., 2010). In live cell imaging 
experiments, overexpressed RAC1 fused to RFP (Hoppe and Swanson, 2004) also localized to 
phagosomes simultaneously with SWAP70-GFP (Figures 5C and 5D; Movie S14). By multi-color 
three-dimensional STED microscopy, we observed strong overlap between RAC1 and SWAP70 
on the surface of phagosomes (Figure 5E; Movie S15). As expected, based on the high overlap 
between SWAP70 and F-actin, RAC1 also overlapped with F-actin on the surface of phagosomes 
(Figure 5F; Movie S16). 
> Fig. 4: SWAP70 Regulates Phagocytosis and Phagosomal F-Actin. (A) Knockdown of dendritic cells with control (black, 
siControl) or SWAP70 siRNA (orange, siSWAP70) quantified by western blot (mean ± SEM). GAPDH, loading control. (B) 
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Dendritic cells with siSWAP70 were pulsed with FITC-labeled zymosan. Zymosan-positive cells were quantified by FACS 
after 30 and 60 min for at least four donors. See also Figures S5A and S5B. (C) The total zymosan-FITC signal for the zymosan-
positive cells from (B). MFI, mean fluorescence intensity. See also Figures S5C and S5D. (D) Confocal micrographs of FITC-
labeled zymosan (red) pulsed dendritic cells with siControl (left) or siSWAP70 (right). F-actin was stained with phalloidin 
(cyan). Yellow arrowheads, F-actin positive phagosomes. Scale bar, 20 µm. (E) Quantification of phagocytosis from (D) (mean 
± SEM; >40 cells/donor/condition). (F) Rescue experiment of phagocytosis for dendritic cells with siSWAP70 and SWAP70-
GFP (individual donors shown). See also Figures S5E and S5F. (G) The MFI of phalloidin labeling in the zymosan-positive and 
-negative populations of cells from (B). (H) Percentage of phalloidin-positive phagosomes from (D). (I) Quantification of the 
phalloidin signals of F-actin-positive phagosomes from (D). See also Figures S5G, S5H, and S6.
We then decided to test how knockdown of SWAP70 would affect RAC1 activation by measuring 
activated (GTP-bound) RAC1 by a colorimetric assay. Although such global methods are not 
optimal to detect localized changes, SWAP70 knockdown reduced the zymosan-induced 
activation of RAC1 almost completely (Figure 5G). The recruitment of total RAC1 to phagosomes 
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was also reduced upon SWAP70 knockdown by 60% (Figure 5H). We showed that phagosomal 
F-actin was also reduced upon SWAP70 knockdown (Figures 4H and 4I). The residual phagosomes 
that contained RAC1 in the SWAP70 knockdown samples had similar levels of F-actin as the RAC1-
positive phagosomes in the control samples (Figure 5I). This indicates that SWAP70 affects both 
phagosomal RAC1 and F-actin equally. The residual RAC1 and F-actin recruitment could be due to 
functional redundancy (i.e., another scaffolding protein) and/or to residual SWAP70. Our results 
are reminiscent of the reduced levels of activated RAC1 in Mast cells isolated from SWAP70 -/-  
mice (Sivalenka and Jessberger, 2004) and of the reduced RAC1 recruitment to actin-rich areas 
in dendritic cells from SWAP70 -/- mice (Ocana-Morgner et al., 2011). Thus, SWAP70 promotes the 
presence of F-actin and RAC1 on phagosomes.
Discussion
SWAP70 is a multitasking protein, harboring multiple domains that can bind to DNA, 
phosphoinositides, RHO-GTPases, and F-actin. SWAP70 is implicated in many diseases, including 
cancer (Chiyomaru et al., 2011; Fukui et al., 2007; Murugan et al., 2008; Shu et al., 2013), various 
autoimmune diseases (Bahaie et al., 2012; Biswas et al., 2012; Erdag et al., 2012; Turkoglu et al., 
2014; Vural et al., 2009), and HIV (Kimbara et al., 2006). In this study, we show that SWAP70 is 
recruited to the surface of the nascent phagocytic cup in dendritic cells. SWAP70 remains 
associated with phagosomes for 1–3 min but up to 15 min after cup closure, reminiscent of the 
transient localization of SWAP70 to early macropinosomes in mouse dendritic cells and NIH/3T3 
cells (Oberbanscheidt et al., 2007). Knockdown of SWAP70 reduces phagosomal F-actin and 
RAC1 and impairs phagocytosis. SWAP70 localization to phagosomes was much stronger than 
to other F-actin-rich structures such as podosomes (Goetz and Jessberger, 2013). Our results 
indicate that SWAP70 is recruited to phagosomes via association of its PH-domain to PI(3,4)P2. This 
confirms previous phosphoinositide dot-blot results indicating preferential binding of SWAP70 to 
PI(3,4)P2 regulates the actin cytoskeleton for cell protrusion (Hilpela et al., 2003). SWAP70 was also 
identified as a PI(3,4)P2 binding protein in a quantitative phosphoinositide-binding proteomics 
study in HeLa cells (Jungmichel et al., 2014). Finally, binding of SWAP70 to PI(3,4)P2 was observed in 
competitive pull-down experiments, although in this case SWAP70 bound stronger to PI(3,4,5)P3 
(Shinohara et al., 2002). Thus, it seems reasonable to conclude that the PH-domain of SWAP70 
preferentially binds to PI(3,4)P2, although it may also bind to PI(3,4,5)P3.
Phosphoinositides recruit factors promoting the polymerization and tethering of actin fibers to 
phagosomes (Levin et al., 2015). Especially, PI(4,5)P2 is well-understood in these processes via the 
ERM proteins, CDC42 and WASP (Bretscher et al., 2002; Hoppe and Swanson, 2004; Rohatgi et al., 
2001; Yonemura et al., 2002). PI(3,4)P2 has not yet been described to play a role in phagosomal actin 
and was long believed to be merely a transition product in the conversion from PI(3,4,5)P3 to PI(3)P 
(Li and Marshall, 2015). In fact, the action of SHIP1 was even reported to negatively affect both 
CR3 and Fcγ receptor-mediated phagocytosis, as it decreased levels of PI(3,4,5)P3 on the nascent 
phagosome (Horan et al., 2007). However, it is now increasingly clear that PI(3,4)P2 is a signaling 
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phosphoinositide itself with unique roles in phagocytosis and pinocytosis (Li and Marshall, 2015; 
Maekawa et al., 2014; Welliver and Swanson, 2012). Several proteins specifically bind to PI(3,4)P2, 
such as TAPP1 (PLEKHA1) or TAPP2 (PLEKHA2), which are both involved in actin remodeling via 
their interaction with syntrophins (Hogan et al., 2004). PI(3)P is the main phosphoinositide of early 
endosomes/phagosomes, and the RAB5A effector protein EEA1 is recruited to PI(3)P by binding of 
its FYVE-domain (Levin et al., 2015; Simonsen et al., 1998). The finding that SWAP70 does not bind 
to PI(3)P is in accordance with our observations that SWAP70 is recruited to phagosomes prior 
to EEA1 and RAB5A and with the reported finding that SWAP70 recruitment to macropinosomes 
occurs prior to RAB5A (Oberbanscheidt et al., 2007). 
Our super-resolution STED-microscopy showed that SWAP70 aligned with F-actin and RAC1 on 
the surface of phagosomes, forming parallel arches and rings. Upon knockdown of SWAP70, 
these structures were no longer observable. The binding of the C-terminal domain of SWAP70 to 
non-muscle F-actin is well-established (Gomez-Cambronero, 2012; Hilpela et al., 2003; Ihara et al., 
2006; Murugan et al., 2008; Shinohara et al., 2002). SWAP70 can oligomerize and thereby bundle 
actin filaments in both a parallel and anti-parallel fashion and this delays dilution-induced F-actin 
depolymerization (Chacon-Martınez et al., 2013). This bundling of actin by SWAP70 likely explains 
the filamentous-like organization of SWAP70 on the phagosome surface revealed by STED. We also 
observed overlap between SWAP70 and RAC1 and impairment of RAC1 activation upon SWAP70 
knockdown. Although SWAP70 was initially shown to be a guanine nucleotide exchange factor 
(GEF) for RAC1 (Shinohara et al., 2002), this is no longer believed (Oberbanscheidt et al., 2007) 
because mammalian SWAP70 (and also plant SWAP70) (Yamaguchi et al., 2012) binds to activated 
RHOA and RAC1, but not to GDP-bound or nucleotide-free RAC (Ihara et al., 2006; Murugan et 
al., 2008; Oberbanscheidt et al., 2007; Ocana-Morgner et al., 2009). Likely, RAC1 is activated by 
GEFs such as DOCK180 (DOCK1) and VAV (Rossman et al., 2005; Swanson, 2008) and stabilized in 
its active form by SWAP70. Our findings are in accordance with the reduced activation of RAC1 
and decreased recruitment to actin-rich cellular regions in SWAP70 / mice (Shinohara et al., 2002; 
Sivalenka et al., 2008; Ocana-Morgner et al., 2011). Moreover, the aberrant activation of RAC seen 
in Kaposi’s sarcoma requires SWAP70 (Dwyer et al., 2015). Our data and these studies all support 
a role for SWAP70 in regulation of RHO-GTPases and hence we conclude that SWAP70 does not 
only bind and stabilize the phagocytic actin cage, but also promotes their formation via binding-
activated RAC1 (Figure 5J).
 What is the sequence of events of SWAP70, RAC1, and F-actin recruitment to the phagocytic cup? 
Our data show that phosphoinositide binding by the PH-domain of SWAP70 clearly contributes 
to specific phagosomal recruitment. This result corroborates previous findings that a SWAP70 
mutant impaired in PI(3,4,5)P3 binding failed to locate to F-actin rich plasma membrane ruffles 
(Fukui et al., 2007; Shinohara et al., 2002; Wakamatsu et al., 2006). The binding of SWAP70 to 
RAC1 likely also contributes to phagosomal recruitment, as our data show that phagosomal 
recruitment is supported by both the N-terminal fragment (containing the EF-hand motif ) and the 
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putative Dbl-homology domain (DH) (Shinohara et al., 2002) of SWAP70, but not by its C-terminal 
actin-binding region, similar to previous findings with macropinosomes (Oberbanscheidt et al., 
2007). In accordance with this notion, RAC1 is recruited to the extending pseudopods of the 
nascent cup of phagosomes (Hoppe and Swanson, 2004), and SWAP70 is recruited after RAC1 to 
macropinosomes (Oberbanscheidt et al., 2007). However, we did not observe such a clear time-
dependency for phagosomes in dendritic cells and instead saw simultaneous recruitment of 
SWAP70 and RAC1 and reduced RAC1 recruitment upon SWAP70 knockdown. Because SWAP70 
binds to activated RAC1 (Ihara et al., 2006; Murugan et al., 2008; Ocana-Morgner et al., 2009), it 
may well be that SWAP70 and RAC1 are recruited to nascent phagosomes by a positive feedback 
loop, where binding of SWAP70 to PI(3,4)P2 results in recruitment of activated RAC1 and F-actin 
that in turn recruits more SWAP70 (Figure 5J). PI(3,4)P2 may also directly recruit RAC1 itself and 
promote RAC-GEF activation, as is well-established for PI(3,4,5)P3 (Fleming et al., 2000; Hill and 
Welch, 2006; Missy et al., 1998). The notion that SWAP70 is recruited to phagosomes by multiple 
binding partners is supported by the finding that the N-terminal region, the PH-domain, and the 
putative Dbl-homology domain (DH) all contribute to binding of SWAP70 to phagosomes. Such a 
synergistic engagement of multiple binding partners is called coincidence detection (Carlton and 
Cullen, 2005) and is a well-understood mechanism to achieve highly restricted localizations as the 
one we report here for SWAP70 at phagosomes. 
Our data show that SWAP70 plays a role in the assembly of the F-actin cage on phagosomes that 
persists well after cup-closure and depends on PI(3,4)P2. This is not only a novel role for PI(3,4)P2 
in the organization of actin on phagosomes, but it also refutes the long-standing believe that 
F-actin on early phagosomes is primarily depending on PI(4,5)P2 and PI(3,4,5)P3, but not on other 
3-phosphoinositides (Bretscher et al., 2002; Hoppe and Swanson, 2004; Rohatgi et al., 2001; 
Yonemura et al., 2002). Likely, the formation of an F-actin cage by SWAP70 promotes the remodeling 
of the membrane and provides a mechanic pulling force for ingestion of the phagocytic load (May 
et al., 2000). F-actin surrounding newly internalized phagosomes is known to rapidly depolymerize 
upon the conversion of PI(4,5)P2 to PI(3,4,5)P3, which leaves the phagosome membrane available 
to fuse with endosomes and lysosomes (May et al., 2000; Schlam et al., 2015). Retaining the F-actin 
cage on the phagocytic surface by SWAP70 likely delays this phagosomal maturation, which could 
well explain the maturation defects and reduced T cell activation observed in SWAP70-deficient 
dendritic cells (Ocana-Morgner et al., 2009; Ocana-Morgner et al., 2013). Thereby, SWAP70 could 
potentially lead to preservation or rerouting of the phagocytic cargo for specific processing of 
antigen for naive T cell activation.
> Fig. 5: SWAP70 Promotes Phagosomal RAC1 Activity. (A) Confocal micrographs and quantification of RAC1 (green in merge) 
and SWAP70 (magenta) positive phagosomes for seven donors (100 cells/donor). Aver., average ± SEM. (B) Venn diagram 
showing phagosomal distribution of RAC1, F-actin, and SWAP70. (C) Live cell imaging of dendritic cells expressing SWAP70-
GFP (green in merge) and RAC1-RFP (magenta). The inset shows a time series during zymosan uptake. BF, bright field. See 
also Movie S14. (D) Quantification from (C). The histogram shows the time difference of peak recruitment of SWAP70-GFP 
and RAC1-RFP based on fluorescence intensities (88 phagosomes). Negative values indicate that RAC1 was recruited prior 
to SWAP70 and positive values later than SWAP70. (E and F) Multicolor 3D-STED microscopy of zymosan-pulsed dendritic 
cells immunostained for RAC1 (green) and SWAP70 (magenta; E) or F-actin (F). Left: cross-section and orthogonal sections 
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(indicated by dashed yellow lines). Middle: maximum intensity height maps. Right: maximum intensity surface projection. 
Yellow arrowheads, overlap of RAC1 with SWAP70 (E) or F-actin (F) on the surface of the phagosomes. See also Movies S15 
and S16. (G) RAC1 activation upon control (siControl) and SWAP70 siRNA (siSWAP70) after zymosan addition by G-LISA assay 
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(Abs, absorbance units at 490 nm; mean ± SEM). The background (t = 0) is from cells without zymosan. (H) RAC1-positive 
phagosomes upon siControl and siSWAP70 counted by microscopy (>20 cells/donor/condition analyzed; individual donors 
shown). (I) Phagosomes positive for F-actin and/or RAC1 with siControl or siSWAP70. (J) Model of F-actin cage formation by 
SWAP70. SWAP70 is recruited to phagosomes by coincidence detection. Scale bars: 10 µm (A and C), 2 µm (E and F). 
Material and Methods
Antibodies and Reagent
The following primary antibodies were used: rabbit polyclonal anti-SWAP70 (Novus Biologicals; 
cat. no NBP1-82979) at 1:200 dilution (v/v) for immunofluorescence (IF) and 1:500 for western 
blot; mouse IgG1 anti-EEA1 (BD Biosciences; cat. no. 610457) at 1:100; mouse IgG1 anti-LAMP1 
(Biolegend; 328601) at 1:200; mouse monoclonal anti-RAC1 (Cell Biolabs; 240106) at 1:100; mouse 
IgG1 anti-FITC Alexa Fluor 647 (Jackson ImmunoResearch; 200-602-037) at 1:200; rabbit polyclonal 
anti-actin (Sigma; A5060) at 1:100; and mouse IgG1 anti-CYBB (MBL; D162-3) at 1:200. The following 
secondary antibodies were used: goat-anti-mouse Alexa Fluor 488 (Life Technologies; A11029); 
goat-anti-rabbit Alexa Fluor 568 or 647 (Life Technologies; A11036 and A21245); goat-anti-mouse 
STAR635 (Abberior; 2-0002-002-0); sheep-anti-mouse KK114 (Abberior Red); and goat-anti-
rabbit Alexa Fluor 594 (Abcam; ab150084). For immunoblotting goat-anti-rabbit IRDye 800CW 
(Li-Cor; 926- 32211) and goat-anti-mouse IRDye 680CW (Li-Cor; 926-32220) were used. Alexa 
Fluor 633-labeled phalloidin was from ThermoFisher (A22284) and used at 1:200 (v/v). mCLING 
labeled with ATTO647N was from Synaptic Systems (710006AT1) and used at 1:200 (v/v). The RAC1 
activation G-LISA kit was from Cytoskeleton (BK128-S).
Cells and Transfection
Buffy coats from healthy donors (consent obtained and according to national ethics guidelines 
and approved by the institutional review board [Radboud UMC]) were used to isolate peripheral 
monocytes as described (de Vries et al., 2002). Constructs for full-length human SWAP70, the 
PH-domain (residues 210–306), the PH-domain and full-length SWAP70 with R223E and R224E 
mutations, and C- and N-terminal truncations (residues 205–585, 1–313, 1–525, and 1–572) were 
generated as codon-optimized synthetic genes (Genscript) in the EcoRI/BamHI sites of pEGFP-C1 
and pmCherry-C1 (Clontech). RAB5A-mRFP was a gift from Ari Helenius (Addgene plasmid #14437)
(Vonderheit and Helenius, 2005). YFP-RAC1 was a gift from Joel Swanson (Addgene plasmid 
#11391) (Hoppe and Swanson, 2004) and was re-cloned into mCherry-C1. LifeAct-RFP was a gift 
from Michael Sixt (Max Planck Institute of Biochemistry, Martinsried). GFP-C1-PLCD1-PH was a gift 
from Tobias Meyer (Addgene plasmid #21179) (Stauffer et al., 1998). The GFP-tagged PH-domain 
of AKT is described (de Keijzer et al., 2011). NCF4-PX-EGFP was a gift from Michael Yaffe (Addgene 
plasmid #19010) (Kanai et al., 2001). The GFP-tagged residues 179–311 of TAPP2 are described 
(de Keijzer et al., 2011; Haugh et al., 2000). Mouse MCOLN1 residues 1–68 were generated as a 
synthetic gene in the XhoI/BamHI sites of pEGFP-C1. Transfection was performed as described 
(Baranov et al., 2014; Dingjan et al., 2016) and zymosan uptake and imaging experiments were 
performed 8–12 hr post-transfection.
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Microscopy
Samples were imaged with a Leica SP8 confocal microscope fitted with a 63x 1.2 NA water 
immersion objective. For live cell microscopy, cells were imaged 3–5 hr post-transfection with 
IgG-opsonized zymosan at 1:10 cell-to-particle ratio. Imaging was performed in Hank’s balanced 
salt solution (HBSS) (ThermoFisher, 14025050) supplemented with 10 mM HEPES at pH 7.4. 
Samples were imaged with a Leica DMI6000 epi-fluorescence microscope fitted with a 63x 1.4 NA 
oil immersion objective, a metal halide EL6000 lamp for excitation, a DFC365FX CCD camera, and 
GFP and DsRed filter sets (all from Leica). Focus was kept stable with the adaptive focus control 
from Leica. The STED microscope was from Abberior Instruments. Emission of two fluorescent 
markers (excitation [Ex.]: 560/640 nm, emission [Em.]: 580–630 nm/640–720 nm) was depleted 
with a single STED-laser operating at 775 nm with 800 picosecond (ps) long pulses at 40 MHz. 
The STED-laser point-spread-function was shaped by a spatial light modulator. STED-laser power 
in the backfocal-plane was 180 mW, with 65% of that power used for the 2D-donut and 35% 
for the 3D-donut. Zymosan particles were detected by excitation at 485 nm and collecting 
autofluorescence at 500–550 nm. Excitation power of the three excitation lasers 485 nm/560 
nm/640 nm were 4 mW/10 mW/8 mW in the back-focal-plane of an 1003 1.4 NA oil immersion 
objective (Olympus).
Fluorescence-Activated Cell Sorting
For fluorescence-activated cell sorting (FACS), cells were incubated with FITC-labeled zymosan at 
1:10 cell-to-zymosan ratio or 100 mg ml-1 BSA-AF488 for 5 min to 2 hr. Incubation was 1 hr for the 
uptake experiments with 3AC and AS1949490. Cells were fixed in4% PFA (w/v) and F-actin was 
labeled with Alexa Fluor 633 phalloidin in S-PBS (see the Supplemental Information). Data were 
acquired on a FACS-Calibur cytometer (BD Biosciences).
Statistical Analysis
All data were analyzed using Student’s two-tailed paired t tests. A p value < 0.05 was regarded as 
statistically significant (*p < 0.05, **p < 0.01, ***p < 0.001).
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SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures, six figures, and 
sixteen movies and can be found with this article online at http://dx.doi.org/10.1016/j.cel-
rep.2016.10.021.l
^ Fig. S1: related to Figure 2. Phagosomal SWAP70 recruitment occurs prior to EEA1 and is independent of the type of 
antigen. (a) Confocal micrographs of dendritic cells pulsed with uncoated latex beads (top panels) or IgG-opsonized latex 
beads (bottom) immunostained for SWAP70 (magenta in merge) and F-actin (green). Pink arrowheads indicate double-
positive phagosomes. Blue: DAPI. BF: bright field. (b–c) Dendritic cells pulsed with zymosan and immunostained for 
SWAP70 (magenta), EEA1 (green) and F-actin (cyan) (b) and quantification (c; >40 cells/condition for 3 donors; mean ± SEM). 
Arrowheads indicate SWAP70 (pink) and EEA1 (yellow) positive phagosomes. (d–e) Same as panels b–c but now for LAMP1 
(green). No double-positive phagosomes containing both SWAP70 and EEA1 or LAMP1 were observed. Scale bars: 10 μm.
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Figure S1; related to Figure 2. Phagosomal SWAP70 recruitment occurs prior to EEA1 and is 
independent of the type of antigen. (a) Confocal micrographs f dendritic cells pulsed with u coat d latex
beads (top panels) or IgG-opsonized latex beads (bottom) immunostained for SWAP70 (magenta in merge) and 
F-actin (green). Pink arrowheads indicate double-positive phagosomes. Blue: DAPI. BF: bright field. (b–c) 
Dendritic cells pulsed with zymosan and immunostained for SWAP70 (magenta), EEA1 (green) and F-actin 
(cyan) (b) and quantification (c; >40 cells/condition for 3 donors; mean ± SEM). Arrow eads indicate SWAP70 
(pink) and EEA1 (yellow) positive phagosomes. (d–e) Same as panels b–c but now for LAMP1 (green). No 
double-positive phagosomes containing both SWAP70 and EEA1 or LAMP1 were observed. Scale bars: 10 µm.  
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^ Fig. S2: related to Figure 3. PI(3,4)P2 mediates SWAP70 recruitment to the phagosome. (a) SHIP1 (INPP5D) and 2 (INPPL1) 
expression by PCR on cDNA from dendritic cells. The position of the forward (F) and reverse (R) primers as well as the expected 
fragment sizes are indicated. (b) Live cell imaging of dendritic cells pulsed with zymosan (arrowhead) and expressing a GFP-
tagged PI(3,4)P2-binding probe (the PH-domain of TAPP2 (PLEKHA2); green in merge) and SWAP70-mCherry (magenta). 
The inset shows a time series during zymosan uptake. See also Movie S10. BF: bright field. (c) Quantification from b. The 
histogram shows the time difference of peak recruitment of SWAP70-mCherry and the PI probe based on fluorescence 
intensities (>10 phagosomes). Negative values indicate that the PI probe was recruited prior to and positive values later than
SWAP70-mCherry. (d–e) Same as b–c, but now for a PI(3,4,5)P3-binding probe (PH-domain of AKT). See also Movie S11. (f–g) 
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Same as b–c, but now for a PI(4,5)P2-binding probe (PH-domain of PLCδ1 (PLCD1)). See also Movie S12. (h–i) Same as b–c, but 
now for a PI(3)P-binding probe (PX-domain of NCF4 (p40phox)). See also Movie S13. Scale bars: 10 μm.
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Figure S3; related to Figure 3. PH-domain mediates SWAP70 recruitment to the phagosome by PI(3,4)P2. 
(a) Confocal images of zymosan-pulsed dendritic cells co-expressing GFP-tagged phosphoinositide probes (PI 
probe; green in merge) with the mCherry tagged PH-domain of SWAP70 (PH-SWAP70; magenta). Yellow 
arrowheads indicate PH-SWAP70-positive phagosomes. BF: bright field. (b) Pearson correlation coefficients for 
the PI probes and PH-SWAP70 from panel a (mean ± SEM; >25 phagosomes/condition for at least 3 donors). (c) 
Confocal image of zymosan-pulsed dendritic cells expressing GFP-tagged PH-SWAP70 (magenta) carrying 
^ Fig. S3: relat d to Figure 3. PH-domain mediates SWAP70 recruitment to the phagosome by PI(3,4)P2. (a) Confocal images 
of zymosan-pulsed dendritic cells co-expressing GFP-tagged phosphoinositide probes (PI probe; green in merge) with 
the mCherry tagged PH-domain of SWAP70 (PH-SWAP70; magenta). Yellow arrowheads indicate PH-SWAP70-positive 
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phagosomes. BF: bright field. (b) Pearson correlation coefficients for the PI probes and PH-SWAP70 from panel a (mean ± 
SEM; >25 phagosomes/condition for at least 3 donors). (c) Confocal image of zymosan-pulsed dendritic cells expressing 
GFP-tagged PH-SWAP70 (magenta) carrying mutations R223E and R224E. Arrowheads: phagosomes positive for F-actin 
(green). No recruitment of mutant PH-SWAP70 to phagosomes was observed. (d) Cell viability of dendritic cells by the MTT 
assay for different concentrations of the SHIP1 (INPP5D) inhibitor 3AC (mean ± SEM for 3 donors). EtOH: ethanol solvent 
control. (e) Same as panel d, but now for the SHIP2 (INPPL1) inhibitor AS1949490. DMSO: solvent control. (f) Confocal image 
of zymosan-pulsed (magenta) dendritic cells expressing the PI(3,4)P2 probe (green) in presence or absence of 25 μM 3AC. 
DAPI is blue in merge. (g) Quantification of phagosomes positive for the PI(3,4)P2 probe for the 3AC concentrations indicated 
(individual donors shown; >30 phagosomes/donor/condition; mean ± SEM). (h) Same as panel g, but now for AS1949490. 
(i) Confocal image of dendritic cells pulsed with zymosan (yellow) and immunolabeled for SWAP70 (green) and CYBB 
(gp91phox; magenta). Cells were treated with 10 μM AS1949490. DAPI is blue in merge. (j) Quantification of gp91phox-positive 
phagosomes for the 3AC concentrations indicated (individual donors shown; >80 phagosomes/donor/condition; mean ± 
SEM). (k) Same as panel j, but now for AS1949490. Scale bars: 10 μm (a, c, f) and 20 μm (i).
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Figure S4; related to Figure 3; Phagosomal SWAP70 recruitment by phosphoinositides and RAC1but not 
or less by F-actin. (a) Representative confocal micrographs of zymosan-pulsed dendritic cells overexpressing 
full-length or mutant SWAP70 N-terminally fused to GFP (magenta in merge). F-actin was labeled with 
phalloidin (green). Yellow arrowheads indicate F-actin-rich phagosomes. The graphs show the intensity plot 
profiles as indicated. The position of phagosomes is indicated by the yellow shaded areas. FL: full-length 
SWAP70 (residues 1–585); PH: PH-domain of SWAP70 (209–306); ΔAB1: C-terminal truncation mutant of 
SWAP70 with part of its actin-binding (AB) domain removed (1–572); ΔAB2: C-terminal truncation mutant of 
SWAP70 with its entire AB domain removed (1–525); ΔDH, ΔAB: C-terminal truncation mutant of SWAP70 
with its putative Dbl-homology (DH) domain (Shinohara, et al. (2002) Nature. 416, 759-763) and AB domain 
removed (1–313); ΔEF: N-terminal truncation mutant of SWAP70 with its EF-hand motif removed (205–585); 
FL (R223E, R224E): full-length SWAP70 carrying mutations R223E and R224E. BF: bright field. Scale bars: 10 
µm (b) Domain topologies of the tested mutants and summary of their phagosomal recruitment as judged from 
the confocal images. Representative images for the PH-domain of SWAP70 (PH-SWAP70) carrying mutations 
R223E and R224E are in figure S3c. –: no association; +: some association; ++: regular association.  
  
^ Fig. S4: related to Figure 3; Phagosomal SWAP70 recruitment by phosphoinositides and RAC1but not or less by F-actin. 
(a) Representative confocal micrographs of zymosan-pulsed dendritic cells overexpressing full-length or mutant SWAP70 
N-terminally fused to GFP (magenta in merge). F-actin was labeled with phalloidin (green). Yellow arrowheads indicate 
F-actin-rich phagosomes. The graphs show the intensity plot profiles as indicated. The position of phagosomes is indicated 
by the yellow shaded areas. FL: full-length SWAP70 (residues 1–585); PH: PH-domain of SWAP70 (209–306); ΔAB1: C-terminal 
truncation mutant of SWAP70 with part of its actin-binding (AB) domain removed (1–572); ΔAB2: C-terminal truncation 
mutant of SWAP70 with its entire AB domain removed (1– 25); ΔDH, B: C-terminal truncation mutant of SWAP70 with its 
pu at ve Dbl-homology (DH) domain (Shin hara, et al. (2002) Na ure. 416, 759-763) and AB domain removed (1–313); ΔEF: 
N-terminal truncation mutant of SWAP70 with its EF-hand motif removed (205–585); FL (R223E, R224E): full-length SWAP70 
carrying mutations R223E and R224E. BF: bright field. Scale bars: 10 μm (b) Domain topologies of the tested mutants and 
summary of their phagosomal recruitment as judged from the confocal images. Representative images for the PH-domain 
of SWAP70 (PH-SWAP70) carrying mutations R223E and R224E are in figure S3c. –: no association; +: some association; ++: 
regular association.
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^ Fig. S5 related to Figure 4. SWAP70 regulates phagocytosis via F-actin. (a) FACS plot of dendritic cells transfected with 
control (siControl) or SWAP70 siRNA (siSWAP70). Cells were pulsed with FITC-labeled zymosan (zymosan-FITC) for 60 
min, fixed and stained with phalloidin conjugated to Alexa Fluor 633 (phalloidin-AF633). (b) Percentage of zymosan-
phagocytosing cells relative to total cells for a representative donor with siControl (black) or siSWAP70 (orange). (c) Mean 
fluorescence intensity (MFI) of zymosan-FITC for the zymosan-positive cells from panel b. (d) Fluorescence distribution of 
the zymosan-FITC signal of zymosan-positive cells for a representative donor 60 min after uptake. (e) SWAP70 knockdown 
efficiency for the rescue experiments. siRNA was transfected simultaneously with plasmid encoding SWAP70-GFP and 
knock-down levels were determined 24 h post-transfection by Western blot (mean ± SEM for 3 donors). GAPDH: loading 
control. (f) Epi-fluorescence microscopy image of rescue experiment. Note that the cell expressing SWAP70-GFP (green) 
contains more zymosan particles (arrowheads) than the surrounding cells without rescue. Scale bar, 10 μm. (g) Uptake of 
BSA labeled with Alexa Fluor 488 (BSA-AF488) by FACS with siControl or siSWAP70 for 3 different donors. Cells were pulsed 
with BSA for 60 min. (h) Fluorescence distribution of phalloidin-AF633 staining in siControl or siSWAP70 for a representative 
donor 15 min after zymosan uptake.
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Figure S5; related to Figure 4. SWAP70 regulates phagocytosis via F-actin. (a) FACS plot of dendritic cells 
transfected with control (siControl) or SWAP70 siRNA (siSWAP70). Cells were pulse  with FITC-lab led 
zymosan (zymosan-FITC) for 60 min, fixed and stained with phalloidin conjugated to Alexa Fluor 633 
(phalloidin-AF633). (b) Percentage of zymosan-phagocytosing cells relative to total cells for a representative 
donor with siControl (black) or siSWAP70 (orange). (c) Mean fluorescence intensity (MFI) of zymosan-FITC 
for the zymosan-positive cells from panel b. (d) Fluorescence distribution of the zymosan-FITC signal of 
zymosan-positive cells for a representative donor 60 min after uptake. (e) SWAP70 knockdown efficiency for 
the rescue experiments. siRNA was transfected simultaneously with plasmid encoding SWAP70-GFP and 
knock-down lev ls were determined 24 h pos -transfection by Western blot (mean ± SEM for 3 donors). 
GAPDH: loading control. (f) Epi-fluorescence mi roscopy image of rescue experiment. N te that the cell 
expressing SWAP70-GFP (green) contains more zymosan particles (arrowheads) than the surrounding cells 
without rescue. Scale bar, 10 µm. (g) Uptake of BSA labeled with Alexa Fluor 488 (BSA-AF488) by FACS with 
siControl or siSWAP70 for 3 different donors. Cells were pulsed with BSA for 60 min. (h) Fluorescence 
distribution of phalloidin-AF633 staining in siControl or siSWAP70 for a representative donor 15 min after 
zymosan uptake.   
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^ Fig. S6 related to Figure 4. SWAP70 knockdown affects the phagosomal F-actin cage,  phosphoinositides are still present. 
(a) Super-resolution multicolor 3D-STED microscopy of dendritic cells with siRNA knockdown of SWAP70. Cells were pulsed 
with zymosan (blue in merge) and immunostained for Factin (green) and SWAP70 (magenta; the SWAP70 signal is absent 
due to the knockdown). Shown are crosssections (left), orthogonal sections (middle; indicated by the dashed yellow lines) 
and a depth-encoded maximum intensity height map of the F-actin (right) for 4 representative phagosomes. Note the 
absence of parallel arches or ring-like structures of F-actin on the surface of the phagosomes. (b) Same as a, but now 
with non-targeting siRNA control. Arrowhead: ring-like structure of F-actin on the surface of the phagosome (depicted 
in the inset). (c) GFP-tagged phosphoinositide probes (PI probe-GFP; green in merge) were co-expressed with non-
targeting siRNA (siControl) or SWAP70 siRNA (siSWAP70) in zymosan-pulsed dendritic cells. The PI probes for PI(4,5)P2 (PH-
domain of PLCδ1 (PLCD1)), PI(3,4,5)P3 (PH-domain of AKT) and PI(3,4)P2 (PH-domain of TAPP2 (PLEKHA2)) were used. Left: 
representative confocal images (from 3–5 donors/condition). Arrowheads: PI probe-positive phagosomes. BF: bright field. 
Right: representative Western blots and quantifications of knockdown efficiencies (mean ± SEM). GAPDH: loading control. 
Scale bars: 2 μm (a, b), 10 μm (c).
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Figure S6; related to Figure 4. SWAP70 knockdown affects the phag somal F-actin cage, 
phosphoinositides are still present. (a) Super-resolution multicolor 3D-STED microscopy of dendritic cells 
with siRNA knockdown of SWAP70. Cells were pulsed with zymosan (blue in merge) and immunostained for F-
actin (green) and SWAP70 (magenta; the SWAP70 signal is absent due to the knockdown). Shown are cross-
sections (left), orthogonal sections (middle; indicated by the dashed yellow lines) and a depth-encoded maximum 
intensity height map of the F-actin (right) for 4 representative phagosomes. Note the absence of parallel arches 
or ring-like structures of F-actin on the surface of the phagosomes. (b) Same as a, but now with non-targeting 
siRNA control. Arrowhead: ring-like structure of F-actin on the surface of the phagosome (depicted in the inset). 
(c) GFP-tagged phosphoinositide probes (PI probe-GFP; gr en in merge) wer  co-exp ssed with non-targeting 
siRNA (siContr l) r SWAP70 i A (siSWAP70) in zymosan-pulse  dendritic cells. The PI probes for 
PI(4,5)P2 (PH-domain of PLCδ1 (PLCD1)), PI(3,4,5)P3 (PH-domain of AKT) and PI(3,4)P  (PH-domain of 
TAPP2 (PLEKHA2)) were used. Left: representative confocal images (from 3–5 donors/condition). Arrowheads: 
PI probe-positive phagosomes. BF: bright field. Right: representative Western blots and quantifications of 
knockdown efficiencies (mean ± SEM). GAPDH: loading control. Scale bars: 2 µm (a, b), 10 µm (c).  
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Supplemental Experimental Procedures
Particle preparation and phagocytosis assays
IgG-coated latex beads were produced by incubating 0.3% streptavidin bead suspension with 
1.3 mg ml-1 biotin-SP (long spacer) Chrompure human IgG (Jackson ImmunoResearch; 009-060-
003) for 30 min at 37 oC followed by extensive washing. The beads were added at a 1:10 cell-to-
beads ratio. IgG opsonized zymosan particles were produced by incubating 20 mg/ml zymosan 
suspension with an equal volume of Opsonizing solution from ThermoFisher (Z2850) for 60 min 
at 37 oC followed by extensive washing. FITC-labeled zymosan was purchased from ThermoFisher 
(Z2841). Unlabeled zymosan was from Sigma (Z4250-1G). The same zymosan was labeled with 
Alexa fluor 633 maleimide (Life Technologies) by incubating 16.4 mg ml-1 with 77 μM in 0.2 M 
Na-carbonate at pH 9.0 for 1 hour followed by vigorous washing. BSA Alexa fluor 488 conjugate 
was from ThermoFisher (cat. No. A13100). For the SHIP1 (INPP5D) or SHIP2 (INPPL1) inhibition, cells 
were incubated with zymosan at 1:10 cell-to-particles and either with 3AC (Echelon; B-0341; 10–
200 μM in ethanol) or AS1949490 (Echelon; B-0342; 1.25–200 μM in DMSO).
Cell viability assay
For cell viability, 0.66 mg/ml MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; 
Sigma M2128-1G) was applied to the cells together with 3AC or AS1949490 for 2 h. The MTT 
reaction was stopped with lysis buffer containing 90% isopropanol, 0.0125% SDS and 0.04 M HCl. 
Absorbance was measured at 595 nm to determine cell death.
siRNA knock-down
Knockdown in human dendritic cells was performed as described (Dingjan et al., 2016), except 
that 3 day differentiated monocytes were used for transfection and samples were used 24-72 h 
post-transfection. A mix of 3 siRNAs was used (Life Technologies): GCCUU CAGAC UCAAG UGGAA 
CUUCA, AAAGA AGCUG GAGAU GGCAA CUAAU, and CAGAA GAGAU UGAAU ACCUG CUUAA. 
Control samples were transfected with irrelevant ON-TARGET plus non-targeting (NT) siRNA 
(Dharmacon). For the rescue experiments and the combination of siRNA with phosphoinositide 
probes, day 6 differentiated monocytes were simultaneously transfected with siRNA and plasmid 
DNA and used 24 h post-transfection. For all experiments, only samples with knockdown levels 
above 70% (72 h post-transfection) or 40% (24 h) were used.
Immunofluorescence
For immunofluorescence, cells were incubated with zymosan at 1:10 cell-to-zymosan ratio in 
serum-free medium for 15 to 60 minutes. The cells were subsequently fixed with 4% PFA in PBS 
and permeabilized in SPBA (0.1% Saponin, 0.5% BSA and 0.01% NaN3 in PBS) for 5 min. Primary 
and secondary antibodies were incubated in S-PBA. Cells were embedded in DAPI containing 
mounting medium containing 0.01% (v/v) 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic 
acid and 68% (v/v) glycerol in 200 mM sodium phosphate buffer at pH 7.5. In order to label the 
phagocytic cups, FITC-labeled zymosan was used and samples were labeled with an antibody 
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directed against FITC prior to permeabilization.
PCR
The total mRNA from day 6 differentiated monocytes was isolated with the Quick-RNA MiniPrep 
kit (Zymo Research, R1055) and reversely transcribed into cDNA. SHIP1 (INPP5D) mRNA was 
amplified by PCR with 3 forward primers (nucleotides 128–147: GCGTG CTGTA TCGGA ATTGC; 
354–372: AAGTG TCGTG TCTCC ACCC; 433–454: TTTTC AAACG AGAAT CCCCG AG) and 3 reverse 
primers (232–211: TGGTG AAGAA CCTCA TGGAG AC; 452–430: CGGGG ATTCT CGTTT GAAAA AGG; 
579–559: GGCGA GCTGA GTGCT TAAAT A). SHIP2 (INPPL1) mRNA was amplified with one forward 
primer (198–217: GCACA CGTAT CGCAT TCTGC) and reverse primer (364–344: CTCGC TCACC 
CTCTA CAGGA A).
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Abstract
We recently identified a key role for SWAP70 as the tethering factor stabilizing F-actin filaments 
on the surface of phagosomes in human dendritic cells by interacting both with Rho-family 
GTPases and the lipid phosphatidylinositol (3,4)-bisphosphate. In this study, we aimed to 
investigate whether this role of SWAP70 was general among immune phagocytes. Our data 
reveal that SWAP70 is recruited to early phagosomes of macrophages and dendritic cells from 
both human and mouse. The putative inhibitor of SWAP70 sanguinarine blocked phagocytosis 
and F-actin polymerization, supporting a key role for SWAP70 in phagocytosis as demonstrated 
previously with knock-down. Moreover, SWAP70 was recently shown to sequester the F-actin 
severing protein cofilin and we investigated this relationship in phagocytosis. Our data show an 
increased activation of cellular cofilin upon siRNA knockdown of SWAP70. Finally, we explored 
whether SWAP70 would be recruited to the immune synapse between dendritic cells and T 
cells required for antigen presentation, as the formation of such synapses depends on F-actin. 
However, we observed that SWAP70 was depleted at immune synapses and specifically was 
recruited to phagosomes. Our data support an essential and specific role for SWAP70 in tethering 
and stabilizing F-actin to the phagosomal surface in a wide range of phagocytes.
Introduction
Actin has a well-understood role in the phagocytosis of microbes and tumor cells by immune 
cells (24, 40, 50, 55). Although the precise course of F-actin formation depends on the phagocytic 
receptors engaged (4, 13, 37), F-actin filaments are generally assembled early during phagocytosis 
at the site of phagosome formation and F-actin depolymerizes within several minutes after 
sealing of the phagosome (6, 21, 38). We recently showed an essential role for the adaptor protein 
SWAP70 in phagocytosis by human dendritic cells derived from blood-isolated monocytes (6). 
In our study, we demonstrated that SWAP70 is transiently recruited to phagosomes ingested by 
different phagocytic receptors (6). This phagosomal recruitment of SWAP70 coincided with the 
presence of F-actin on the phagosomal surface, and occurred before recruitment of the early 
endosomal small GTPase Rab5 (6, 42). SWAP70 is well known to bind to and stabilize F-actin with its 
C-terminal region (14, 30, 34, 35, 41, 46, 51). Using 3-dimensional multicolor super-resolution STED 
microscopy, we showed that SWAP70 organizes F-actin as parallel fibers or concentric rings on the 
surface of phagosomes (6). In our previous study (6), we also showed that the specific recruitment 
of SWAP70 to phagosomes is driven by its binding to the small Rho-family GTPase Rac1 (35, 42, 
45, 54) and to phosphatidylinositol (3,4)-bisphosphate (PI(3,4)P2) (34, 51). Our data indicated that 
SWAP70 binds to and stabilizes activated Rac1 at the phagosomal surface (6), although it is most 
likely not a guanine exchange factor (GEF) itself (42). We also showed that SWAP70 was not or less 
recruited to other F-actin rich cellular regions (6), such as podosomes which are involved in cell 
migration and trans-epithelial antigen sampling (7, 8). 
In this study, we further explored the role of SWAP70 in phagocytosis. First, we aimed to determine 
whether the role for SWAP70 in phagocytosis was only present in human dendritic cells or was also 
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observable in other immune phagocytes and other species. Our data show specific recruitment 
of SWAP70 to phagosomes in murine primary immune cells as well as the murine macrophage 
cell line RAW264.7. Second, we explored how phagocytosis and F-actin polymerization would 
be affected by the putative SWAP70 inhibitor sanguinarine (15, 26). Corroborating our previous 
findings that siRNA knockdown of SWAP70 results in phagocytic defects (6), we found that 
sanguinarine blocked phagocytosis in human dendritic cells. Third, we investigated the link 
between SWAP70 and cofilin in phagocytosis. Cofilin is an F-actin severing factor (18) that is 
sequestered by SWAP70 and this in turn interferes with its F-actin depolymerizing activity (14). In 
line with this, we observed increased activation of cellular cofilin upon knockdown of SWAP70 by 
siRNA. Finally, we addressed the possibility whether SWAP70 would be recruited to the immune 
synapses of dendritic cells with T cells required for antigen presentation. Similar to phagocytosis, 
the formation of these immunological synapses relies on cellular rearrangements of the F-actin 
cytoskeleton, local turnover of phosphoinositides and activation of Rho-GTPases (2, 9, 10, 22, 53, 
58), and all these factors could potentially recruit SWAP70 to the synapse. However, we observed 
no enrichment but rather a depletion of SWAP70 at the immune synapse between dendritic cells 
with T cells, both with a murine antigen specific immune synapse model and with the human 
allogenic mixed leukocyte reaction. Overall, these data support a broad role for SWAP70 as a 
specific tether and stabilizing factor of the phagosomal F-actin cage.
Results
SWAP70 is recruited to early phagosomes in murine dendritic cells and the 
macrophage cell line RAW264.7
In our recent study (6), we demonstrated that SWAP70 is essential for phagocytosis by human 
dendritic cells derived from blood-isolated monocytes (monocyte-derived dendritic cells; 
moDCs). To determine how general this mechanism is among other phagocytes of the immune 
system and other species, we first tested for the expression of SWAP70 in mouse dendritic cells 
and human monocyte-derived macrophages. We also tested for the expression of SWAP70 in the 
murine macrophage cell line RAW264.7, which is a widely-studied model system for phagocytosis. 
Mouse dendritic cells were derived from bone marrow stem cells (bone marrow-derived dendritic 
cells; BMDC) by culturing with granulocyte-macrophage colony-stimulating factor (GM-CSF) (39, 
42) and human macrophages were derived from blood monocytes by culturing with macrophage 
colony-stimulating factor (M-CSF). Human and mouse SWAP70 amino acid sequences are 95% 
identical and could both be recognized by our polyclonal antibody by Western blot (Fig. 1A). 
SWAP70 was expressed both in mouse BMDCs and RAW264.7 macrophages, as has been reported 
previously (42-45, 20, 29). SWAP70 was expressed in mouse BMDCs at slightly lower levels 
than in moDCs, whereas the expression of SWAP70 was higher both in human macrophages 
and the mouse RAW264.7 macrophage cell line (Fig. 1B). Expression levels of SWAP70 did not 
notably change upon exposure of the cells to the fungal adjuvant zymosan (prepared from 
Saccharomyces cerevisiae). Additionally, we tested SWAP70 expression in the naturally occurring 
myeloid (mDC; CD1c-positive) and plasmacytoid (pDC; BDCA4-positive) dendritic cell subsets 
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isolated from human blood (Fig. 1A). Whereas SWAP70 was expressed by mDCs, we observed 
almost no expression of SWAP70 in pDCs (Fig. 1B). This low expression of SWAP70 in pDCs could 
relate to their low phagocytic ability (36, 49). Stimulation of the mDCs with the bacterial adjuvant 
lipopolysaccharide (LPS) did not result in a significantly altered expression of SWAP70.
In the next step, we examined whether SWAP70 would be present on phagosomes of mouse 
BMDCs and RAW264.7 macrophages. In these experiments, we tested BMDCs differentiated 
both with GM-CSF or with FMS-like tyrosine kinase-3 ligand (FLT3L). Culturing in the presence 
of FLT3L results mainly in mixed populations of pDCs and conventional dendritic cells (cDCs), 
compared with the more heterogeneous mixture of macrophages and dendritic cells present in 
GM-CSF-differentiated BMDCs (32, 33, 39). Similar to our previous study (6), we used zymosan 
particles as phagocytic cargo and selectively searched for early phagosomes containing semi-
internalized particles (i.e. nascent phagocytic cups). We loaded the cells with zymosan-FITC and 
immunolabeled with an anti-FITC antibody in absence of permeabilization, resulting in exclusive 
labeling of partially internalized and uninternalized zymosan-FITC particles (Fig. 1C; blue). In all cell 
types, endogenous SWAP70 was recruited in a polarized fashion to phagosomes and very often 
was found at nascent phagocytic cups. In GM-CSF differentiated dendritic cells and RAW264.7 
macrophages, on average about ~10% of all phagosomes was positive for SWAP70 and about 
~35% of all SWAP70-positive phagosomes were phagocytic cups (Fig. 1D), which resembles our 
previous observations with human moDCs (6). Compared to GM-CSF-differentiated dendritic cells 
and RAW264.7 macrophages, SWAP70 was present at significantly more nascent cups for FLT3L-
differentiated dendritic cells, and this probably relates to a lower phagocytic capability and/or 
altered kinetics of uptake. In the same set of experiments, we compared the phagocytic ability 
of BMDCs and RAW264.7 macrophages by counting the fully internalized zymosan particles in 
those cells. Overall, FLT3L-differentiated BMDCs and RAW264.7 were phagocytosing much less 
zymosan per cell compared with GM-CSF-differentiated BMDCs (Fig. 1E). RAW264.7 is an Abelson
murine leukemia virus-induced tumor cell line cultured for over 4 decades (47) and perhaps 
has lower phagocytic capability than primary phagocytes. FLT3L-differentiated BMDCs are 
substantially smaller (~30 µm diameter) compared with GM-CSF-differentiated BMDCs (~70 µm 
diameter) and perhaps their small cell size limits uptake of zymosan particles (average zymosan 
particle is ~3–5 µm in diameter). 
In moDCs, we previously showed by live cell imaging transient recruitment of SWAP70 to 
early phagosomes concomitantly with F-actin (6). We made similar observations for RAW264.7 
macrophages transiently co-expressing SWAP70 fused to GFP (SWAP70-GFP) together with the 
F-actin binding probe LifeAct fused to RFP (LifeAct-RFP), and observed simultaneous recruitment 
of both proteins to phagosomes engulfing zymosan (Fig. 2A, Movie S1). We also performed 
immunolabeling experiments for Rac1 to determine whether Rac1 was present at SWAP70 and 
F-actin-rich phagosomes in RAW264.7 macrophages, GM-CSF-differentiated BMDCs and FLT3L-
differentiated BMDCs (Fig. 2B). In all 3 cell types, we frequently observed the co-localization of Rac1 
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to SWAP70 and F-actin-positive phagosomes (Fig. 2C), very similar to our previous observations 
with moDCs (6). These data show that SWAP70 is not only recruited to phagosomes in human 
dendritic cells, but also to phagosomes in murine dendritic cells and macrophages.
^ Fig. 1: Phagosomal role of SWAP70 is conserved in human and mouse immune cells. (A) SWAP70 expression in human 
moDCs, human macrophages (MF), mouse GM-CSF-differentiated BMDCs, RAW264.7 macrophages and primary human 
blood-isolated mDCs and pDCs by Western blot. GAPDH: loading control. (B) Quantification of SWAP70 band intensities 
normalized to GAPDH (statistical significance only observed for unstimulated mDC and pDC; P =0.0493, 2-sided paired t- 
test). (C) Representative confocal micrographs of zymosan-FITC (green in merge) pulsed GM-CSF-differentiated BMDCs, 
FLT3L-differentiated BMDCs and RAW264.7 macrophages with immunolabeling for SWAP70 (magenta). Nascent phagocytic 
cups of zymosan-FITC were labeled with an anti-FITC antibody (cyan) in absence of permeabilization (i.e., only uninternalized 
portions of zymosan-FITC are labeled). BF: bright-field. The right-hand schemes depict the positions of the cells and 
phagosomes. Yellow arrowheads: positions of the phagocytic cups. Scale bars: 5 µm. (D) Left-hand graph: the percentages 
of SWAP70-positive phagocytic cups compared with the total number of all internalized zymosan particles from panel C. 
Right-hand graph: percentages of SWAP70-positive phagocytic cups to all SWAP70-positive phagosomes (N=3; >200 cells/
time point). (E) Number of fully internalized zymosan particles over time of uptake for the cells from panel C. Statistical 
significance was assessed for triplicates of the experiment using 1-way ANOVA with post hoc Tukey.
The putative inhibitor of SWAP70 sanguinarine blocks F-actin polymerization and 
phagocytosis
In our recent study, we demonstrated that siRNA knockdown of SWAP70 in human moDCs results 
in a defect in F-actin polymerization and phagocytosis in human moDCs (6). In the current study, 
we aimed to extent these findings and tested whether pharmacological inhibition of SWAP70 with 
the putative SWAP70 inhibitor sanguinarine (15, 26) would result in a similar functional outcome 
and block phagocytosis and F-actin polymerization. Sanguinarine is a quaternary ammonium 
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compound produced by a variety of plants and an inhibitor of the Na+/K+-ATPase. Although not 
directly proven, sanguinarine is proposed to inhibit SWAP70 action based on the findings that it 
can reverse the oncogenic transforming phenotypes of mouse embryo fibroblasts (MEFs) and the 
COS-7 fibroblast cell line expressing wild-type or an oncogenic mutant of SWAP70 (15, 26). 
We tested the effect of sanguinarine on cell viability, phagocytosis and F-actin polymerization. 
moDCs were pre-cultured for 1 hr with sanguinarine before the 1 hr incubation with zymosan-
FITC and phagocytic kinetic was measured by flow cytometry and confocal microscopy. Under 
these experimental conditions, sanguinarine did not affect viability as measured by the MTT 
assay (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and co-staining with 
7-aminoactinomycin D (7AAD; Fig. 3A). MTT is a substrate for mitochondrial reductases and 
allows to measure metabolic activity. 7AAD is a DNA intercalating dye that labels necrotic cells. 
However, we observed a significant increase in staining with the phosphatidylserine-binding 
probe Annexin-V at the highest concentration of sanguinarine tested (24 µm), suggesting that 
some moDCs entered the early apoptotic state (Fig. 3A). We then tested the effect of sanguinarine 
on phagocytosis by flow cytometry (Fig. 3B–D) and confocal microscopy (Fig. 3E–G). For all 
donors tested, the fraction of moDCs that took up zymosan-FITC was significantly reduced by 
sanguinarine and this zymosan-positive fraction took up considerably less particles than without 
sanguinarine (Fig. 3C–F). Similar phagocytic defects caused by sanguinarine were observed for 
neutrophils (1). Moreover, immunofluorescence microscopy revealed a reduced recruitment of 
SWAP70 to phagosomes upon sanguinarine treatment (Fig. 3G), in line with a role for SWAP70 in 
phagocytosis. We also investigated the effect of sanguinarine on the cellular content of F-actin 
filaments by staining the cells with the F-actin binding probe phalloidin conjugated to Alexa fluor 
647. Using both flow cytometry and confocal microscopy, the phalloidin intensity was reduced by 
sanguinarine in a dose dependent manner (Fig. 3H–J). Thus, sanguinarine blocked phagocytosis 
and caused a defect in F-actin polymerization. These results mirror our previous observations 
with siRNA knockdown of SWAP70 in moDCs (6).
SWAP70 inhibits cofilin activity in dendritic cells
In the next set of experiments, we explored the link between SWAP70 and cofilin in phagocytosis. 
Recently, SWAP70 was described to directly regulate cofilin activity in vitro (14). The role of cofilin 
as a severing factor of filamentous actin is well-established (18) although its role in phagocytosis is 
still controversial (24). Cofilin is tightly spatiotemporally regulated by direct binding to regulatory 
proteins, phosphorylation and subcellular localization (23, 28, 57). Cofilin is also negatively 
regulated by binding to phosphatidylinositol (4,5)-bisphosphate (11). SWAP70 is reported to 
directly sequester cofilin and thereby interferes with its F-actin depolymerizing activity (14). In 
line with this finding, we observed that siRNA knockdown of SWAP70 in moDCs (75% knockdown 
efficiency by Western blot; Fig. 4A) resulted in a small (~15%) but significant decrease in the cellular 
content of inactive cofilin (Serine 3 phosphorylation (5, 56, 60)) (Fig. 4B–C). However, the detection 
of phosphorylated cofilin by Western blot is a global method that potentially underestimates 
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local effects at the phagosomal surface. Indeed, immunolabeling showed the enrichment of 
the inactive form of cofilin at actin-rich phagosomes (Fig. 4D), suggesting that cofilin was locally 
sequestered at phagosomes. We were unable to perform co-labeling experiments of inactive 
cofilin together with SWAP70 due to the incompatibilities of the antibodies (both same host 
species and isotype). Thus, SWAP70 depletion not only leads to a reduced activation of Rac1 
at the phagosomal surface as we have shown previously (6), but also to increased activation of 
cofilin. Both these effects likely contribute to the formation and stabilization of F-actin at the 
phagosomal surface by SWAP70.
^ Fig. 2: SWAP70 in murine cells localizes on the phagosomal surface with F-actin and Rac1. (A) Live cell epi-fluorescence 
imaging of RAW264.7 macrophages expressing SWAP70-GFP (green in merge) and LifeAct-mRFP (magenta). The inset 
shows a time series during zymosan uptake (yellow square). See also Movie S1. BF: bright-field. Scale bar: 10 µm. (B) Confocal 
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micrographs of zymosan-pulsed GMCSF-differentiated BMDCs, FLT3L-differentiated BMDCs and RAW264.7 macrophages 
with immunolabeling for SWAP70 (red in merge) and Rac1 (green). F-actin was labeled with phalloidin (magenta). Yellow 
arrowheads: phagosomes positive for SWAP70, Rac1 and F-actin. Scale bars: 5 µm. (C) Venn diagrams and bar graphs from 
panel B showing phagosomal distributions of Rac1, F-actin and SWAP70 (N=3; >100 cells per cell type). Statistical significance 
was assessed for triplicates of the experiment using 1-way ANOVA with post hoc Tukey.
SWAP70 is not enriched at the immunological synapse between dendritic cells 
and T cells
The phagosome is not the only F-actin-rich structure in dendritic cells and macrophages. We 
recently showed that although SWAP70 is present at actin-dense mechanosensitive structures 
called podosomes (31), it is much more enriched at phagosomes (6). This is in line with the 
findings that phagocytosis depends on SWAP70 (6), whereas podosome formation and turnover 
do not depend on SWAP70 (31). Another F-actin-rich region is the immunological synapse formed 
between dendritic cells and T cells. The immunological synapse is a highly organized tight cellular 
interface that provides a platform for the presentation of antigen in major histocompatibility class 
I and II complexes (MHC class I and II) on the surface of the dendritic cell/macrophage to receptors 
on the surface of the T cell (58). In T cells, the actin cytoskeleton is well-understood to play an 
important role in synapse formation, and retrograde transport over F-actin filaments mediates 
the centripetal motion of T cell receptors and adhesion molecules to the synapse (48). F-actin 
also plays a key role at the dendritic cell-side of the immunological synapse, because it provides 
a mechanical counter force that keeps the immunological synapse in a more disorganized state 
with less clustering of T cell receptors (12, 25, 58). Here, the actin cytoskeleton of the dendritic cell 
polarizes toward the immunological synapse and this polarization is required for complete T cell 
activation (2, 3). 
We tested whether SWAP70 would be enriched at the immunological synapse between dendritic 
cells and T cells with 2 model systems for immunological synapse formation. First, we performed 
a mixed leukocyte reaction, where human moDCs were co-incubated with leukocytes isolated 
from blood of a different donor. The C-type lectin DC-SIGN was used for labeling the dendritic 
cells, while the T cells were recognized by labeling for CD3. We did not observe clear localization 
of SWAP70 to the immunological synapse (Fig. 5A–B). When we included zymosan particles 
during the dendritic cell incubation with T cells, we observed massive enrichment of SWAP70 to 
phagosomes, but not to the immunological synapse (Fig. 5B). Second, we tested the recruitment 
of SWAP70 to an antigen-specific immunological synapse in mouse BMDCs. In these experiments, 
mouse FLT3L-differentiated BMDCs depleted of pDCs (B220Ccells) were used as these better 
resemble the conventional resident dendritic cells than GM-CSF-differentiated BMDCs (33,59).
The BMDCs were activated in presence of the adjuvants LPS and 5'-C-phosphate-G-3' (CpG) and 
preincubated with a peptide contained in the model antigen ovalbumin (OVA, residues 257–
264). These dendritic cells can present the OVA257–264 peptide in MHC class I to CD8
+ cytotoxic 
T cells isolated from OT-I mice which express a T cell receptor specific for this peptide (17). We 
observed almost complete exclusion of SWAP70 from the immunological synapse, while SWAP70 
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was detectable in the F-actin-rich region facing away from the immunological synapse (Fig. 
5C). Interestingly, in these FLT3L-differentiated BMDCs, SWAP70 was recruited to phagosomes 
containing latex beads of comparable size to T-cells (~6 µm diameter) (Fig. 5D). These data show 
that SWAP70 is not enriched at the immunological synapse between dendritic cells and T cells, 
but is specifically recruited to phagosomes.
^ Fig. 3: Putative SWAP70 inhibitor sanguinarine blocks phagocytosis and impairs F-actin polymerization in human 
moDC. (A) Viability tests of human moDCs by the MTT assay (Abs: absorbance units at 592 nm) and by flow cytometry with 
AnnexinV and 7AAD staining for the sanguinarine concentrations indicated (0-concentration: methanol control; MeOH). 
(B–D) MoDCs were pretreated with sanguinarine at the concentrations indicated and stimulated with zymosan-FITC for 1 
hour. Shown are the flow cytometry histograms (panel B), the percentages of zymosan-positive cells (panel C; right from 
the gray dashed lines in panel B), and the mean fluorescence index (MFI) of zymosan-FITC (panel D). (E–G) Similar to panels 
B–D, but now phagocytic capability was determined by confocal microscopy. (E) representative confocal micrographs of 
moDCs with internalized zymosan-FITC (green in merge), immunolabeling for SWAP70 (red) and F-actin staining (magenta). 
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BF: bright-field. Scale bar, 10 µm. F: Phagocytic index calculated as the number of internalized zymosan per cell normalized 
to the condition without sanguinarine (N=3 donors, >90 cells/condition/donor). (G) Quantification of SWAP70-positive 
phagosomes per cell. H–I. Same as panels B and D, but now for the phalloidin Alexa Fluor 647 signal (phalloidin-647; F-actin) 
instead of zymosan-FITC. J. Same as panel G, but now for phalloidin-647-positive phagosomes. Statistical significance was 
assessed using one-way ANOVA with post hoc Tukey.
Discussion
In this study, we demonstrate that SWAP70 is recruited to phagosomes in murine dendritic 
cells and macrophages. This adds to our previous finding of transient recruitment of SWAP70 to 
phagosomes in human dendritic cells, and supports that SWAP70 could potentially be a general 
marker of early phagocytosis. We previously showed that phagosomal recruitment of SWAP70 is 
highly specific, and its recruitment to other F-actin-rich regions such as podosomes is much less 
compared with phagosomes (6). In the present study, we show that SWAP70 is not enriched at the 
immunological synapse, even though F-actin has a role in synapse formation and organization 
(2, 3, 12, 25, 5).
activated in presence of the adjuvants LPS and 50-C-phos-
phate-G-30 (CpG) and preincubated with a peptide con-
tained in the model antigen ovalbumin (OVA, residues
257–264). These dendritic cells can present the OVA257–
264 peptide in MHC class I to CD8C cytotoxic T cells
isolated from OT-I mice which express a T cell receptor
speciﬁc for this peptide.17 We observed almost complete
exclusion of SWAP70 from the immunological synapse,
while SWAP70 was detectable in the F-actin-rich region
facing away from the immunological synapse (Fig. 5C).
Interestingly, in these FLT3L-differentiated BMDCs,
SWAP70 was recruited to phagosomes containing latex
beads of comparable size to T-cells (»6 mm diameter)
(Fig. 5D). These data show that SWAP70 is not enriched
at the immunological synapse between dendritic cells and
T cells, but is speciﬁcally recruited to phagosomes.
Discussion
In this study, we demonstrate that SWAP70 is recruited to
phagosomes in murine dendritic cells and macrophages.
This adds to our previous ﬁnding of transient recruitment
of SWAP70 to phagosomes in human dendritic cells, and
supports that SWAP70 could potentially be a general
marker of early phagocytosis. We previously showed that
phagosomal recruitment of SWAP70 is highly speciﬁc,
and its recruitment to other F-actin-rich regions such as
podosomes is much less compared with phagosomes.6 In
the present study, we show that SWAP70 is not enriched
at the immunological synapse, even though F-actin has a
role in synapse formation and organization.2,3,12,25,58
SWAP70 colocalized at the phagosome with the Rho-
GTPase Rac1 and F-actin, and this strengthens our
Figure 4. SWAP70 inhibits the activity of coﬁlin. (A) Knock-down of SWAP70 in human moDCs (gray; siSWAP70) or non-targeting siRNA
(black; siControl) by Western blot (mean § s.e.m; paired 2-sided t test). GAPDH: loading control. (B) Ser3-phosphorylated (inactive) coﬁ-
lin (P-coﬁlin) compared with GAPDH by Western blot upon SWAP70 knockdown. (C) Quantiﬁcation of panel B for moDCs from 4 and 3
different donors (individual donors shown; paired 2-sided t tests). (D) Representative confocal micrographs of zymosan-pulsed dendritic
cells immunostained for P-coﬁlin (magenta in merge) and F-actin (green). Yellow arrowheads indicate double-positive phagosomes.
Scale bar: 5 mm
SMALL GTPASES 7
^Fig. 4: SWAP70 inhibits the activity of cofilin. (A) Knock-down of SWAP70 in human moDCs (gray; siSWAP70) or non-
targeting siRNA (black; siControl) by Western blot (mean ± s.e.m; paired 2-sided t test). GAPDH: loading control. (B) 
Ser3-phosphorylated (inactive) cofilin (P-cofilin) compared with GAPDH by Western bl t upon SWAP70 knockdown. (C) 
Quantification of panel B for moDCs from 4 and 3 different donors (individual donors shown; paired 2-sided t tests). (D) 
Representative confocal micrographs of zymosan-pulsed dendritic cells immunostained for P-cofilin (magenta in merge) 
and F-actin (green). Yellow arrowheads indicate double-positive phagosomes. Scale bar: 5 µm.
SWAP70  co-localized at the phagosome with the Rho-GTPase Rac1 and F-actin, and this strengthens 
our previous conclusion that SWAP70 specifically tethers Factin at the phagosome via Rac1 and 
PtdIns(3,4)P2 (6). Since we did not bserve enrichment of SWAP70 to the immun logic l synapse, 
it seems logical that one or both of these factors are not sufficiently present at the synapse. 
83
SWAP70 iS A univerSAl GeF-like AdAPtor For tetherinG Actin to PhAGoSomeS
4
Finally, we showed that SWAP70 promotes the inactivation of cofilin, likely by sequestering the 
inactive form of cofilin on the phagosomal surface as has been shown in vitro (14). As cofilin is a 
severing factor of filamentous Factin (18), this likely contributes to the stabilization of F-actin on 
the phagosomal surface by SWAP70 (6).
^Fig. 5: SWAP70 is not enriched at the immunological synapse between dendritic cells and Tcells. (A) Representative 
confocal micrographs of human moDCs cultured with allogenic human peripheral-blood leukocytes and immunolabeled 
for the dendritic cell marker DC-SIGN (magenta in merge) and SWAP70 (red). F-actin was labeled with phalloidin (green). The 
right-hand scheme depicts the position of the moDC and T cell. Orange arrowhead: position of the immunological synapse. 
(B) Same as panel A, but now with immunolabeling for the T cell marker CD3 (magenta) instead of DC-SIGN, and exposure of 
the cells to zymosan for 1 h before fixation. Yellow arrowhead: SWAP70-positive zymosan-containing phagosome (marked 
with ‘P’ in scheme). (C) Same as panel A, but now with OVA-antigen loaded mouse FLT3L-differentiated BMDCs and OVA-
antigen specific CD8+ cytotoxic OT-I T cells. Yellow arrowhead: SWAP70 localization opposite to the immunological synapse. 
(D) Confocal micrograph of FLT3L-differentiated BMDC pulsed with 6 µm-sized latex beads and immunostained for SWAP70. 
Yellow arrowhead: SWAP70-positive bead-containing phagosome. Scale bars: 10 µm.
Our findings are of particular interest given the increasing evidence that SWAP70 has a potential 
role in cancer. SWAP70 is targeted by microRNAs in prostate cancers, and silencing of SWAP70 
exhibited anti-tumor effects (16). In mouse embryo fibroblasts (MEFs), SWAP70 was necessary 
for acquiring an oncogenic phenotype upon v-Src transformation (27, 41) as well as for their 
spontaneous transformation (15). NIH3T3 cells and MEFs overexpressing SWAP70 bearing 
naturally occurring mutations exhibited increased growth rates and skewed signaling pathways 
(26, 52). Our data now show that besides its previously described role in promoting oncogenesis, 
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SWAP70 could also be required for the clearance of cancer material by phagocytes of the immune 
system. All these studies put SWAP70 forward as an interesting potential target for future anti-
cancer therapeutic intervention.
Material and Methods
Animals
Wild-type female C57Bl/6JRccHsd mice were purchased from Charles River (Sulzfeld, Germany). 
For experiments including immune synapses of murine cells, the C57BL/6-Tg(TcraTcrb)1100Mjb/J/
Thy1 strain (OT-I) was used. Mice were housed at the Central Animal Laboratory of the Radboud 
University Medical Center, Nijmegen. All animal experiments were performed under approval by 
the Animal Experimental Committee of the Radboud University Medical Center, and in accordance 
with European, national and institutional guidelines.
Cells
BMDCs were generated from 7–11 weeks old mice. Briefly, bone marrow cells were isolated 
and cultured in RPMI 1640 medium (Gibco), supplemented with 10% fetal calf serum (FCS), 1% 
L-alanyl-L-glutamine, 0.1% β-mercapto-ethanol and 0.5% antibiotics/antimycotics (AA, Gibco). For 
differentiation, this complete medium was supplemented with either 20 ng/ml GM-CSF or 200 
ng/ml FLT3L (both from Peprotech) on the day of culture onset (Day 0). In both cases cells were 
used on day 8 of culture. MoDCs were generated as described (7), human macrophages were 
generated from blood-derived adherent monocytes by culturing in presence of recombinant 
human M-CSF (40 ng/ml) (R&D Systems; 216-MC-005) for 6 d. The fully differentiated human 
moDCs and macrophages were validated by comparative expression analysis of CD14, CD163 
and CD206 with flow cytometry. Primary mDCs and pDCs were isolated from donor’s blood 
by magnetic bead separation with CD1c+ (Miltenyi Biotec; 130–090–506) and BDCA4+ (Miltenyi 
Biotec; 130–090–532) isolation kits. SiRNA knockdown procedures are described (6, 19). For live 
cell microscopy of RAW264.7 macrophages, cells were transfected with Fugene HD (Promega; Lot 
0000027400; REF E231) following the manufacturer’s guidelines. The SWAP70-GFP and LifeAct-RFP 
plasmids and imaging protocols have been described (6). Cells were pulsed with IgG-opsonized 
zymosan as described (6). Day 8 FLT3L-differentiated BMDCs (depleted of B220+ cells with mouse 
CD45R MicroBeads, Miltenyi Biotec; 130–049–501) and activated for 4 h with 1 μg/ml LPS and 1 
μg/ml CpG-B 1826) were pulsed with 6.0 μm-sized Polybead Carboxylate beads (Polysciences; 
Cat. No. 17141) for 1 h before fixation and staining.
Immunological synapse models
For the mixed leukocyte reaction, moDCs cultured on coverslips (50,000 cells) were first activated 
with LPS (1 µg/ml) for 3 h in complete in RPMI 1640 medium containing 10% FCS, 1% L-alanyl-L-
glutamine and AA in a humidified, 5% CO2-containing atmosphere. MoDCs were then co-cultured 
for another 3 h with peripheral leukocytes (100,000 cells) that were directly isolated from blood 
of a different donor. Zymosan was added at a 1:10 cell-to-particle ratio during the final 1 hour 
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of incubation. For the OVA-specific immunological synapses, day 8 FLT3L-differentiated BMDCs 
(depleted of B220+ cells) were activated for 4 h with LPS and CpG-B. The OVA-derived 257–264 
(SIINFEKL) antigenic peptide was added during the last 30 min of incubation. OT-I splenocytes 
were isolated from a 6 month old OT-I male mouse with a CD8a+ T Cell Isolation Kit (Miltenyi 
Biotec; 130–104–075). CD8a+ T cells were labeled with CFSE (ThermoFisher; C34554) for 10 min at 
RT and washed with MACS buffer. They were then resuspended in BMDC medium at a ratio of 2 
OT-I cells to 1 FLT3Ldifferentiated cell. Synapses were allowed to form by culturing for 3 h. Cells 
were fixed for 20 min in 4% PFA and stained for SWAP70 and F-actin as described (6).
Immunoblotting, flow cytometry, MTT and AnnexinV-7AAD viability assays
Detailed immunoblotting procedures are described. Cofilin was immunolabeled with a rabbit 
monoclonal IgG anti-phospho cofilin (Ser3) (Cell Signaling; 3313P; used at 1:500). Immunolabeling 
protocols, FACS and MTT assays were performed as described (6, 19). Cells were treated with 
sanguinarine at 2, 6, 12, 24 μM concentrations in RPMI medium from a 1 mM stock in methanol 
similar to as described for the SHIP inhibitors (6). 2.4% methanol in RPMI was used as a solvent 
control (i.e., equivalent to the methanol content at the highest concentration of sanguinarine). 
AnnexinV-FITC (BD Biosciences; 56419) and 7AAD (eBioscience; 00–6993–50) viability tests were 
done according to the manufacturer’s guidelines. In short, drug-treated cells were stained on ice 
for 10 min in the presence of 1.5 mM CaCl2.
Microscopy
Protocols for immunofluorescence labeling and staining of the phagocytic cup with zymosan-
FITC are described (6). The following primary antibodies were used: rabbit polyclonal anti-SWAP70 
(Novus Biologicals; cat. no NBP1–82979) at 1:200 dilution (v/v) for IF and 1:500 for Western blot; 
mouse monoclonal anti-Rac1 (Cell Biolabs; 240106) at 1:100; mouse IgG1 anti-FITC Alexa fluor 
647 (Jackson ImmunoResearch; 200–602–037) at 1:200; mouse IgG2b anti-human DC-SIGN (BD 
PharMingen;551186; clone DCN46) at 1:100; mouse IgG2a kappa anti-CD3 (BioXcell; clone OKT3) 
at 500 ng/ml. Alexa fluor 633 labeled phalloidin was from ThermoFisher (A22284) and used at 
1:200 (v/v). The following secondary antibodies were used: goat-anti-mouse Alexa fluor 488 (Life 
Technologies; A11029); goat-anti-rabbit Alexa fluor 568 or 647 (Life Technologies; A11036 and 
A21245). Samples were imaged on a Leica SP8 confocal microscope as described (6), or on a Zeiss 
LSM880 confocal microscope with 405 nm and 561 nm diode lasers, a multi-line argon laser and 
a 633 nm laser for excitation and a 63 x 1.40 NA oil immersion objective. Live cell microscopy was 
performed on a Leica DMI6000 epi-fluorescence microscope as described (6).
Statistics
All data were analyzed for a minimum of 3 independent donors/repeats using 1-way ANOVA (with 
post hoc Tukey) or with Student’s 2-tailed paired t tests (*P < 0.05; **P < 0.01; ***P < 0.001; ns: not 
significant). Data are plotted as average of SEM.
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Abstract
Antigen presentation to T cells in major histocompatibility complex class II (MHC class II) requires 
the conversion of early endo/phagosomes into lysosomes by a process called maturation. 
Maturation is driven by the phosphoinositide kinase PIKfyve. Blocking PIKfyve activity by small 
molecule inhibitors caused a delay in the conversion of phagosomes into lysosomes and in 
phagosomal acidification, whereas production of reactive oxygen species (ROS) increased. 
Elevated ROS resulted in reduced activity of cathepsin S and B, but not X, causing a proteolytic 
defect of MHC class II chaperone invariant chain Ii processing. We developed a novel universal 
MHC class II presentation assay based on a bio-orthogonal ‘‘clickable’’ antigen and showed that 
MHC class II presentation was disrupted by the inhibition of PIKfyve, which in turn resulted in 
reduced activation of CD4+ T cells. Our results demonstrate a key role of PIKfyve in the processing 
and presentation of antigens, which should be taken into consideration when targeting PIKfyve 
in autoimmune disease and cancer.
Introduction
Endocytosis and phagocytosis of microbial pathogens, virus-infected cells, and cancer cells is 
essential for their immune clearance by phagocytes of the immune system (Fairn and Grinstein, 
2012; Neefjes et al., 2017). In addition, dendritic cells present peptides derived from ingested 
antigens on major histocompatibility complex (MHC) classes I and II to T lymphocytes and are 
thereby responsible for the initiation of adaptive immune responses (Banchereau and Steinman, 
1998). There are various types of endocytosis and phagocytosis, which differ in the receptors 
engaged, the role of the cytoskeleton, cage proteins, and lipid composition (Fairn and Grinstein, 
2012; Levin et al., 2015; Nunes et al., 2013). Following uptake, endosomes and phagosomes undergo 
a transition from early to late endo/phagosomes and eventually to lysosomes. This process is 
mediated by membrane remodeling called maturation, where endosomes and phagosomes 
fuse with other endosomes and lysosomes and recruit cytosolic proteins to their membranes, 
such as Rab-GTPases and tethering factors (Egami, 2016; Fairn and Grinstein, 2012; Flannagan 
et al., 2012; Naufer et al., 2018; Neefjes et al., 2017; Uribe-Querol and Rosales, 2017; Vieira et al., 
2003). Early endosomes and phagosomes are only mildly acidic or even basic (Flannagan et al., 
2009; Mantegazza et al., 2008; Savina et al., 2006), whereas lysosomes and phagolysosomes are 
very acidic due to activation of vacuolar proton pumps (pH < 5; Trombetta et al., 2003) and have 
increased presence and activity of metabolic enzymes for the degradation of ingested material 
(Kinchen and Ravichandran, 2008). 
The MHC class II loading of proteolytically derived peptides occurs within specialized lysosome-
like compartments called MHC class II compartments (MIIC) (Amigorena et al., 1994; Calafat et 
al., 1994; Castellino and Germain, 1995; Sadegh-Nasseri, 2016; Tulp et al., 1994; West et al., 1994). 
Within these acidic luminal compartments, the non-polymorphic chain of MHC class II Ii is 
proteolytically activated by its cleavage, reducing it to the 24-amino acid class II-associated Ii 
peptide (CLIP) (Jasanoff et al., 1999). Ii is a chaperone carrying sorting signals on its cytoplasmic 
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tail and interacting with MHC class II thereby controlling its trafficking from the endoplasmic 
reticulum to the trans-Golgi network (TGN), endosomal compartments, and eventually to the cell 
surface (Jones et al., 1978; Teyton et al., 1990). Ii prevents premature antigen loading into the cleft 
of MHC class II, whereas CLIP can be exchanged in MIIC for an antigen peptide by the chaperone 
human leukocyte antigen (HLA)-DM. The protease cathepsin S (CatS) plays an essential role for Ii 
processing to CLIP and for the proteolytic processing of ingested antigen (Honey and Rudensky, 
2003; Riese et al., 1996; Villadangos and Ploegh, 2000), and only three cathepsins (CatB, CatH, and 
CatS) suffice for generating essential immunodominant epitopes in vitro (Kim et al., 2014a).
A central hallmark of endo/phagosomal maturation is the progressive change in the content 
of phosphoinositide lipids on the endosomal and phagosomal membrane (Levin et al., 2015; 
Shisheva, 2001). These phosphoinositides are important for endo/phagosomal maturation, as 
they are major determinants of organellar identity and form anchor points for numerous proteins 
involved in membrane trafficking or cytoskeletal tethering (Baranov et al., 2016, 2017; Levin et 
al., 2015). Within minutes after uptake, phosphatidylinositol 4,5-bisphosphate, which is the 
main phosphoinositide species at the plasma membrane, is converted into phosphatidylinositol 
3-phosphate (PI(3)P) by various kinases and phosphatases. PI(3)P is the main phosphoinositide 
species at early endosomes and phagosomes and resides there for 5–10min (Ellson et al., 2001a; 
Fratti et al., 2001; Gillooly et al., 2000; Vieira et al., 2003) before the acidification of these organelles 
(Naufer et al., 2018). The maturation of early into late endo/phagosomes and lysosomes requires 
the conversion of PI(3)P into phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) (Ho et al., 2012; 
Sbrissa et al., 2002). PI(3,5)P2 is a low-abundance phosphoinositide amounting to 0.04%–0.1% 
of the total phosphoinositide pool (Ho et al., 2012; McCartney et al., 2014). Phosphoinositide 
5-kinase (PIKfyve; yeast ortholog Fab1p) is the sole enzyme capable of producing PI(3,5)P2 from 
PI(3)P, which it targets via its FYVE domain (Ho et al., 2012; Sbrissa et al., 2002; Shisheva et al., 2015). 
Blocking of PIKfyve activity delays phagosomal maturation, leading to the buildup of cellular PI(3)
P and a drastic reduction of cellular levels of PI(3,5)P2 (Hazeki et al., 2012; Kim et al., 2014b). Given 
the late endosome/lysosome-like nature of MIIC, a role of PI(3,5)P2 and PIKfyve in MHC class II 
presentation can be expected, but has not been shown. 
PIKfyve can be inhibited by two small molecule inhibitors: apilimod (STA-5,326) (Cai et al., 2013) 
and YM201636 (Hazeki et al., 2012; Jefferies et al., 2008). Apilimod was originally developed to treat 
inflammatory diseases (Burakoff et al., 2006; Krausz et al., 2012; Sands et al., 2010; Wada et al., 2007, 
2012) and was later found to specifically target and inhibit PIKfyve (Cai et al., 2013). YM201636 is a 
specific antagonist of PIKfyve (Jefferies et al., 2008), and although it has not been tested in clinical 
trials, it is commonly used to inhibit PIKfyve (Compton et al., 2016; Gomez et al., 2018; Hazeki 
et al., 2012; Ikonomov et al., 2009; Kerr et al., 2010; Kim et al., 2014b; Krishna et al., 2016; Sbrissa 
et al., 2012). Pharmacological inhibition of PIKfyve or expression of a dominant negative form 
of PIKfyve (Ikonomov et al., 2001; Jefferies et al., 2008; Shisheva, 2001) causes the formation of 
enlarged (‘‘foam-like’’) vacuoles (Cai et al., 2013; Dong et al., 2010; Jefferies et al., 2008; Min et al., 
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2014), likely because of osmotic differences caused by the reduced activity of PI(3,5) P2-dependent 
cation channels such as the lysosomal cation channel TRPML1/MCOLN1 (Compton et al., 2016). 
These enlarged vacuoles are likely endosomes that cannot be reformed into lysosomes (Bissig 
et al., 2017), and their formation can be used as a readout of depletion of cellular PI(3,5)P2 (Kim et 
al., 2014b). 
Given the role of late endosome/lysosome-related MIIC in the proteolytic processing of antigen 
and subsequent MHC class II loading, we hypothesized that interfering with PIKfyve activity 
would inhibit the degradation and presentation of antigen by dendritic cells. To address this 
hypothesis, we studied the effects of PIKfyve inhibition by apilimod and YM201636 on endo/
phagosomal maturation, protease activity, and antigen presentation. As reported (Cai et al., 2013, 
2014), PIKfyve inhibition blocked interleukin (IL)-12 secretion in monocyte-derived dendritic cells. 
PIKfyve inhibition also affected the maturation of phagosomes, with impaired acidification and 
lower recruitment of the lysosomal proteins lysosome-associated membrane protein 1 (LAMP1) 
and mannose 6-phosphate receptor (M6PR) to phagosomes, whereas the early phagosomal 
markers PI(3)P and EEA1 were more abundant (Compton et al., 2016; Dayam et al., 2017; Dove et 
al., 2009; Gayle et al., 2017a; Gomez et al., 2018; Hazeki et al., 2012; Ikonomov et al., 2009; Kerr et 
al., 2010; Kim et al., 2014b; Krishna et al., 2016; Sbrissa et al., 2007, 2012). Moreover, inhibition of 
PIKfyve selectively blocked the activity of cathepsin B and S, and this resulted in an increased 
presence of Ii-bound MHC class II within the cell, but not on the cell surface. PIKfyve inhibitors 
caused prolonged presence of the NADPH oxidase NOX2, which is present on early, but not late, 
endosomes and phagosomes (Dingjan et al., 2017a, 2017b). This resulted in increased reactive 
oxygen species (ROS) production, leading to lower activity of CatS. We show that the impaired 
processing of Ii and MHC class II trafficking defects upon blockage of endo/phagosomal 
maturation with PIKfyve inhibitors results in lower MHC class II antigen presentation. This was 
demonstrated with a novel assay based on a viral antigen carrying an unnatural amino acid 
amendable to bio-orthogonal labeling of the MHC-class-II-presented epitope. The combined 
effects of reduced proteolytic processing and reduced MHC class II presentation upon blocking 
PIKfyve result in an impaired activation of antigen-specific T cells. These results show a key role 
for PIKfyve in T cell activation, and this should be taken into consideration for the use of PIKfyve-
targeting drugs in clinical trials.
Results
PIKfyve Inhibition Delays Phagosomal Maturation
We started by determining whether PIKfyve would localize to antigen-containing compartments. 
To visualize the localization of PIKfyve in live cells, we transfected dendritic cells differentiated 
from human-blood derived monocytes with plasmids coding for GFP-tagged PIKfyve (PIKfyve-
GFP) (Figure 1A; Video S1). The actin cytoskeleton was visualized by simultaneous transfection 
with a plasmid coding for the F-actin-binding probe LifeAct fused to the red-shifted fluorescent 
protein mRFPruby (Riedl et al., 2008). Late endo/phagosomes and lysosomes were identified 
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with LAMP1 fused to red fluorescent protein (RFP) (Figure 1B; Video S2) (Sherer et al., 2003). The 
dendritic cells were pulsed with the model pathogen zymosan, relatively large yeast-derived 
particles (4–5 µm diameter) that allow for the unequivocal assignment of phagosomal localization 
of candidate proteins by microscopy and result in an increased expression of PIKfyve (Figure S1A). 
We observed that PIKfyve-GFP was recruited within 2 min after the formation of the phagosomal 
F-actin cytoskeleton (Figure 1A), which we recently showed is formed at the nascent cup of 
emerging phagosomes by tethering to phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2) and is 
subsequently removed after closure of the phagocytic cup (Baranov et al., 2016). At later time 
points after uptake (>7 min), the signal of PIKfyve-GFP gradually decreased at the phagosomes, 
whereas the signal of LAMP1-RFP increased (Figure 1B). We also immunostained zymosan-pulsed 
dendritic cells expressing PIKfyve-GFP for endogenous LAMP1 as well as for the early endosomal 
marker EEA1 (Figure 1C). EEA1 is known to bind to early endo/phagosomes by interactions of its 
FYVE domain with PI(3)P (Ho et al., 2012; Sbrissa et al., 2002), which is the substrate for PIKfyve. 
PIKfyve-GFP was partially co-residing with EEA1 on phagosomes, whereas overlap with LAMP1 
was lower (Figure 1D). Together, these results show that PIKfyve is recruited to phagosomes within 
minutes after their formation and remains present at early phagosomes before their conversion 
into late phagosomes.
^ Fig. 1: PIKfyve Is Present Early during Phagosomal Maturation (A) Live cell imaging of a human monocyte-derived dendritic 
cell overexpressing human PIKfyve-GFP (green in merge) together with the F-actin-binding probe RFP-LifeAct (red) and 
pulsed with IgG-opsonized zymosan particles. The insets show snapshots at the indicated time points. Yellow arrowheads, 
time series of phagosome. See also Video S1. BF, brightfield. (B) Same as (A), but now with PIKfyve-GFP (green) and LAMP1-
RFP (red). See also Video S2. (C) Confocal micrograph of representative zymosan-pulsed (1 hr) dendritic cell overexpressing 
PIKfyve-GFP (yellow in merge) with immunostaining for EEA1 (green) and LAMP1 (magenta). Yellow arrowheads, PIKfyve-
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GFP and EEA1 double-positive phagosomes. (D) Quantification of (C) (150 phagosomes per donor; three donors). Scale bars, 
10 µm. See also Figure S1.
Next, we validated the reported inhibition of endosome and phagosome maturation by blockage 
of PIKfyve activity with apilimod and YM201636 (Compton et al., 2016; Dayam et al., 2017;Dove et 
al., 2009;Gayle et al., 2017a; Gomez et al., 2018; Hazeki et al., 2012; Ikonomov et al., 2009; Kerr et al., 
2010; Kim et al., 2014b; Krishna et al., 2016; Sbrissa et al., 2007, 2012). We selected concentrations 
of 200 nM apilimod (Cai et al., 2013; Compton et al., 2016; Terajima et al., 2016; Wada et al., 2012; 
Wong et al., 2017) and 4 µM YM201636 (Currinn et al., 2016; Ikonomov et al., 2009), which did not 
significantly affect the viability of the dendritic cells, although metabolic activity was somewhat 
affected by apilimod (by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
assay; Baranov et al., 2016; Baranov et al., 2017; Dingjan et al., 2016) and YM201636 treatment 
non-significantly increased the fraction of early apoptotic cells (by annexin V staining; Figures 
S1B–S1D). These concentrations were used in previous studies and resulted in inhibition of IL-
12 production by the dendritic cells (Cai et al., 2013;Wada et al., 2012) (Figure S1E). Treatment of 
dendritic cells with apilimod or YM201636 resulted in massive cellular vacuolization (Figure S1F), 
a well-known effect of PIKfyve inhibition (Cai et al., 2013; Dayam et al., 2017; Krishna et al., 2016). 
This vacuolization was also observed when a dominant negative form of PIKfyve was expressed 
(PIKfyve-GFP with K1831E [Cai et al., 2013; Ikonomov et al., 2001; Sbrissa et al., 2000]) (Figure S1G) 
and with small interfering RNA (siRNA) knockdown (Figure S1H). Moreover, treatment of dendritic 
cells by apilimod or YM201636 compromised phagocytosis of the zymosan particles as well as 
endocytosis of fluorescently labeled albumin by almost half (Figures S1I and S1J). Previously 
reported PIKfyve perturbations led to inhibition of IgG-latex bead uptake by neutrophils (Dayam 
et al., 2017) and mouse RAW 264.7 macrophages (Kim et al., 2014b) and to lower Escherichia coli 
uptake by RAW 264.7 macrophages (Wong et al., 2017). To account for this reduced antigen uptake, 
we present our results relative to the total number of phagosomes per cell. Both apilimod and 
YM201636 treatment resulted in blockage of phagosome maturation, as apparent from a reduced 
fraction of LAMP1 and increased fractions of EEA1-positive (Figures 2A and 2B) and PI(3)P-positive 
phagosomes (Figures 2C and 2D). In addition, phagosomal recruitment of M6PR, another late 
endosomal marker that is involved in trafficking from the TGN to lysosomes, was also reduced 
upon apilimod and YM201636 treatment (Figures S1K and S1L). To exclude off-target effects of 
the drugs, we performed siRNA knockdown of PIKfyve. Even though we only reached an 50% 
knockdown efficiency of PIKfyve by qPCR (Figure S1M), this led to a reduced recruitment ofLAMP1 
to phagosomes (Figure S1N) similar to the small molecule inhibitors. Finally, acidification of the 
phagosomal lumen was reduced by apilimod or YM201636 treatment, as shown by experiments 
with zymosan conjugated to pHRodo, a pH-sensitive dye with increased fluorescence at low pH 
(Figures 2E and 2F). Similar blockage of acidification was observed with PIKfyve siRNA knockdown 
(Figure 2G).
Cathepsin B and S Activities and Proteolytic Activation of MHC Class II Are 
Reduced upon PIKfyve Inhibition
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Phagosomal maturation and acidification are necessary to trigger the activity of hydrolases 
involved in the degradation of ingested antigen, and thereby for deriving antigenic peptides for 
presentation in MHC class II (Blum et al., 2013; ten Broeke et al., 2013). A major class of proteases 
are cysteine cathepsins, named after the catalytic cysteine located within their active sites (Verma 
et al., 2016) and consisting of 11 family members present in endosomes, phagosomes, and 
lysosomes (Turk et al., 2012). CatS is predominantly expressed by professional antigen-presenting 
cells, such as dendritic cells and B cells (Blum et al., 2013) and, unlike other cathepsins, is active not 
only in acidic but also in neutral and slightly alkaline environments (Jancic et al., 2007; Kirschke et 
al., 1989). As we observed that inhibition of PIKfyve by apilimod or YM201636 impaired lysosomal 
acidification and affected trafficking to late endosomes/lysosomes, we hypothesized that this 
would alter the activity of cathepsins. We applied the activity-based probe BMV109 to living cells 
before lysis (Verdoes et al., 2013). The BMV109 probe results in covalent attachment of a fluorophore 
to the catalytic sites of active cysteine cathepsins (Verdoes et al., 2013), thereby allowing for the 
quantitative assessment of their activities by in-gel fluorescence (Figure S2A). We compared 
unstimulated and zymosan-pulsed dendritic cells treated with apilimod or YM201636 (Figure 3A). 
Analysis of protein levels by western blot showed that PIKfyve inhibitors did not cause changes of 
total cathepsin levels (Figure S2A). For unstimulated cells, we observed reduced cathepsin B and 
S activities by treatment with apilimod or YM201636, whereas the activity of cathepsin X was not 
altered (Figures 3B, 3C, and S2B). However, stimulation of the cells with zymosan diminished these 
effects, and significant differences in cathepsin activity could no longer be detected after 1-hr 
incubation. Immunolabeling of endogenous CatS in phagocytic dendritic cells was visible at the 
core of the zymosan particles (Figure 3D). Microscopy experiments with the activity-based probe 
BMV109 confirmed that this is the site of cathepsin activity (Figures S2C and S2D). BMV109 signal 
became apparent at phagosomes 30–60 min after zymosan uptake and was present in LAMP1-
positive phagosomes (Figure S2C). Immunofluorescence microscopy revealed that the majority 
of CatS-positive phagosomes are also LAMP1 positive (Figure S2E). Treatment with apilimod or 
YM201636 reduced the signals of both CatS immunostaining (Figures 3D–3E) and BMV109 (Figures 
S2D and S2F) at the phagosomes, indicating that trafficking of CatS to phagosomes is reduced by 
PIKfyve inhibitors. To determine whether the reduced CatS activity was solely attributable to its 
reduced recruitment to phagosomes upon PIKfyve inhibition, we performed experiments with 
BMV109 in lysates of dendritic cells (Figure S3A). For some conditions, apilimod and YM201636 still 
reduced the signal of BMV109 for CatS, whereas the signals for cathepsins B and X were unaltered 
(Figures S3B and S3C). We conclude that the reduced CatS activity upon PIKfyve inhibition is not 
solely due to altered trafficking, because CatS activity is also reduced in cell lysates.
v Fig. 2: PIKfyve Controls Phagosomal Maturation. (A) Confocal images of representative dendritic cells treated with 
apilimod (200 nM) or YM201636 (4 µM) for 3 hr and pulsed with zymosan 1 hr before fixation. DMSO, vehicle control. Cells 
were immunolabeled for LAMP1 (magenta in merge). Blue, DAPI staining. BF, brightfield. (B) Quantification of (A) normalized 
to the total number of phagosomes per cell (~150 phagosomes per condition per donor; mean ± SEM of three donors for 
EEA1 and six donors for LAMP1). (C) Epifluorescence microscopy of representative dendritic cells expressing GFP-tagged 
phosphoinositide-probe for PI(3)P based on PX domain of NCF4 (PI(3)P; green in merge) and immunolabeled for LAMP1 
(magenta). The cells were treated as in (A). Yellow arrowheads, PI(3)P-positive phagosomes; cyan arrowheads, LAMP1-
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positive phagosomes. (D) Quantification of (C) normalized to the total number of phagosomes per cell (~116 phagosomes 
per condition per donor; mean ± SEM of three donors). (E) Confocal imaging of dendritic cells treated with DMSO, apilimod, 
or YM201636 for 3 hr before addition of pHRodo-labeled zymosan 1 hr before live imaging. The color intensity of pHRodo 
(magenta) scales with acidic pH. Cyan in merge, Hoechst. (F) Quantification of (E); MFI, mean fluorescence intensity (mean 
± SEM for three donors, ~ 1,000 phagosomes per condition per donor). (G) Same as (F), but now with siPIKfyve (~400 
phagosomes per condition per donor; see also Figure S1M for knockdown levels). Scale bars: 10 µm. *P < 0.05, **P < 0.01, 
***P < 0.001. See also Figure S1.
CatS is expressed at high levels by dendritic cells and has a strong immunological relevance, 
because it controls the generation of CLIP (Honey and Rudensky, 2003; Riese et al., 1996; 
Villadangos and Ploegh, 2000). Within endolysosomes, CLIP is derived from the invariant chain Ii 
via the intermediate fragments Iip23 and Iip10 (Amigorena et al., 1995; Neefjes and Ploegh, 1992; 
Villadangos et al., 2000). The final processing of Iip10 into CLIP is mediated by CatS. The inhibition 
or loss of CatS in mice (Nakagawa et al., 1999; Shi et al., 1999) causes accumulation of Iip10-bound 
MHC class II in endo/lysosomal compartments, impeding MHC class II trafficking to the cell surface 
(Brachet et al., 1997; Riese and Chapman, 2000). As inhibition of PIKfyve results in reduced activity 
of CatS, we hypothesized that apilimod and YM201636 would cause a defect of Ii processing and 
MHC class II trafficking. To address this hypothesis, we first assessed the effects of apilimod or 
YM201636 treatment on plasma membrane localization of MHC class II. Flow cytometry 
experiments with an antibody recognizing the extracellular domain of MHC class II revealed that 
apilimod or YM201636 treatment caused a small (10%–20%) but consistent reduction of the 
presence of MHC class II at the plasma membrane (Figures 4A and 4B). In contrast, total cellular 
levels of MHC class II, measured by immunolabeling in the presence of a detergent, were unaltered 
or even (inconsistently) increased (Figure 4C). Similar observations were made with dendritic cells 
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derived from mouse bone marrow (Figures S4A–S4C). We also performed flow cytometry 
experiments with an antibody recognizing Ii or CLIP-bound to abMHC class II (clone CerCLIP.1; 
Denzin et al., 1994), revealing that the presence of this inactive form of MHC class II was also 
reduced at the plasma membrane, whereas the total cellular levels were increased (Figures S4D–
S4F). The defect in processing of CLIP upon PIKfyve inhibition was also observed by western blot 
with mouse bone-marrow-derived dendritic cells using an antibody recognizing the Iip10 
fragment (Figures S4G and S4H). Here, we used the CatS inhibitor LHVS (morpholinurea-leucine-
homophenylalanin-vinylsulfone-phenyl) as a positive control (Palmer et al., 1995; Riese et al., 
1998). A direct inhibition of CatS with LHVS also had a similar effect on MHC class II trafficking as 
PIKfyve inhibition with apilimod or YM201636 (Figures S4I and S4J). Microscopy imaging of 
phagocytic cells overexpressing fluorescently tagged MHC class II (Zwart et al., 2005) showed that 
MHC class II is recruited to phagosomes after zymosan uptake (Video S3). Immunofluorescence 
microscopy showed that treatment with PIKfyve inhibitors showed increased accumulation of 
endogenous MHC class II on the phagosomes (Figures 4D and 4E), suggesting a trafficking defect. 
Together, these results show that PIKfyve supports CatS activity and thereby regulates the 
proteolytic activation of MHC class II. 
The Inactivation of Cathepsin S upon PIKfyve Inhibition Is due to Oxidative 
Modifications
In dendritic cells, NOX2 produces large amounts of ROS within the lumen of endosomes and 
phagosomes, and this ROS production is sustained for hours after uptake (Dingjan et al., 2016, 
2017a, 2017b; Jancic et al., 2007; Joffre et al., 2012; Kotsias et al., 2013; Mantegazza et al., 2008; 
Nunes et al., 2013; Savina et al., 2006; Vulcano et al., 2004). ROS alter the processing of the ingested 
antigen for MHC classes I and II presentation (Hari et al., 2015; Mantegazza et al., 2008; Rybicka 
et al., 2012), with one of the mechanisms being the oxidative modification of a cysteine located 
within the catalytic site of CatS (Allan et al., 2014; Hari et al., 2015; Jancic et al., 2007; Kanai et 
al., 2001; Rybicka et al., 2012). In line with this, treatment of cells with the membrane-permeable 
organometallic compound phenylarsine oxide, which modifies cysteines, resulted in an inhibition 
of CatS, but not or less of cathepsins B and X (Figures 5A and 5B), indicating that the activity of 
CatS is particularly sensitive to cysteine modifications. We recently showed that NOX2 is already 
present at nascent phagosomes, because the catalytic subunit gp91phox of NOX2 is co-invaginated 
from the plasma membrane together with the antigen during phagocytosis (Dingjan et al., 2017a).
Moreover, NOX2 requires the presence of PI(3,4)P2 and/or PI(3)P for its activity and is active on early 
phagosomes (Anderson et al., 2010; Ellson et al., 2001b; Groemping and Rittinger, 2005; Kanai et 
al., 2001). We also showed that even though NOX2 resides in lysosomal compartments in naive 
dendritic cells, it is gradually removed from phagosomes during their conversion into LAMP1-
positive phagolysosomes (Dingjan et al., 2017a, 2017b). As our data show that blockage of PIKfyve 
led to an accumulation of PI(3)P on phagosomes (Figures 2C and 2D) and delayed the conversion 
of early into late endo/phagosomes, we hypothesized that the reduced CatS activity was caused 
by an increased ROS production resulting from a prolonged presence and increased activity of 
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NOX2. The presence of phagosomal NOX2 upon PIKfyve inhibition by apilimod and YM201636 
was assessed using immunofluorescence staining for its main catalytic subunit gp91phox (Dingjan 
et al., 2017a, 2017b). Treatment with apilimod and YM201636 resulted in a prolonged presence of 
gp91phox at zymosan-containing phagosomes compared with the DMSO control (Figures 5C and 
5D). We also measured ROS production in cells pulsed for 1 hr with zymosan using two different 
assays. First, apilimod treatment resulted in an increased extracellular presence of H2O2 as 
measured with the Amplex Red assay (Dingjan et al., 2016) (Figure 5E). Second, intra-phagosomal 
ROS production was measured with zymosan particles conjugated to the ROS-sensitive probe 
OxyBURST (Dingjan et al., 2017a), and this also showed an increased ROS production upon PIKfyve 
inhibition with apilimod or YM201636 (Figures 5F and 5G). Our data suggest that CatS is more 
sensitive to oxidative modifications than other cathepsins, and the increased ROS production 
upon PIKfyve inhibition can thereby explain the reduced activity of CatS (but not B and X) in 
cell lysates (Figure S3). Together, we conclude that PIKfyve inhibition results in an increased 
production of ROS within endo/phagosomes and that this leads to a reduced activity of CatS, 
which is more prone to oxidative modifications than cathepsins B and X.
PIKfyve Inhibition Impairs MHC Class II Presentation
In the final set of experiments, we tested whether inhibition of PIKfyve would lead to impaired 
MHC class II antigen presentation. We first performed a classical T cell activation assay with T cells 
isolated from transgenic OT-II mice (Barnden et al., 1998). CD4+ T cells from these mice carry a T 
cell receptor specifically recognizing ovalbumin residues 323–339 (OVA323-339) presented on H-2IAb 
MHC class II. Apilimod treatment resulted in an 25% reduction of production of interferon (IFN) γ 
by the OT-II T cells over time, whereas YM201636 even completely blocked IFNγ release (Figures 
S5A and S5B). However, the long incubation times with apilimod or YM201636 required for T cell 
activation, reduced the viabilities of both the dendritic cells and OT-II T cells by 20%–40% (Figures 
S5C and S5D). Moreover, as expected, surface presentation of MHC class II in those experiments 
was reduced by 10-30% upon PIKfyve inhibition (Figures S5E and S5F). Because of these effects, 
the impaired activation of T cells upon PIKfyve inhibition cannot be solely attributed to lower 
antigen presentation. Indeed, control experiments showed that both apilimod and especially 
YM201636 blocked T cell activation independent of antigen presentation, as these compounds 
resulted in reduced production of IFNγ and lower surface expression of the activation markers 
CD25 and CD69 (Figure S6). Thus, although we observed a reduction of T cell activation by 
inhibition of PIKfyve, this is probably mainly caused by direct effects of apilimod and YM201636 
on the T cells and the T cell activation assay does not allow to discern direct effects on MHC class 
II presentation. 
> Fig. 3: Pharmacological Inhibition of PIKfyve Blocks Cathepsin S Activity and Trafficking (A) SDS-PAGE with in-gel 
fluorescence of the BMV109-Cy5 activity-based probe labeling cathepsin X (CatX; top band), cathepsin B (CatB; middle 
band), and cathepsin S (CatS; lower band) in resting dendritic cells (0 hr) or after stimulation with zymosan for 0.5 or 1 
hr. Cells were treated with DMSO (vehicle control), apilimod, or YM201636 for 3 hr before lysis according to the left-hand 
scheme. GAPDH, loading control by western blot. Only part of the SDS PAGE/polyvinylidene fluoride blot is shown; the rest 
of the image carried no information. (B and C) Quantification of (A) (individual donors shown; normalized to DMSO controls). 
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(D) Confocal images of representative dendritic cells treated with PIKfyve inhibitors and stimulated with zymosan as in (A) 
before fixation and staining for CatS (red in merge). Yellow arrowheads, CatS-positive phagosomes. Scale bar, 10 µm. (E) 
Quantification of (D) for cells stimulated with zymosan for 0.5 or 1 hr (>133 phagosomes per condition per donor; mean ± 
SEM of three donors; individual donors shown; normalized to the total number of phagosomes per cell). *P < 0.05, **P < 0.01, 
***P < 0.001. See also Figures S2 and S3.
To overcome this problem, we developed a new method allowing for direct visualization of 
MHC class II presentation. This is based on a recently developed assay for visualization of MHC 
class I presentation (Pawlak et al., 2015, 2016), and employs synthetic peptides as antigen 
carrying a non-natural amino acid amendable to bio-orthogonal ligation with fluorescent dyes. 
Based on the crystal structure of a complex of human HLA-DR1 MHC class II with influenza A 
virus hemagglutinin (HA) (strain A/Aichi/2/1968 H3N2) peptide (322–334 amino acid positions; 
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PKYVKQNTLKLAT; HA322-334) (Stern et al., 1994; Zavala-Ruiz et al., 2004), we synthesized a peptide 
consisting of the MHC class II epitope of influenza extended both N and C terminally with four 
natural amino acids (YGACPKYVKQNTLKLATGMRN; HA318-338) (Figure S7, related to Table S1). This 
extended peptide needs to be processed and loaded by HLA-DM in MIIC to be presented on MHC 
class II. The central lysine (K326) was converted into a propargylglycine. Modeling indicated that 
the alkyne moiety of propargylglycine is solvent accessible when this peptide is bound to MHC 
class II (Figure 6A). This alkyne moiety can be conjugated to CalFluor-488, which increases the 
fluorescence signal by two orders of magnitude, resulting in a low signal-to-noise ratio (Shieh 
et al., 2015). Moreover, the alkyne moiety is only three carbon atoms in size and does not (or 
less) perturb the molecular mechanisms of antigen processing and presentation, in contrast to 
large fluorophores, and survives the harsh environment in lysosomes (Bakkum et al., 2018). By 
incubating human dendritic cells with bio-orthogonal functionalized peptide HA318-338, we could 
show increased MHC class II presentation over time for at least up to 5-hr incubation (Figures 
6B–6D and S8). Moreover, no increase in CalFluor-488 signal was observed with negative control 
experiments with a wild-type HA318-338 peptide (without propargylglycine) or the HA322-334 epitope, 
which cannot be processed for HLA-DM loading onto MHC class II, or by proteolytically cleaving 
surface-exposed MHC class II with trypsin. Compared with the 5-hr time point, longer incubation 
(18 hr) led to reduction of the CalFluor-488 signal, suggesting that the peptide was internalized 
and/or degraded by the cells (Figure S8). When apilimod or YM201636 was present during the last 
3 hr of 5- or 7-hr incubation with the bio-orthogonally functionalized peptide HA318-338, the signals 
from CalFluor-488 were consistently reduced by 20%–80% (depending on the donor) (Figures 
6C–6E), demonstrating that these drugs directly blocked presentation of the HA antigen. Thus 
using bio-orthogonal functionalized antigenic peptide, we could demonstrate that blockage of 
PIKfyve leads to impaired MHC class II antigen presentation.
v Fig. 4: Pharmacological Inhibition of PIKfyve Impairs Proteolytic Activation and Trafficking of MHC Class II (A) Gating 
strategy for flow cytometry of human-monocyte-derived dendritic cells immunolabeled for MHC class II (MHCII-FITC; HLA-
DR, DQ). Light blue in histogram, isotype control; SSC, side scatter; FSC, forward scatter; FITC, fluorescein isothiocyanate.
(B) Representative histograms and quantification of surface MHC class II with flow cytometry experiments of dendritic cells 
treated for 3 hr with apilimod (200 nM) or YM201636 (4 µM) (geometric mean fluorescence intensities [gMFI]; individual 
donors shown; normalized to DMSO control). (C) Same as (B), but now for total MHC class II with detergent permeabilization.
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(D) Confocal images of representative dendritic cells treated with apilimod (200 nM) or YM201636 (4 µM) for 3 hr and pulsed 
with zymosan 1 hr before fixation. DMSO, vehicle control. Cells were immunolabeled for HLA-DR (green in merge) and 
LAMP1 (magenta in merge). Blue, DAPI staining. BF, brightfield. Scale bar, 10 µm. Yellow arrowheads, HLA-DR-positive 
phagosomes; cyan arrowheads, LAMP1-positive phagosomes. (E) Quantification of percentages of HLA-DR-positive and 
LAMP1-positive phagosomes from (D) normalized to the total number of phagosomes per cell (280 phagosomes per 
condition per donor; mean ± SEM of four donors). *P < 0.05, **P < 0.01, ***P < 0.001. See also Figures S4–S6.
Discussion
In this study, we studied the role of PIKfyve in MHC class II antigen presentation by dendritic 
cells. Our data confirm the key role of PIKfyve in phagosome maturation (Compton et al., 
2016; Dayam et al., 2017; Dove et al., 2009; Gayle et al., 2017a; Gomez et al., 2018; Hazeki et al., 
2012; Ikonomov et al., 2009; Kerr et al., 2010; Kim et al., 2014b; Krishna et al., 2016; Sbrissa et al., 
2007, 2012) and treatment of dendritic cells with apilimod and YM201636 blocked recruitment 
of LAMP1, M6PR, and CatS to phagosomes. A still open question is via which mechanisms the 
reduced levels of cellular PI(3,5)P2 cause these trafficking defects. Endosomal maturation via the 
conversion of Rab5- to Rab7-positive membranes by the endosomal tethering complexes CORVET 
(class C core vacuole/endosome tethering) and HOPS (homotypic fusion and protein sorting) 
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is well understood (Balderhaar and Ungermann, 2013). The role of PI(3,5)P2 and downstream 
effectors of PI(3,5)P2 in endosomal maturation is uncertain, and PI(3,5)P2 might govern trafficking 
events via several possible mechanisms. The best characterized downstream effector of PI(3,5)
P2 is the cation channel TRPML1; its activity directly depends on PI(3,5)P2. However, it is also not 
known if and how TRPML1 affects endo/phagosomal maturation. As TRPML1 triggers the efflux 
of Ca2+ from lysosomes to the cytosol, one possibility is that it might be able to activate ALG-2, 
a dynein-interacting protein sensitive to Ca2+. Dyneins promote retrograde vesicular migration 
along the tubular tracks, and this might somehow facilitate endosome-lysosome fusion (Li et al., 
2016). Alternatively or additionally, the increased Ca2+ efflux might directly promote intracellular 
fusion events via Ca2+-sensing proteins (Hay, 2007). Another downstream effector of PI(3,5)P2 is 
the V-ATPase, as yeast strains with mutations in the PIKfyve ortholog Fab1p showed impaired 
vacuolar acidification (Li et al., 2014), and this might explain the reduced acidification upon 
pharmacological inhibition or siRNA knockdown of PIKfyve.
^ Fig. 5: Pharmacological Inhibition of PIKfyve Promotes NOX2-Mediated ROS Production. (A) SDS-PAGE with in-gel 
fluorescence for the cathepsin-activity-based probe BMV109-Cy5 for dendritic cells pulsed with zymosan for 0.5 or 1 hr and 
untreated (0 hr). PAO, cysteine-modifying agent phenylarsine oxide; DMSO, vehicle control; GAPDH, loading control by 
western blot. (B) Quantification of (A) (individual donors shown; normalized to DMSO controls). (C) Confocal images of 
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representative dendritic cells pulsed with zymosan for 15, 30, or 120 min in the presence of apilimod (200 nM) or YM201636 
(4 µM) for 3 hr and immunostained for gp91phox. Yellow arrowheads, gp91phox-positive phagosomes. Scale bar, 5 μm. (D) 
Quantification of (C); Gp91phox-positive phagosomes were counted and normalized to the total number of phagosomes per 
cell (mean ± SEM for three donors, 300 phagosomes per condition). (E) Extracellular H2O2 measurements with Amplex Red 
assay for dendritic cells treated for 3 hr with apilimod and 1 hr with zymosan. (F and G) Phagosomal ROS production 
determined with zymosan labeled to both OxyBURST and Alexa Fluor 633 (AF633) and confocal live imaging. Cells were 
treated for 3 hr with apilimod (F) or YM201636 (G) and incubated for 1 hr with zymosan-OxyBURST/AF633. Signals from 
OxyBURST signal were normalized to that of AF633 (3,000 phagosomes per condition; individual donors shown). *P < 0.05, 
**P < 0.01, ***P < 0.001.
Our results showed that the blockage of phagosome maturation by PIKfyve inhibition resulted in 
reduced activity of CatS and B, but not of cathepsin X. Our data suggest that the reduced activity 
of CatS upon apilimod or YM201636 treatment might be attributed to both a reduced trafficking 
to phagosomes and an increased ROS production by NOX2. Our microscopy data show that CatS 
trafficking to LAMP1-positive phagosome relies on PIKfyve activity. Moreover, we showed that 
NOX2-produced ROS affect cysteine cathepsins, including CatS, because the ROS can modify 
cysteines within their catalytic cores (Allan et al., 2014; Hari et al., 2015; Jancic et al., 2007; Rybicka et 
al., 2012). The increased ROS production caused by a prolonged presence of NOX2 at phagosomes 
upon apilimod or YM201636 treatment might even be amplified by higher phagosomal levels of 
PI(3)P, which might enhance NOX2 activity through NOX2 subunit p40phox binding to PI(3)P by its 
PX domain (Anderson et al., 2010; Ellson et al., 2001b; Groemping and Rittinger, 2005; Kanai et al., 
2001). An open question is why addition of zymosan reduced the inactivation of cathepsin B and 
S. As we also observe this effect in our lysate controls, perhaps the zymosan particles sequester 
ROS species and thereby prevent the oxidative modification of CatS. This suggests that the NOX2-
mediated reduction of CatS activity will mainly have physiological relevance in the absence of 
phagocytic cargo, and thereby might be involved in the maintenance of self-tolerance (Steinman 
and Nussenzweig, 2002), for instance, for the induction of Th2 responses by immature dendritic 
cells (Na et al., 2016). In any case, our data show that PIKfyve-mediated phagosomal maturation 
affects the activity of cysteine cathepsins via NOX-produced ROS, and this can modulate the 
epitope repertoire for MHC presentation (Balce et al., 2011; Rybicka et al., 2010, 2012). Because 
NOX2 mediates the disulfide reduction of protein antigens (Ewanchuk and Yates, 2018), the 
effects of NOX2-produced ROS on antigen processing will be even more pronounced. Only linear 
peptide/protein stretches are accessible to proteases for cleavage, hence all inter- and intra-
disulfide bonds have to be reduced before antigen processing (Bogunovic et al., 2010), as has been 
also demonstrated for MHC class II with model antigens (Jensen, 1991). γ-Interferon-inducible 
lysosomal thiol reductase activity can be inhibited by ROS, and this may cause different antigen 
processing patterns leading to altered repertoires of peptides for presentation, because some of 
the proteins cannot be unfolded and are therefore not accessible to proteinases for degradation 
(Ewanchuk and Yates, 2018). 
In addition to the proteolytic processing of ingested antigens, CatS mediates the activation of 
MHC class II in MIIC via the processing of Ii to CLIP and is thereby required for antigen presentation 
(Nakagawa et al., 1999; Riese and Chapman, 2000; Shi et al., 1999). Our data show that inhibition 
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of PIKfyve by apilimod or YM201636 results in an accumulation of Iip10, the precursor of CLIP, and 
in reduced trafficking ofMHC class II to the cell surface. This is in line with the finding that the 
inhibitor of PIKfyve AS2795440 caused a marked reduction of surface MHC class II expression on 
CD45R+ B cells in anti-IgM-stimulated whole blood from rats (Terajima et al., 2016). These findings 
can be explained by the decreased activity of CatS, as incomplete invariant chain degradation is 
known to result in disturbance of MHC class II presentation and blockage of MHC class II transfer 
from endocytic compartments to the cell surface (Brachet et al., 1997; Riese and Chapman, 2000), 
as confirmed by our experiments with the CatS inhibitor LHVS. The proteolytic truncation of Ii to 
MHC-class-II-bound CLIP peptide is a prerequisite for antigen loading and thereby for MHC class II 
antigen presentation (Roche and Furuta, 2015), and surface trafficking of MHC class II is important 
for successful antigen presentation (Rocha and Neefjes, 2008). This might explain the reduced 
presentation of influenza virus HA322–334 on HLA-DR1 by human dendritic cells upon YM201636 
or apilimod treatment. Unsurprisingly, we also observed reduced activation of CD4+ T cells upon 
PIKfyve inhibition, although this is probably caused by the combined effects of (1) reduced uptake 
of antigen, (2) blocked production of IL-12/IL-23 and type I IFN (Cai et al., 2013, 2014), (3) reduced 
MHC class II presentation, (4) reduced cell viability of both the dendritic cells and T cells, and (5) 
other direct effects of apilimod and YM201636 on T cells. 
^ Fig. 6: PIKfyve Inhibition Impairs MHC Class II Presentation. (A) Crystal structure of human HLA-DR1 (DRA, DRB1*0101; 
PDB: 1DLH) in complex with a virus HA (strain A/Aichi/2/1968 H3N2) peptide residues 322–334. The position of a clickable 
non-naturalized amino acid L-C-propargylglycine {pra} for bio-orthogonal labeling with CalFluor-488 is indicated (bright 
green); pockets for peptide binding at the HLA-DR1 cleft are highlighted in different colors. A scheme of the bio-orthogonal 
reaction is also shown. (B) Time line of stimulation with HA peptide residues 318–338 for MHC class II presentation by 
human dendritic cells. (C) Flow cytometry gating strategy for quantification of HLA-DR1 presented HA by labeling with 
CalFluor-488 as depicted in (A and B). Cell viability was assessed with fixable viability dye eFluo780. Surface levels of HLA-
DR1 were assessed with HLA-DR-APC. (D) Quantification of HA-CalFluor-488 signals from (C) after 5 hr of stimulation with 
HA-peptide (bar graphs). Gray, non-specific background from CalFluo labeling of dendritic cells that were not incubated 
with HA-peptide; green, trypsin-positive control for HA removal from the cell surface; line graphs, individual donors with 
background subtracted and normalized to DMSO control. (E) The same as (D), but now for 7 hr of stimulation with HA 
105
The PhosPhoinosiTide Kinase PiKfyve PromoTes CaThePsin-s-mediaTed mhC-ii anTigen PresenTaTion 
5
peptide. *P < 0.05, **P < 0.01, ***P < 0.001. See also Figures S7 and S8 and Table S1.
To overcome this, we developed a new universal assay allowing for the direct visualization 
of MHC class II antigen presentation. This assay is an adaptation of a recent assay to measure 
antigen presentation on MHC class I (Pawlak et al., 2015, 2016) and is based on synthetic peptides 
containing an MHC class-II compatible epitope (in this case from HA residues 318–338 containing 
epitope residues 322–334). One residue on the epitope, which remains solvent exposed when 
bound to MHC class II, is converted to a non-natural propargylglycine, which contains an alkyne 
moiety of only three atoms in size. In contrast to large fluorescent labels, peptides carrying 
propargylglycine can still be proteolytically processed and loaded onto MHC class II. After fixation 
of the cells, the peptide bound to MHC class II at the surface of the dendritic cells can be labeled 
with CalFluor dyes that increase in fluorescence signal by orders of magnitude (Shieh et al., 2015). 
As previously shown for MHC class I (Pawlak et al., 2015, 2016), this signal increase allows for 
the detection of the limited amounts of MHC class-II-presented epitopes by flow cytometry. In 
contrast to assays that assess T cell priming and rely on co-stimulatory factors, such as the OT-II 
assay, the assay developed in this study provides a direct and quantitative readout of MHC class II 
presentation and is easily adaptable for different antigens and MHC haplotypes. 
^ Fig. 7: Delayed Phagosomal Maturation Results in a Reduced MHC Class II Antigen Presentation. Model figure showing 
antigen uptake by a dendritic cell and subsequent processing within phagosomes by ROS and cathepsins. Upon phagosomal 
maturation, MHC class II bound to Ii is trafficked to the phagosome where cathepsin S is involved in the processing of Ii to 
CLIP, which can then be exchanged by an antigen to be presented by MHC class II on the cell surface. Inhibiting PIKfyve 
delays phagosomal maturation, and due to prolonged ROS formation, cathepsin S becomes oxidized and deactivated, 
thereby blocking CLIP-to-antigen exchange and eventually resulting in impaired antigen presentation.
In conclusion, we showed that the phagosomal maturation driven by phosphoinositide kinase 
PIKfyve is essential for MHC class II antigen presentation (Figure 7). Disruption of this process by 
the PIKfyve inhibitors apilimod and YM201636 delays the maturation process of the phagosome. 
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Delayed phagosomal maturation, in turn, results in elevated levels of ROS thereby deactivating 
CatS, which plays a key role in the proteolytic cleavage of Ii to CLIP and is essential for MHC class II 
antigen presentation. PIKfyve inhibition results in an incomplete processing of CLIP, and Ii-bound 
MHC class II is retained in phagosomes. Apilimod is proposed as a promising treatment for multiple 
variations of B cell non-Hodgkin lymphoma (NHL) due to its cytotoxic effect on B-NHL cancer cells 
lines (Gayle et al., 2017b) and was used in clinical trials for blocking IL-12/IL-23-mediated Th1/17 
pro-inflammatory response in Crohn disease, psoriasis, and rheumatoid arthritis (Burakoff et al., 
2006; Krausz et al., 2012; Sands et al., 2010; Wada et al., 2007, 2012). As concluded from NHL cancer 
cell line experiments, these cells have maximal sensitivity to apilimod, due to non-understood 
modulatory effects of PI(3,5)P2 on the transcription factor TFEB and apilimod leading to elevated 
expression of genes coding for lysosomal proteins, resulting in lysosomal swelling and disruption 
of lysosomal homeostasis and maturation, proliferation block, and cell death. In addition, 
PIKfyve might be a potential target for targeting solid tumors, as it plays a role in metastasis and 
promotes cancer cell migration and invasion together with the phosphoinositide phosphatase 
myotubularin-related protein 3 (MTMR3), which converses PI(3,5)P2 to PI(5)P (Oppelt et al., 2014). 
Depletion of PIKfyve and MTMR3, as well as inhibition of PIKfyve alone by YM201636, resulted in 
decreased in vitro migration of cancer cell lines of lung, rhabdomyosarcoma, and osteosarcoma 
origins (Oppelt et al., 2014), indicating that PIKfyve could be a novel therapeutic target in cancer 
migration. However, our results show that inhibition of PIKfyve impairs antigen presentation by 
dendritic cells and reduces activation of T cells. These effects on immune activation must be taken 
into account in clinical trials targeting PIKfyve.
Limitations of the Study
In this study, we addressed the role of phagosomal and endosomal maturation of MHC class 
II presentation with a focus on the phosphoinositide kinase PIKfyve. Most of our results are 
obtained using the small molecule inhibitors that are shown to be specific for PIKfyve: apilimod 
(Cai et al., 2013) and YM201636 (Jefferies et al., 2008). We confirmed that PIKfyve inhibition with 
these compounds was similar to PIKfyve siRNA knock down in primary human monocyte-derived 
dendritic cells, and both resulted in formation of enlarged endosomes, delayed phagosomal 
acidification, and delayed LAMP1 recruitment. However, the efficiency of our siRNA knockdown 
was incomplete, leading to less pronounced functional effects compared with the inhibitors. Our 
work could benefit from stable knockdown/out of PIKfyve to demonstrate that all experiments 
with drug inhibitors are comparable to knockout. However, the primary human monocyte derived
dendritic cells used in our study are terminally differentiated and not amenable to CRISPR/Cas 
knockout.
A potential caveat of our study is that we only managed to immunolabel endogenous CatS, but 
not the other two cathepsins X and B. Therefore we cannot draw clear conclusions on the effects 
of PIKfyve inhibition on the trafficking of those cathepsin species. 
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We admit that MHC class II labeling with CalFluor-488 method has still some limitations, mainly 
a low signal-to-noise ratio, which is likely caused by a low number of MHC-class-II-presented 
epitopes. Additional optimizations of this method will be required in future.
In our live cell microscopy experiments we followed the trafficking of MHC class II to phagosomes, 
revealing that a large portion of it is recruited from the cell surface during formation of the 
phagosome. However, we only followed the fate of MHC class II during PIKfyve inhibition for a 
short time and never studied longer time points after zymosan uptake. It would be interesting 
to determine whether MHC class II also reaches phagosomes from an intracellular pool, as we 
recently showed for NOX2 (Dingjan et al., 2017a).
Our study raises the key open question as to which effectors of PI(3,5)P2 mediate phagosomal 
maturation, as explained in the Discussion section. It would be interesting to identify those in the 
future.
Material and methods
Antibodies and reagents
The following antibodies were used: mouse monoclonal IgG1 anti-EEA1 at 1:100 (BD Biosciences; 
610456 and 610457); rabbit polyclonal anti-LAMP-1 (CD107a) at 1:100 (Sigma; L1418); mouse 
monoclonal IgG1, κ anti-LAMP-1 (CD107a) at 1:100 (Biolegend; 328601, clone H4A3); mouse 
monoclonal IgG2a anti-M6PR at 1:50 in methanol fixed samples (Abcam; ab2733); rabbit polyclonal 
anti-GAPDH (14C10) at 1:1,000 (Cell Signaling; 2118); goat monoclonal IgG anti-Cathepsin X at 
1:500 (R&D Systems; AF1033-SP); rabbit polyclonal anti-Cathepsin S at 1:250 (Novus Biologicals; 
NBP2-85807); mouse monoclonal IgG2a anti-Cathepsin B at 1:500 (Calbiochem; IM27L); mouse 
IgG2a,κ anti-HLA-DR, DP, DQ conjugated to FITC at 1:4 (BD Biosciences; clone Tü39) with isotype 
control mouse FITC-conjugated IgG2a,κ at 1:10 (BioLegend; 400208; clone MOPC-173); mouse 
monoclonal IgG1 anti-HLA-DR in complex with CLIP at 1:50 (Santa Cruz; sc-12725; clone CerCLIP.1); 
mouse IgG1, κ isotype control conjugated to APC at 1:10 (eBioscience; 17-4714-82); rat IgG2 anti- 
mouse CD74 at 1:500 (Biolegend; 151002); mouse monoclonal IgG1 anti-gp91phox at 1:100 (D162-
3; MBL); mouse anti-human-HLA-DR conjugated to APC at 1:100 (BD Biosciences; 559866; clone 
G46-6, RUO); mouse monoclonal IgG2a, κ anti-human-HLA-DR at 1:100 (Biolegend; 307614; clone 
L243); rat IgG2b,k anti-mouse I-A/I-E (MHC-II) conjugated to BV510 or PE at 1:200 (BioLegend; 
clone M5/114.15.2) with isotype control rat IgG2b,κ–BV510 or PE at 1:400 (Biolegend; 400645; clone 
RTK4530); anti-mouse CD69-PE from hamster at 1:100 (BD Biosciences; 553237; clone H1.2F3,RUO); 
anti-mouse CD25-APC from rat at 1:400 (eBioscience; 17-0251-82; clone PC61.5); OT-II were labeled 
with CellTrace Far Red labeling following the manufacturer’s guidelines (ThermoFisher; C34564). 
The following secondary antibodies were used at (1:400): donkey-anti-mouse IgG (H&L) Alexa 
Fluor 647 (ThermoFisher; A-31571); donkey-anti-rabbit IgG (H&L) Alexa Fluor 568 (ThermoFisher; 
A-10042); goat-anti-mouse IgG (H&L) Alexa Fluor 488 (ThermoFisher; A-11029); goat-anti-Rabbit 
IgG (H + L) labeled with IRDye 800CW at 1:5,000 (LI-COR; 926-32211); goat-anti-rat Alexa Fluor 680
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at 1:5,000 (ThermoFisher; A-21096). 
Cell viability was assessed with the fixable viability dye eFluor450 (ThermoFisher; 65-0863-14) or 
eFluor780 (ThermoFisher; 65-0865-18) at 1:2,000 in PBS for 30 min on ice prior to 4% PFA fixation. 
The labeling for Flow cytometry was done as described (Baranov et al., 2016; Wimmers et al., 
2016). All surface flow cytometry stainings were in PBA buffer (0.5% BSA and 0.01% NaN3 in PBS) 
and intracellular/total staining in PBA supplemented with 0.1% saponin as a detergent, all labeling 
was done for 10-30 min, PBS was used for washing. Annexin V-FITC (BD Biosciences;556419) and 
7AAD (eBioscience; 00–6993–50) labeling was performed as described (Baranov et al., 2017) on 
ice for 10 min in buffer containing 1.5 mM CaCl2. The MTT assay was performed as described 
(Baranov et al., 2016; Baranov et al., 2017) as follows: 0.66 mg/ml MTT (3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide; Sigma M2128-1G) was in contact with the cells for 2 h before 
lysis with the following buffer: 90% isopropanol, 0.0125% SDS and 0.04 M HCl. Absorbance was 
analyzed at 595 nm. 
Apilimod (STA-5326) was from Axon Medchem (ID 1369; CAS 541550-19-0) and MT-Diagnostics 
(USbiol-002800) and was used at 200 nM. YM201636 was from Calbiochem (ID 524611; CAS 
371942-69-7) and used at 4 μM. Phenylarsine oxide (PAO) (at 1 μM) was incubated for 1 hour as 
described (Dingjan et al., 2016). LHVS (at 25 nM) was used as selective inhibitor for cathepsin S 
(provided by Dr. M. Bogyo, Stanford School of Medicine, CA, USA) (Koblansky et al., 2013). For 
control conditions, 1% DMSO was used (i.e., the highest vehicle content in all drug dilutions). In 
the cathepsin activity and confocal microscopy experiments, phagocytosis was induced using 
un-opsonized zymosan particles at a 1:10 and 1:5 cell-to-particle ratio respectively. For live cell 
microscopy, IgG-opsonized zymoson was used as described (Baranov et al., 2016). Briefly, 20 mg/
ml zymosan suspension with an equal volume of opsonizing solution from ThermoFisher (Z2850)
was incubated for 60 min at 37 oC and vigorously washed in PBS. BSA conjugated to Alexa fluor 488 
was used at 10 μg/ml (ThermoFisher; A13100). Human IL12 was measured by ELISA using 96 flat 
bottom well plates (Microlon; 655092), coating antibody at 3 μg/ml (Pierce Endogen; M122), IL-12/
IL-23 p40 detection antibody at 250 ng/ml (Thermo Scientific; M121B). Mouse IL12p70 (eBioscience; 
88-7121-88) and INFγ (Invitrogen; 88-7314-88) were measured by ELISA following manufacturer’s 
kit guidelines. All flow cytometry experiments were done on a FACS-Calibur cytometer or a FACS 
Verse system (both BD Bioscience). 
Animals
OVA-T cell receptor transgenic OT-I mice purchased from Charles River Laboratories (Sherbrooke, 
PQ) and OT-II mice purchased from Jackson Laboratories (Bar Harbor, ME) were held in a 
pathogen-free environment in Nijmegen Central Animal Laboratory, Netherlands, in accordance 
with institutional and European guidelines and approved by the Animal Experimental Committee 
(Radboud UMC). CD8+ T cells recognizing OVA257-264 SIINFEKL peptide or CD4
+ T cells recognizing 
OVA323-339 peptide presented on H-2IAb MHC-II, were isolated from spleen as described (den Brok 
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et al., 2016; Dolen et al., 2016).
MHC-II-restricted OVA presentation to OT-II
For BMDCs differentiation, bone marrow cells of 7-11 weeks old mice was isolated and cultured 
in RPMI 1640 medium (Gibco) (10% fetal calf serum (FCS), 1% L-alanyl-L-glutamine, 0.1% 
β-mercaptoethanol and 0.5% antibiotics/anti-mycotics (AA, Gibco)) supplemented with 20 ng/
ml GM-CSF (Peprotech). BMDCs were collected between day 6-7 for experiments (Baranov et al., 
2017). Poly(lactic-co-glycolic acid) (PLGA) particles containing OVA were prepared as described 
(Dolen et al., 2016) and 200 μg of particles containing 10 μg OVA were used to stimulate 50,000 
GM-CSF-cultured day 6-7 mouse BMDCs in 100 μl per well (96 well plate) starvation serum-free 
RPMI (2.1 mM ultra-glutamine and 50 μM β-mercaptoethanol) for 3 hours before drug addition to 
ensure comparable OVA-PLGA uptake. Next, free OVA-PLGA particles were washed away and the
medium was changed to 200 μl per well complete RPMI (10% FBS, 2.1 mM ultra-glutamine and 
50 μM β-mercaptoethanol) containing 100,000 OT-II pre-labeled with CellTrace Far Red (DMSO, 
Apilimod and YM201636 were added in concentrations mentioned above). The supernatants 
for ELISA and cells for flow cytometry were collected at 12, 24 and 48 hours and the cells were 
immediately pretreated with viability dye eFluor on ice as mentioned above, then fixed and 
antibody-labeled for flow cytometry. OT-I cells were isolated from splenocytes as described 
(Baranov et al., 2017) from a 6 month old OT-I male mouse with a CD8a+ T Cell Isolation Kit (Miltenyi 
Biotec; 130–104–075) and directly stimulated with OVA257-264 peptide (SIINFEKL) at 1 μg/ml.
Receptor stimulation, RNA isolation, cDNA synthesis and qPCR
For stimulation of pathogen recognition receptors the following ligands were used: 
polyionosinic:polycytidylic acid (Poly:IC) (TLR3 agonist) at 100 μg/ml for 4 hours; 
lipopolysaccharides (LPS) (TLR4 agonist) at 1 μg/ml for 4 hours; resiquimod (R848) (TLR7 agonist) 
at 2.5 μg/ml for 4 hours; Pam(3)Cys (TLR2 agonist) at 5 μg/ml for 4 hours; zymosan (Dectin-1 and 
TLR2 agonist) at 2x108 particles/ml for 1 hour; pepdidoglycan (PGN) (LTR2 agonist) at 10 μg/ml for 
1 hour; OVA (CD206 mannose receptor agonist) at 1 μg/ml for 1 h. After stimulation, RNA isolation 
was performed from 1 million dendritic cells using Quick-RNA MiniPrep kit (ZymoResearch) in 
accordance with the manufacturer’s guidelines. For generating cDNA, master mix 1 (1 μl Random 
Hexamers (100 μM), 1.2 μl dNTPs (10 mM), RNA (1 μg) and H2O) was made. This mix was incubated 
at 65 °C for 5 minutes and directly chilled on ice. Mastermix 2 (4 μl 1st Buffer (5x), 2 μl DTT, 1μl 
RNAsin, 1 μl Reverse Transcriptase or H2O) was added and the RT-program on a PCR machine was 
started. The RT-program consisted of the following steps: 10 min 25 °C, 50 min 37 °C, 15 min 70 
°C, pause at 4 °C. After cDNA synthesis, qPCR was performed using 10 μl Sybr Green, 1.2 μl Primer 
Mix F + R (10 μM), 4.8 μl MQ and 4 μl cDNA (80 ng) dilution per well. The qPCR-program consisted 
of the following steps: 50 °C for 2 minutes, 95 °C for 10 minutes, 95 °C for 15 seconds, 60 °C for 1 
minute and repeated 39 times. The results were analyzed using the Bio-RAD Prime PCR program. 
The primers that were used for qPCR of PIKfyve were 5’-TGTCT GTGCT TGATC CAAGT G-3’ and 
5’-GCCAG GCCAA ATCAT CCTCT AA-3’.
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siRNA knockdown assays
Post 72 hour knock-down in human dendritic cells was performed as described (Baranov et al., 
2016). As control, siRNA irrelevant ON-TARGET plus non-targeting (NT) (Dharmacon) was used. The 
following cocktail of siRNAs was used for knockdown of PIKfyve (Invitrogen): 5’-GGAAA GGAAU 
UAGUC AACUG GCUAA-3’, 5’-GGAGA CCUCC GAGCU UGCAC AUAUU-3’, 5’-GAGGC CAGGG AGAAC 
AGCAG CCUUU-3’. Knockdown efficiency was measured with qPCR. 
Microscopy and image processing
For the microscopy experiments, 100,000 dendritic cells were plated on 12 mm-diameter glass 
coverslips in serum free RPMI medium with 1% antibiotics/antimycotics and 2 mM ultra-glutamine 
and incubated at 37ºC and 5% CO2. Fixation in most cases was done with 4% PFA solution in 
PBS. For CatS immunostaining, we performed antigen retrieval according to the manufacturer’s 
protocol (R&D Systems; CTS013, CTS014, CTS015, CTS016). Fixation in 3% v/v glyoxal (Sigma‐
Aldrich #128465) for CatS and LAMP1 immunolabeling was done for 20 min as described (Richter 
and Revelo, 2018) and the solution mix was made with following ratios: 19.84 ml ddH2O, 5.52 ml 
ethanol (absolute, for analysis), 2.18 ml glyoxal, 0.21 ml acetic acid, 1M NaOH was used to adjust 
pH to 4 or 5. Immunolabeling and blocking was performed with saponin permeabilization, as 
described (Baranov et al., 2016), in CLSM buffer (PBS with 20 mM glycine and 3% (w/v) BSA). Primary 
antibodies were incubated overnight, and secondary for 0,5-1h. In between, washing was done 
with PBS. Live cell imaging for BMV109 was done for 50,000 cells per well in μCLEAR F-bottom 
96 well cell culture microplates (Greiner bio-one; 65500) in phenol red free and antibiotic free 
RPMI medium. The inhibitor and BMV109 concentrations and pipetting schemes were identical 
as for the in-gel fluorescence experiments. Samples were imaged with a Leica SP8 confocal laser 
scanning microscope with a 63x 1.20 NA water immersion objective (Leica HC PL APO 63x/1.20 W 
CORR CS2) or Leica DMI6000 epi-fluorescence microscope fitted with a 40×0.85 NA dry objective, 
a metal halide EL6000 lamp for excitation, a DFC365FX CCD camera, and GFP and DsRed filter sets 
(all from Leica). Images were analyzed with Fiji (ImageJ).
Solid-phase peptide synthesis
Peptides were synthesized on a pre-loaded Wang resin (0.05 mmol, 0.27-0.32 mmol/g; Nova 
Biochem) on a Liberty Blue CEM microwave-assisted peptide synthesizer. The synthesis was 
conducted via a standard Fmoc/tBu-protocol using the recommended coupling (5 eq. amino 
acids, 5 eq. DIC, 5 eq. OxymaPure in DMF, 1: 75 °C, 170 W, 15 s, 2: 90 °C, 30 W, 50 s) and deprotection 
methods (piperidine/DMF, 1:4, v/v, 1: 75 °C, 155W, 15 s, 2: 90 °C, 30W, 50 s). The following L-amino 
acid building blocks were used in the automated synthesis: Fmoc-Ala-OH, Fmoc-Arg(Pbf)-OH, 
Fmoc-Asn(Trt)-OH, Fmoc-Cys(Trt)-OH, Fmoc-Gln(Trt)-OH, Fmoc-Gly-OH, Fmoc-Ile-OH, Fmoc-
Leu-OH, Fmoc-Lys(Boc)-OH, Fmoc-Met-OH, Fmoc-Pro-OH, Fmoc-Thr(tBu)-OH, Fmoc-Tyr(tBu)-OH, 
Fmoc-Val-OH and Fmoc-Pra-OH (GL Biochem; ABCR). For all amino acids, except for arginine, 
single couplings were performed. Special care was taken for the incorporation of Cys, Pra and Arg 
residues. For cysteine and propargylglycine, the temperature of the microwave-assisted coupling
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was reduced and the reaction time elongated (1: 25 °C, 0 W, 120 s, 2: 50 °C, 30 W, 480 s). Arginine 
was introduced by double coupling ((a) 1: 25 °C, 0 W, 1500 s, 2: 75 °C, 30 W, 120 s, (b) 1: 75 °C, 30 W, 
300 s). After synthesis, the resin was filtered off, washed successively with DMF (5 times), methanol 
(5 times) and DCM (10 times) and dried in vacuo. Acidic cleavage from the resin was achieved by 
treatment with a mixture of trifluoroacetic acid (TFA) / triisopropylsilane / ethanedithiol / water 
(94:2.5:2.5:1, 5 ml, 2 h). The resin was extracted with additional TFA (5 ml), and the combined 
extracts were concentrated to 2 ml under a flow of nitrogen. The crude peptide was then 
precipitated in cold diethylether (10 ml) and isolated by centrifugation and decantation of the 
supernatant. The precipitate was washed twice with ice-cold diethylether and subsequently 
dissolved in 5 mL of water and then freeze-dried to give a fine white solid.
Peptide purification
Peptides were purified by preparative reversed-phase HPLC using a Pharmacia Äcta Basic 900 
device (pump type P-900, variable wavelength detector UV-900) at flow rates of 10 ml/min, and 
a Macherey-Nagel Nucleodur 100-5-C18 ec, (250 mm by 21 mm, 5 μm) reversed-phase column. 
Linear gradients of water and acetonitrile or methanol (solvent A: water, 0.1 % TFA, solvent B: 
acetonitrile / water 4:1, 0.1 % TFA or methanol, 0.1 % TFA) over 30 min were used for purification.
Peptide characterization
Peptides were characterized by electrospray ionisation (ESI) and high-resolution (HR-MS-
ESI) mass spectrometry on a Bruker maXis spectrometer (Billerica, USA). Analytical HPLC 
measurements were performed using a Thermo chromatography system (pumps UltiMate 3000, 
detector UltiMate 3000, autosampler UltiMate 3000 diode array) and an ACE Excel 2 C18 (2 μm, 
2.1 x 100 mm) reversed-phase column at a flow rate of 0.4 ml/min. For peptide characterization, 
a linear gradient of water and methanol run (buffer A: water, 0.1 % TFA, buffer B: methanol, 0.85 
% TFA) from 20-90 % buffer B over 15 min was used. Chromatograms were monitored at 220 nm 
wavelengths. The column was run at a controlled temperature of 50 °C.
Cell culture and transfection
Cultures of human monocyte-derived dendritic cells derived from peripheral blood monocytes 
(PBMCs) were obtained from buffy coats of healthy donors as described (Baranov et al., 2014; 
Baranov et al., 2016). Briefly, adherent monocytes isolated from the blood of healthy donors 
were in culture for 6 days in RPMI 1640 medium (Life Technologies) supplemented with 10% 
fetal bovine serum (FBS, Greiner Bio-one), 1 mM ultra-glutamine (BioWhittaker), antibiotics (100 
U ml−1 penicillin, 100 μg ml−1 streptomycin and 0.25 μg ml−1 amphotericin B, Gibco), IL-4 (500 U 
ml−1) and GM-CSF (800 U ml−1). After that moDCs were detached from the plastic within 1h under 
cold PBS at 4 °C before freezing in liquid nitrogen in 10% DMSO and 40% FBS. Mouse GM-CSF 
differentiated BMDCs were generated as described (Baranov et al., 2017) and outlined above. The 
construct for full-length human PIKfyve was from Invivogen (cat nr puno1< hPIKFYVEb >) and 
subcloned in the EcoRI/BamHI sites of pEGFP-C1. pEGFP-HA-PIKfyve and pEGFP-HA-PIKfyveK1831E 
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within pEGFP-C2 were obtained from Assia Shisheva (Ikonomov et al., 2001). LifeAct-RFP was a 
gift from Michael Sixt (Max Planck Institute of Biochemistry, Martinsried, Germany) (Riedl et al., 
2008). The mRFP-tagged LAMP1 is described (Sherer et al., 2003) and LAMP1-mGFP was a gift 
from Esteban Dell'Angelica (Addgene plasmid # 34831 (Falcon-Perez et al., 2005)). NCF4-PX-EGFP 
was a gift from Michael Yaffe (Addgene plasmid #19010, (Kanai et al., 2001)). The YFP was replaced 
by mCherry in HLA-DRA-IRES-HLA-DRB-YFP, which was a gift from Jacques Neefjes (Netherlands 
Cancer Institute, Amsterdam, Netherlands) (Zwart et al., 2005). Transfection was performed as 
described (Baranov et al., 2014; Baranov et al., 2016) with a Neon Transfection system (Invitrogen), 
a ratio of 3 μg of DNA per 1*106 cells was used, resuspended in 100 μl buffer R (Invitrogen) and 
electroporated (2 pulses of 40 ms, 1,000 V). After transfection, the cells were kept in antibiotic-free 
and serum-free RPMI medium (Invitrogen) for 3h before addition of full medium. Zymosan uptake 
and imaging experiments were performed 5–12 h post-transfection.
pHRodo zymosan
Dendritic cells (200,000 cells/well) were cultured in RPMI-1640 with 1% glutamine without phenol 
red in the presence of Apilimod or YM201636 for 3 h, in the final hour with drugs the cells were 
stimulated with 200 μl pHRodo Red Zymosan Bioparticles Conjugate for Phagocytosis (0.5 mg/ml) 
(ThermoFisher; P35364). Hoechst (5 μg/ml) was added 15 minutes before imaging. Samples were 
imaged with a Leica SP8 confocal laser scanning microscope with a 63x 1.20 NA water immersion 
objective (Leica HC PL APO 63x/1.20 W CORR CS2). Images were independently analyzed with Fiji 
(ImageJ) with identical treshholding parameters.
Cathepsin activity-based probe
Dendritic cells (300,000 cells/well) were cultured in RPMI-1640 with 1% ultra-glutamine (without 
Phenol Red) and incubated with different pharmacological treatments. Cells were stimulated 
using 15 μl unlabeled zymosan per well for 0, 0.5 or 1 h prior to lysis. Cathepsin probe BMV109-Cy5 
at 1 μM (Verdoes et al., 2013) was added 0.5 h before lysis or in lysate control experiments probe 
BMV109-Cy5 was added immediately after lysis and incubated on ice for 1.5 h. In lysate control 
experiments probe BMV109-Cy5 was added immediately after lysis. Cells were centrifuged and 
washed with ice-cold PBS, lysed in hypotonic lysis buffer (50 mM PIPES pH 7.4, 10 mM KCl, 5 mM 
MgCl2, 2 mM EDTA, 4 mM DTT, and 1% NP-40). The cells were cooled on ice for 10 minutes. The 
lysates were transferred to new tubes and BCA protein determination was performed (Micro 
BCA™ Protein Assay Kit, Thermo Scientific; 23235). The samples were resolved on 15% SDS-PAGE 
and in-gel fluorescence of BMV109-Cy5 of active cathepsins was tested with a TRIO+ Typhoon 
scanner (670BP-500PMT-Rex-ex-Focal plane 3x). The SDS gel was subsequently blotted and 
immunostained for GAPDH loading control. The membrane was incubated with secondary 
antibody coupled with IRDye 680 or 800 at a dilution of 1:5000 for 1 h. The membrane was washed 
three times with 0.05% Tween-20 for 10 minutes each and scanned with an Odyssey scanner (LI-
COR). PAO was added to dendritic cells at 1 μM (Dingjan et al., 2016).
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ROS measurements
ROS in apilimod treated dendritic cells was measured with the Amplex Red assay as described 
(Dingjan et al., 2016). Zymosan particles were co-labeled with ROS-sensor OxyBurst-Green 
H2DCFDA (ThermoFisher; D-2935) and Alexa-Fluor-633 C5-maleimide (A-20342, ThermoFisher) 
and live cell imaging was performed as described (Dingjan et al., 2017). For analysis, the OxyBurst 
fluorescence signal from each zymosan particle was divided by that of Alexa-Fluor-633.
HLA-DR1-restricted presentation of viral influenza HA
Peptides containing influenza A virus haemagglutin (strain A/Aichi/2/1968 H3N2) peptide (HA) 
residues 322-334 with or without lysine 326 converted into L-propargylglycine were synthesized 
(as described in Solid-phase peptide synthesis section). 100,000 dendritic cells were pre-stimulated 
for 5 h in 100 μl serum-free RPMI with a water solution of HA-peptide at 5 μM final concentration. 
Apilimod or YM201636 were added 3 h prior to the end of the HA-stimulation. As a control, cells 
were incubated for 15 min at 37 oC with trypsin-containing buffer (NaCl 0.8% (w/v), KCl 0.04% (w/v), 
D-glucose 0.1% (w/v), NaHCO3 0.058% (w/v), EDTA 0.02% (w/v), trypsin 0.05% (w/v) (BD Difco 250; 
215240)). Cell viability was traced with eFluor780 (ThermoFisher; 65- 0865-18) and cells were fixed 
in 4% PFA in PBS. At all steps before and during viability staining or click-labeling, the cells were 
washed at least 2 times with either PBS or HBS (N2-bubbled, NaCl 150 mM, HEPES 20 mM, pH 7.4). 
Autofluorescence was reduced after 20 min by washing with quenching buffer (100 mM glycine, 
100 mM NH4Cl), surface presentation of HA was labeled for 1 h with CalFluor488 (Shieh et al., 
2015) in HBS containing 1 mM CuSO4, 0.5 mM THPTA (Tris(3-hydroxypropyltriazolylmethyl)amine), 
5 mM sodium Lascorbate; 0.01% (w/v) BSA, aminoguanidine 2.2% (w/v). Finally, surface HLA-DR1 
was labeled with mouse anti-human-HLA-DR conjugated to APC at 1:100 (BD Biosciences; 559866; 
clone G46-6, RUO) in PBA buffer (0.5% BSA and 0.01% NaN3 in PBS).
Statistical Analysis
All data were analyzed using Student’s two-tailed paired t tests. A p value < 0.05 was regarded as 
statistically significant (*p < 0.05, **p < 0.01, ***p < 0.001).
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Figure S1. Characterization of PIKfyve inhibitors apilimod and YM201636. Related to Figure 2. (A) 
Expression of PIKfyve by qPCR in human monocyte-derived dendritic cells after 1 h stimulation with 
polyionosinic:polycytidylic acid (poly(I:C)) (TLR3 agonist); lipopolysaccharides (LPS) (TLR4 agonist); 
^ Fig. S1: Characterization of PIKfyve inhibitors apilimod and YM201636. Related to Figure 2. (A) Expression of PIKfyve by 
qPCR in human m nocyte-derive  dendritic cells after 1 h stimulation with polyionosinic:polycytidylic acid (poly(I:C)) (TLR3 
agonist); lipopolysaccharides (LPS) (TLR4 agonist); resiquimod (R848) (TLR7 agonist); Pam(3)Cys (TLR2 agonist); zymosan 
(Dectin-1 and TLR2 agonist); pepdidoglycan (PGN) (TLR2 agonist); OVA (CD206 mannose receptor agonist). The expression 
levels were normalized to hydroxymethyl-bilane synthase (HMBS)(mean ± SEM for multiple donors). (B) Viability of human 
dendritic cells treated for 3 h with the indicated concentrations of apilimod or YM201636 by MTT assay (left) or fixable 
viability stain eFluo780 (right) (mean ± SEM for three donors). Black arrowheads: drug concentrations used throughout this 
study. DMSO: solvent control. (C) Representative flow cytometry dot-blots of dendritic cells stained with annexin-V (early 
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apoptotic cells) and 7ADD (necrotic cells) after 3 h treatment with apilimod (200 nM) or YM201636 (4 μM). (D) Quantification 
of panel C (individual donors shown). Left panel: quantification of sum of Q2 and Q3 population of annexin-V positive early 
apoptotic cells. Right panel: quantification of populations in Q1 and Q2 of 7AAD-positive necrotic cells. NS: not significant. (E) 
IL-12 production measured after 24 h LPS (1 μg/ml) stimulation by human monocyte-derived dendritic cells (left) or murine 
bone-marrow-derived dendritic cells (middle and right) in the absence or presence of apilimod or YM201636 (mean ± SEM 
for three donors or mice). (F) Confocal images of monocyte-derived human dendritic cells treated with DMSO, apilimod or 
YM201636 and immunostained for LAMP1 (magenta in merge). Cyan: DAPI. BF: bright-field. Yellow arrowheads: enlarged 
vacuoles. (G) Confocal images of representative dendritic cells expressing LAMP1-RFP with mouse wild-type or kinase-
dead (K1831E) PIKfyve-GFP. Yellow arrowheads: enlarged vacuoles with the kinase-dead PIKfyve-GFP. (H) Representative 
images of moDC with siRNA knockdown of PIKfyve (siPIKfyve). siControl: non-targeting siRNA control. Yellow arrowheads: 
enlarged vacuoles. BF: bright-field. (I) Phagocytosis by dendritic cells measured with flow cytometry and FITC-labeled 
zymosan particles (zymosan-FITC) and DMSO, apilimod or YM201636 treatment. Cells were labeled with phalloidin-Alexa 
Fluor 647 (phal-AF647). Bar graphs show quantification of phagocytosing cells (Q2 population in representative scatter 
plots; mean ± SEM of 3 donors). (J) Same as panel I, but now for endocytosis of BSA-Alexa Fluor 488 (BSA-AF488) for 1 h. 
Representative histograms shown. (K) Confocal images of zymosan-pulsed dendritic cells immunolabeled for mannose-6-
phosphate receptor (magenta in merge) and with 3 h treatment with DMSO (solvent control), apilimod or YM201636. Yellow 
arrowheads: phagosomes positive for mannose-6-phosphate receptor. (L) Graph: quantification of panel G for 3 donors 
(~300 phagosomes/condition/donor; mean ± SEM). (M) Quantification of siPIKfyve by qPCR (mean ± SEM of 3 donors). (N) 
Quantification of LAMP1-positive phagosomes as in main Fig. 2A-D, but now with siPIKfyve. Zymosan was added for 1 h 
before fixation (~160 phagosomes/condition/donor). Scale bars: 10 μm.
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Figure S2. Control experiments for cathepsin activity and trafficking in human dendritic cells. Related to 
Figure 3. (A) Upper row: SDS-PAGE followed by in-gel fluorescence of human monocyte-derived dendritic 
cells treated with zymosan and activity-based probe BMV109-Cy5 (red bands in merge). Middle row: 
^ Fig. S2:  Control experiments for cathepsin activity and trafficking in human dendritic cells. Related to Figure 3. (A) Upper 
row: SDS-PAGE followed by in-gel fluorescence of human monocyte-derived dendritic cells treated with zymosan and 
activity-based probe BMV109-Cy5 (red bands in merge). Middle row: subsequent immunoblotting to PVDF and labeling 
with antibodies specific for cathepsins (Cat) X, B and S and GAPDH (green bands in merge). Lower row: merged images of 
BMV109 probe (red) and immunolabeled cathepsins (green) or GAPDH (green, only labeled on the bottom right blot). Every 
column of images is from a separate donor. Full SDS PAGE/PVDF blots are shown. (B) Quantification of CatS activity measured 
from panel A. Normalization of each condition is either to GAPDH or total CatS (individual donors shown; normalized to 
DMSO controls). (C) Confocal live cell imaging of representative dendritic cells expressing GFP-tagged LAMP1 (LAMP1-GFP; 
green in merge) and pulsed with BMV109 (red in merge) after 1h of zymosan stimulation. Yellow arrowheads: phagosomes 
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positive for LAMP1-GFP and BMV109 signal. BF: bright-field. (D) Representative confocal live cell image of dendritic cells 
treated as in panel A (1h with zymosan). (E) Confocal image of zymosan-pulsed dendritic cell with immunolabeling for 
LAMP1 (magenta in merge) and cathepsin S (green). Blue: DAPI. Yellow arrowheads: phagosomes positive for LAMP1 and 
CatS. Orange arrowhead: phagosome with CatS only. (F) Quantification of panel D (~500 images per condition/donor; mean
± SEM of 3 donors). Scale bars: 10 μm
5 
 
 
Figure S3. Cathepsin activity in lysate of human monocyte-derived dendritic cells. Related to Figure 3. (A) 
Zymosan pulsed dendritic cells were lysed and BMV109 probe was added to the cell lysates and incubated on 
ice for 1.5h. Lysates were resolved with SDS-PAGE and in-gel fluorescence (right-hand scheme). GAPDH: 
loading control by Western blot. Only part of the SDS PAGE/PVDF blot is shown, the rest of the image carried 
no information. (B) Quantification of BMV109 signals from panel A (3 donors; individual donors shown; 
^ Fig. S3:  Cathepsin activity in lysate of human monocyte-deriv d den ritic cells. Related to Figure 3. (A) Zymosan pulsed 
dendritic cells were lysed and BMV109 probe was added to th  cell lysates and incubated on ice for 1.5 h. Lysates were 
resolved with SDS-PAGE and in-gel fluorescence (right-ha  scheme). GAPDH: loading co trol by W stern blot. Only part of 
the SDS PAGE/PVDF blot is shown, the rest of the image carried no information. (B) Quantification of BMV109 signals from 
panel A (3 donors; individual donors shown; normalized to DMSO controls). (C) Same as panel B, but now BMV109 signal for 
CatS normalized to CatX and CatB.
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Figure S4. Control experiments for cathepsin activity and trafficking in human and mouse dendritic cells. 
Related to Figure 4. (A) Gating strategy for flow cytometry experiments with mouse bone-marrow derived 
dendritic cells (BMDCs) where surface MHC-II (I-A/I-E(MHCII)-BV510) was accessed in non-permeabilized 
cells negative for the fixable viability dye eFluo780. Representative histograms show the geometric mean 
fluorescence intensities (gMFI). Cells were treated for 3 h with apilimod or YM201636; SSC: side scatter. FSC: 
forward scatter. Light blue: isotype control. (B) Quantification of viable eFluo780-negative cells and surface 
MHC-II signals from panel A normalized to DMSO solvent controls (individual mice shown; normalized to 
DMSO controls). (C) Same as panels A-B, but now in presence of detergent permeabilization for assessment of 
total cellular MHC-II. (D) Gating strategy for flow cytometry of human monocyte-derived dendritic cells 
(moDC) immunolabeled using an antibody recognizing CLIP-bound MHC class II (CLIP-MHCII-AF647) 
labeled with Alexa Fluor-647 (AF647). (E) Representative histograms and quantification of surface CLIP-bound 
MHC class II (CLIP-MHCII-AF647) with flow cytometry experiments of moDCs treated for 3h with apilimod 
^ Fig. S4:  Control experiments for cathepsin activity and trafficking in human and mouse dendritic cells. Related to 
Figure 4. (A) Gating strategy for flow cytometry experiments with mouse bone-marrow derived dendritic cells (BMDCs) 
where surface MHC-II (I-A/I-E(MHCII)-BV510) was accessed in non-permeabilized cells negative for the fixable viability 
dye eFluo780. Representative histograms show the geometric mean fluorescence intensities (gMFI). Cells were treated for 
3 h with apilimod or YM201636; SSC: side scatter. FSC: forward scatter. Light blue: isotype control. (B) Quantification of 
viable eFluo780-negative cells and surface MHC-II signals from panel A normalized to DMSO solvent controls (individual 
mice shown; normalized to DMSO controls). (C) Same as panels A-B, but now in presence of detergent permeabilization 
for assessment of total cellular MHC-II. (D) Gating strategy for flow cytometry of human monocyte-derived dendritic cells 
(moDC) immunolabeled using an antibody recognizing CLIP-bound MHC class II (CLIP-MHCII-AF647) labeled with Alexa 
Fluor-647 (AF647). (E) Representative histograms and quantification of surface CLIP-bound MHC class II (CLIP-MHCII-AF647) 
with flow cy ometry experiments of moDCs treated for 3h wi h apilimo (200 nM) or YM201636 (4 μM) (geometric mean 
fluorescence intensities (gMF ); individual donors sh wn; normalized to DMSO control). (F) Same as panel E, but now for 
total CLIP-bound MHC-II (Total CLIP-MHCIIAF647) with detergent permeabilization. (G) Representative Western blot of 
lysates from murine BMDCs labeled for CLIP. lip10: 10 kDa precursor fragment of CLIP. LHVS: selective cathepsin S inhibitor. 
GAPDH: loading control. Only part of the SDS PAGE/PVDF blot is shown, the rest of the image carried no information. (H) 
Quantification of panel G normalized to GAPDH (BMDCs from different mice shown; normalized to DMSO control). (I-J) Same 
as D-F, but now using an antibody recognizing MHC-II (HLA-DR1) conjugated with APC and an extra condition with CatS 
inhibitor LHVS (25 nM) (individual donors shown; normalized to DMSO controls).
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Figure S5. Control experiments for OT-II T cell priming experiments. Related to Figure 4. (A) Time line of 
murine OT-II T cell activation. Bone-marrow derived dendric cells (BMDC) were pre-incubated with PLGA-
OVA particles for 3 hours. Subsequently, OVA323-339-recognizing OT-II cells were added and the cells were 
exposed to apilimod or YM201636 for 12, 24 or 48 hours. (B) INFγ in supernatants by ELISA as indicated in 
panel A (mean from 3 independent experiments ± SEM). (C-E) Viability of experiment from panels A-B of OT-
II cells (C) and BMDCs (D), and gating strategy (E). Viability was assessed with fixable viability dye eFluo405. 
OT-II cells were identified with OTII-CellTrace Far Red. SSC: side scatter; FSC: forward scatter (mean from 3 
independent experiments ± SEM). (F) Surface expression of MHC class II (I-A/I-E-PE) for the experiments from 
panels A-E. gMFI: geometric mean fluorescence intensity. Representative histogram and quantifications are 
shown (normalized to DMSO control at 12 h; mean from 3 independent experiments ± SEM). 
  
< Fig. S5:  Control experiments for OT-II T cell 
priming experiments. Related to Figure 4. (A) 
Time line of murine OT-II T cell activation. Bone-
marrow derived dendric cells (BMDC) were 
pre-incubated with PLGA-OVA particles for 3 
hours. Subsequently, OVA323-339-recognizing OT-
II cells were added and the cells were exposed 
to apilimod or YM201636 for 12, 24 or 48 hours. 
(B) INFγ in supernatants by ELISA as indicated in 
panel A (mean from 3 independent experiments 
± SEM). (C-E) Viability of experiment from panels 
A-B of OTII cells (C) and BMDCs (D), and gating 
strategy (E). Viability was assessed with fixable 
viability dye eFluo405. OT-II cells were identified 
with OTII-CellTrace Far Red. SSC: side scatter; 
FSC: forward scatter (mean from 3 independent 
experiments ± SEM). (F) Surface expression of 
MHC class II (I-A/I-E-PE) for the experiments from 
panels A-E. gMFI: geometric mean fluorescence 
intensity. Representative histogram and 
quantifications are shown (normalized to DMSO 
control at 12 h; mean from 3 independent 
experiments ± SEM).
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Figure S6. Apilimod and YM201636 impair T cell function. Related to Figure 4. (A) Scheme of experiment. 
OT-I T cells specifically recognizing ovalbumin residues 257-264 (SIINFEKL) in context of MHC-I were 
incubated with the epitope and PIKfyve inhibiting drugs apilimod or YM201636. (B) INFγ in the supernatants of 
the OT-I T cells from panel A. Note that YM201636 (but not or less apilimod) results in reduced production of 
INFγ. (C-F) Flow cytometry gating strategy and representative histograms (C) for T cell viability (D) and 
activation (E-F). Viability of OT-I T cells with fixable viability dye eFluo405 (D). Viable OT-I T cells were 
gated for early activation marker CD69-PE (E) or CD25-APC (F). SSC: side scatter; FSC: forward scatter; 
gMFI: geometric mean fluorescence intensity (mean from 3 independent experiments ± SEM).  
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< Fig. S6: Apilimod and YM201636 impair T cell function. Related to Figure 4. (A) Scheme of experiment. OT-I T cells specifically 
recognizing ovalbumin residues 257-264 (SIINFEKL) in context of MHC-I were incubated with the epitope and PIKfyve 
inhibiting drugs apilimod or YM201636. (B) INFγ in the supernatants of the OT-I T cells from panel A. Note that YM201636 
(but not or less apilimod) results in reduced production of INFγ. (C-F) Flow cytometry gating strategy and representative 
histograms (C) for T cell viability (D) and activation (E-F). Viability of OT-I T cells with fixable viability dye eFluo405 (D). Viable 
OT-I T cells were gated for early activation marker CD69-PE (E) or CD25-APC (F). SSC: side scatter; FSC: forward scatter; gMFI: 
geometric mean fluorescence intensity (mean from 3 independent experiments ± SEM).
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Figure S7. Analytical HPLC profiles and mass spectrometry validation of synthesized peptides. Related to 
Figure 6. Analytical HPLC chromatograms of: (A) hemagglutinin (HA) (residues 318-338) long clickable, (B) 
HA(318-338) long non clickable, (C) HA(322-334) short non clickable, and (D) HA(322-334) short clickable. 
ESI and HR-ESI-MS spectra of (E)  HA(318-338) long clickable m/z (ESI) = 775.3956 [M+3H]3+, 1162.5909 
[M+2H]2+ and m/z (HR-ESI-MS) = calculated: 775.0610 [M+3H]3+, found: 775.0613 [M+3H]3+ , (F) HA(318-
338) long non clickable m/z (ESI) = 472.2 [M+5H]5+, 590.0 [M+4H]4+, 786.4 [M+3H]3+, 1079.0 [M+2H]2+ and 
m/z (HR-ESI-MS) = calculated: 1178.6168 [M+2H]2+, found: 1178.6183 [M+2H]2+, (G) HA(322-334) short non 
clickable m/z (ESI) = 376.7 [M+4H]4+, 501.9 [M+3H]3+, 752.4 [M+2H]2+ and m/z (HR-ESI-MS) = calculated: 
752.4483 [M+2H]2+, found: 752.4491 [M+2H]2+ and (H) HA(322-334) short clickable m/z (ESI) = 490.9 
^ Fig. S7: Analytical HPLC profiles and mass spectrom try validation of synthesized pepti es. Related to Figure 6. Analytical 
HPLC chromatograms of: (A) hemagglutinin (HA) (residues 318-338) long clickable, (B) HA(318-338) long non clickable, (C) 
HA(322-334) short non clickable, and (D) HA(322-334) short clickable. ESI and HR-ESI-MS spectra of (E) HA(318-338) long 
clickable m/z (ESI) = 775.3956 [M+3H]3+, 1162.5909 [M+2H]2+ and m/z (HR-ESI-MS) = calculated: 775.0610 [M+3H]3+, found: 
775.0613 [M+3H]3+ , (F) HA(318-338) long non clickable m/z (ESI) = 472.2 [M+5H]5+, 590.0 [M+4H]4+, 786.4 [M+3H]3+, 1079.0 
[M+2H]2+ and m/z (HR-ESI-MS) = calculated: 1178.6168 [M+2H]2+, found: 1178.6183 [M+2H]2+, (G) HA(322-334) short non 
clickable m/z (ESI) = 376.7 [M+4H]4+, 501.9 [M+3H]3+, 752.4 [M+2H]2+ and m/z (HR-ESI-MS) = calculated: 752.4483 [M+2H]2+, 
found: 752.4491 [M+2H]2+ and (H) HA(322-334) short clickable m/z (ESI) = 490.9 [M+3H]3+, 735.9 [M+2H]2+ and m/z (HR-ESI-MS) 
= calculated: 735.9194 [M+2H]2+, found: 735.9198 [M+2H]2+.
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^ Fig. S8: Control experiments for bio-orthogonal labeling of MHC-II presented epitope. Related to Figure 6. (A) Human 
dendritic cells were incubated with hemagglutinin (HA) peptides carrying an unnatural propargylglycine amino acid 
amendable to bio-orthoginal labeling with CalFluor488. Left: flow cytometry dotblots with dendritic cells with (green) 
and without (background; black) HA peptide. SSC: side scatter. Right: gMFI (geometric mean fluorescence intensity) and 
population of HA-presenting cells incubated for the indicated times with long (residues 318-338) or short (residues 322-
334) HA peptides with or without clickable propargylglycine amino acids. (B) The cells from panel A were tested for surface 
exposed MHC-II (HLA-DR) by flow cytometry. Representative histograms (left) and quantification by gMFI and population of 
HLA-DR-positive cells (right) are shown (mean from 5 donors ± SEM).
12 
 
[M+3H]3+, 735.9 [M+2H]2+ and m/z (HR-ESI-MS) = calculated: 735.9194 [M+2H]2+, found: 735.9198 
[M+2H]2+. 
 
Figure S8. Control experime ts for bio-orthogonal labeling of MHC-II presented epitope. Related to 
Figure 6. (A) Human dendritic cells were incubated with hemagglutinin (HA) peptides carrying an unnatural 
propargylglycine amino acid amendable to bio-orthoginal labeling with CalFluor488. Left: flow cytometry dot-
blots with dendritic cells with (green) and without (background; black) HA peptide. SSC: side scatter. Right: 
gMFI (geometric mean fluorescence intensity) and population of HA-presenting cells incubated for the indicated 
times with long (residues 318-338) or short (residues 322-334) HA peptides with or without clickable 
propargylglycine amino acids. (B) The cells from panel A were tested for surface exposed MHC-II (HLA-DR) 
by flow cytometry. Representative histograms (left) and quantification by gMFI and population of HLA-DR-
positive cells (right) are shown (mean from 5 donors ± SEM).  
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Table S1. Related to Figure 6. Synthesized hemagglutinin (HA) peptides with and without 
propargylglycine. 
HA(318-338) 
long clickable 
C102H163N29O29S2 
2323.7 [g/mol] 
 
HA(318-338) 
long non 
clickable 
C103H170N30O29S2 
2356.8 [g/mol] 
 
HA(322-334) 
short non 
clickable 
C69H118N18O19 
1503.8 [g/mol] 
 
HA(322-334) 
short clickable 
C68H111N17O19 
1469.8 [g/mol] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
^ Table. S1: Related to Figure 6. Synthesized hemagglutinin (HA) peptides with and without propargylglycine.
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Abstract
Dendritic cells sample the environment for antigens and play an important role in establishing the 
link between innate and acquired immunity. Dendritic cells contain mechanosensitive adhesive 
structures called podosomes that consist of an actin-rich core surrounded by integrins, adaptor 
proteins and actin network filaments. They facilitate cell migration via localized degradation of 
extracellular matrix. Here, we show that podosomes of human dendritic cells locate to spots of low 
physical resistance in the substrate (soft spots) where they can evolve into protrusive structures. 
Pathogen recognition receptors locate to these protrusive structures where they can trigger 
localized antigen uptake, processing and presentation to activate T-cells. Our data demonstrate a 
novel role in antigen sampling for the podosomes of dendritic cells.
Introduction
The main function of dendritic cells is antigen presentation. Immature dendritic cells are localized 
in the spleen and other non-lymphoid tissues and constantly sample tissue and blood for antigens 
by so-called pattern recognition receptors (PRRs) (Lipscomb and Masten, 2002; McGreal et al., 
2005; Takeda and Akira 2005; Kaparakis et al., 2007). Dendritic cells express many different PRRs 
that recognize pathogen-associated molecular patterns (PAMPs), such as lipopolysaccharide, 
from the outer membrane of gram-negative bacteria, as well as peptides of bacterial, fungal or 
viral origin. Binding of antigen to some PRRs, such as C-type lectins, can trigger uptake of antigen 
via receptor-mediated endocytosis or phagocytosis. Recognition of antigen results in maturation 
of dendritic cells and surface presentation of the antigen by major histocompatibility complex 
(MHC) molecules, upregulation of specific co-stimulatory molecules and finally migration to the 
lymph nodes, where dendritic cells prime T-cells (Banchereau and Steinman, 1998; McGreal et 
al., 2005). Because only dendritic cells can induce a primary immune response in resting naive 
T-lymphocytes, they are considered a crucial component that balances the innate and adaptive 
immune systems. For antigen sampling, immature dendritic cells need to migrate from their 
sites of origin (i.e. bone marrow) to specific sites of sampling activity (peripheral tissues), and for 
activation of T-cells, mature dendritic cells need to travel to the draining lymph nodes where they 
present antigen to T-cells.
Immature dendritic cells form particular cell–matrix contacts called podosomes that facilitate cell 
migration within peripheral tissues (reviewed in Buccione et al., 2004; Gimona et al., 2008; Linder et 
al., 2011; Murphy and Courtneidge, 2011; Schachtner et al., 2013b). Podosomes consist of an actin-
rich core region surrounded by integrins from which anti-parallel actin filaments radiate (Schmidt 
et al., 2011; van den Dries et al., 2013b). Adaptor proteins such as vinculin, talin and paxillin connect 
the cortical actin cytoskeleton to the plasma membrane and to integrins, and are enriched around 
the actin-rich cores of podosomes. Unlike focal adhesions, podosomes contain the protein WASP 
that can recruit the actin nucleating complex Arp2/3 (Linder et al., 1999; Burns et al., 2001; Jones et 
al., 2002; Calle et al., 2006). Podosomes are points of concentrated release of the metalloproteinase 
MMP14 (also called MT1-MMP) and several other proteases that locally degrade the extracellular 
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matrix (ECM) (van Helden et al., 2006; Gimona et al., 2008; Linder et al., 2011; Murphy and 
Courtneidge, 2011). Protease release at podosomes promotes cell invasiveness and facilitates cell 
migration through endothelium, epithelium and connective tissue (Matı´ as-Roma´n et al., 2005; 
Carman et al., 2007; Linder, 2007; Schachtner et al., 2013b). In fact, podosomes are commonly 
located at the leading edge of migrating cells and their turnover is required for cell migration and 
passage through endothelium (Burns et al., 2001; Calle et al., 2006). WASP-deficient leukocytes do 
not form podosomes and chemotactic migration is severely compromised in these cells (Zicha et 
al., 1998; Jones et al., 2002; Dovas et al., 2009). Podosomes are mechanosensitive (Collin et al., 2008) 
as demonstrated by their selective localization on the edges of 3D-micropatterned substrates (van 
den Dries et al., 2012). 
Podosomes are not only formed by dendritic cells (Burns et al., 2001) but also by many other types 
of adherent cells, such as smooth muscle cells, endothelial cells, megakaryocytes, fibroblasts, 
macrophages, osteoclasts, microglia and at the postsynaptic site of the neuromuscular junction 
(Buccione et al., 2004; van Helden et al., 2006; Proszynski et al., 2009; Linder et al., 2011; Schachtner 
et al., 2013a). Although podosomes are very similar to the well-studied invadopodia of cancer cells 
(Wolf and Friedl, 2009), which are involved in cancer metastasis (Sabeh et al., 2004; Bravo-Cordero 
et al., 2012), they are considered to differ from invadopodia in at least two ways. First, podosomes 
are very dynamic with lifetimes that can be as short as 1 to 12 min, whereas invadopodia can persist 
for hours (reviewed in Linder et al., 2011; Murphy and Courtneidge, 2011). Second, podosomes are 
smaller and measure only 0.5 to 2 μm in diameter and protrude only about 0.4 to 2 μm, whereas 
invadopodia can reach 8 μm in diameter and can protrude more than 5 µm from the cell surface 
into the extracellular environment (Linder et al., 2011; Murphy and Courtneidge, 2011). However, this 
limited protrusion depth of podosomes is contradicted in a recent study where it was shown that 
podosomes of dendritic cells could protrude more than 3 µm into the pores of polycarbonate filters 
(Gawden-Bone et al., 2010). Thus, the geometry of the substrate not only dictates the localization 
of podosomes (van den Dries et al., 2012), but might also affect the morphology of podosomes and 
allow podosomal protrusion into the extracellular environment. 
The study by Gawden-Bone et al. (Gawden-Bone et al., 2010) demonstrated that when dendritic 
cells were cultured on filters, podosomes formed precisely on top of the pores and could extend 
into the lumen of the filter pores. Both the release of MMP14-containing vesicles and uptake of 
extracellular material occurred at the tips of these protrusive structures (Gawden-Bone et al., 2010). 
These results are interesting because dendritic cells are well known to be capable of sampling 
for antigen in the lumen of the lung, gut and small intestine by extending ‘protrusive dendrites’ 
through the epithelium of these organs (Rescigno et al., 2001; Niess et al., 2005; Chieppa et al., 2006; 
Vallon- Eberhard et al., 2006; Lelouard et al., 2012; Thornton et al., 2012; Farache et al., 2013; Shan et 
al., 2013; Strisciuglio et al., 2013). We speculated that this trans-epithelial antigen sampling might be 
related to the protrusive podosome-like structures first described by Gawden-Bone et al. (Gawden-
Bone et al., 2010) and performed a molecular characterization of these actin-rich structures. Here, 
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we demonstrate that podosomes of human dendritic cells can evolve into protrusive structures 
that help the cell to sample for antigen from deeper within the substrate. A wide range of PRRs 
locate to these protrusive structures where they can trigger receptor-mediated uptake of antigen. 
Our results show a direct role for podosomes in antigen presentation, and this constitutes a new 
mechanism of how cells might be able to sense extracellular signals through physical barriers.
Results
Podosomes extend in soft spots of the substrate
When human dendritic cells are cultured on a glass substrate, they form clusters of podosomes 
(Fig. 1A) (Burns et al., 2001; van Helden et al., 2006). Podosomes on glass appear as dome-shaped
actin-rich structures with an actin core of , ~350 nm diameter and a height of , ~500 nm, surrounded 
by a 250-nm wide ring of integrins and integrin-associated proteins, such as vinculin, talin and 
paxillin (Labernadie et al., 2010; Schmidt et al., 2011; Cox et al., 2011; van den Dries et al., 2012; 
van den Dries et al., 2013b). It has been recently reported that when dendritic cells are cultured 
on polycarbonate filters with pores of defined size, podosomes locate on top of the filter pores 
(Gawden-Bone et al., 2010). This alignment of the podosomes with the filter pores is likely related 
to the mechanosensitivity of podosomes that form around local deformations of the substrate 
(van den Dries et al., 2012). Indeed, when we cultured human dendritic cells for 1 hour on gelatin-
soaked polycarbonate filters with 400-nm diameter pores, almost all podosomes formed directly 
on top of the filter pores (Fig. 1B–E). The actin-rich cores of these podosomes were surrounded by 
adaptor proteins, such as talin, vinculin and paxillin, similar to podosomes formed by cells on glass 
substrates (Linder et al., 2011). Optical z-sectioning by confocal microscopy revealed that these 
podosomes did not protrude into the lumen of the 400-nm-sized pores of the polycarbonate 
filters (less than 1 μm protrusion depth; Fig. 1B). 
We speculated that a pore size of 400 nm might be too small to allow for protrusion of podosomes. 
To address this, we cultured dendritic cells on gelatin-impregnated filters with larger pores of 1 
µm diameter, identical to those employed by Gawden-Bone et al. (Gawden-Bone et al., 2010). 
Indeed, as reported previously (Gawden-Bone et al., 2010), we observed clear protrusion of actin-
rich structures into these 1-µm-sized pores (Fig. 2A) and regardless of whether the filters were 
impregnated with gelatin. The actin-rich core of these podosome-like structures could penetrate 
through the entire filter of ~10-µm thickness. The actin-rich cores were surrounded by adaptor 
proteins, such as vinculin, which was predominantly present at the base of the pores and did not 
seem to protrude into the 1-µm-sized pores. However, vinculin increasingly protruded into the 
lumen of the pores when cells were cultured on filters with larger pore sizes of 2 µm and 3 µm 
in diameter (Fig. 2B,C). On filters with these larger pore sizes, podosomes were not exclusively 
colocalized with the pores but were increasingly also present in between the pores (Fig. 2D). On 
filters with 3-µm-sized pores, small individual podosomes could be distinguished at the edges of 
the pores and the pore size was large enough to facilitate migration of the whole cell through the 
filter pores (Fig. 2C,E), as reported previously (Gawden-Bone et al., 2010). Thus, for cells cultured 
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on polycarbonate filters with increasing pore sizes from 400 nm to 3 µm, the morphology of the 
podosomes differs; in smaller pores, the actin core and, in larger pores, adaptor proteins, such as
vinculin, can progressively protrude into the lumen of the pores.
^ Fig. 1: Podosomes locate to spots of low physical resistance from the substrate. (A) Human-monocyte-derived dendritic 
cells cultured on glass substrate and stained with primary antibodies directed against vinculin, talin and paxillin, and 
secondary antibodies conjugated to Alexa Fluor 488 (AB, green). Actin was stained with phalloidin–Alexa-Fluor-564 (Phal, 
magenta). Shown are confocal images of representative cells with podosomes immediately at the glass surface. Yellow 
arrowheads indicate randomly chosen podosomes. Bar graphs show the percentage of AB-positive actin cores (means±s.d.). 
(B) Same as A, but cells were grown on polycarbonate filters with pore sizes of 400 nm. The filters were soaked in gelatin 
conjugated to Alexa Fluor 633 (Filter, gray). Yellow lines indicate the positions of the orthogonal views. The red arrowhead 
indicates the approximate location of the filter surface. (C) Quantification of the alignment of the podosomes to the filter 
pores from panel B (mean±s.d.). (D,E) Schemes of dendritic cells with non-protrusive podosomes on glass (D) and filters with 
pore sizes of 400 nm (E) (actin, magenta; vinculin, green). Scale bars: 5 µm.
Overall, a picture is emerging where the initial non-protrusive podosomes of dendritic cells 
search for soft spots of low physical resistance in the substrate (e.g. the filter pores). When such a 
place is found, podosomes become increasingly invasive and can protrude into the substrate by 
local degradation of extracellular matrix and by exerting mechanical forces (Gawden-Bone et al.,
2010; Labernadie et al., 2010). This results in growth of a protrusive podosome-like structure 
and at some point (i.e. for pores above 3 µm in diameter; Gawden-Bone et al., 2010) facilitates 
transmigration of the cell through physical barriers. Dendritic cells and other blood leukocytes 
have to cross blood vessel and lymphatic endothelium in order to activate the immune system 
(Muller, 2011; Vestweber, 2012). Secretion of the metalloproteinase MMP14 and turnover of 
podosomes are well-known to be essential for this transendothelium migration (Matıas-Roman 
et al., 2005; Calle et al., 2006; Carman et al., 2007). Indeed, dendritic cells can migrate through 
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monolayers formed by the endothelial cell line EA.hy926 (supplementary material Fig. S1A,B). 
Dendritic cells are also able to penetrate and pass monolayers formed by the epithelial cell line 
Caco-2 (supplementary material Fig. S1C–E) (Rescigno et al., 2001; Strisciuglio et al., 2013) and, 
for megakaryocytes, podosomes have also recently been shown to play a role in this epithelial 
penetration (Schachtner et al., 2013a). Thus, it is increasingly clear that podosomes facilitate cell 
migration across both endothelial and epithelial barriers.
Characterization of protrusive podosome-like structures
To further investigate the protrusive podosome-like structures on filter substrates, we performed 
immunostainings for typical podosomal marker proteins on dendritic cells cultured on filters with 
1-µm pore sizes. Similar to podosomes of cells cultured on glass (Fig. 1A), the F-actin-rich core 
of protrusive podosome-like structures was surrounded by rings or clusters of talin, paxillin and 
the integrins ITGAM (a subunit of integrin αMβ2) and ITGB1 (integrin b1) (Fig. 3A). Interestingly, 
protrusive podosome-like structures often (for ~10–30% of all podosomes), but not always (for 
the remaining ~70–90% of podosomes), contained a ring of actin at the base of the protrusions, as 
could be observed with both phalloidin in fixed cells (Fig. 3B) and with the F-actin-binding probe 
LifeAct-GFP in live cells (supplementary material Fig. S2A,B). This is in clear contrast to podosomes 
formed by cells on glass substrate, which are generally considered to contain solid cores of actin 
(Fig. 1A). Integrins stimulate the production of phosphatidylinositol 4,5-bisphosphate (PIP2), which 
stimulates WASP activity (Prehoda et al., 2000) and binds directly to talin and vinculin (Brakebusch 
and Faessler, 2003), and PIP2 accumulates at and is essential for the formation of invadopodia 
of cancer cells (Yamaguchi et al., 2010). We therefore probed for PIP2 by exogenously adding 
bacterially expressed pleckstrin homology domain of phospholipase C delta subunit fused to 
citrine (PLCδ-PH) (van den Bogaart et al., 2011). PLCδ-PH stained a ring surrounding the actin-
rich core, demonstrating the presence of PIP2 in this region (Fig. 3C). Podosome-like protrusive 
structures still depended on WASP (Linder et al., 1999; Burns et al., 2001; Jones et al., 2002; Calle 
et al., 2006), because treatment of the cells with wiskostatin, a selective and reversible inhibitor of 
WASP (Peterson et al., 2004), resulted in disassembly of the actin-rich protrusions at a similar rate 
to that of podosomes of cells cultured on glass (Fig. 3D,E) (Dovas et al., 2009; Tsujita et al., 2013). 
Degradation of ECM occurs at podosomes and is dependent on the local release of 
metalloproteinases, such as MMP14 (Buccione et al., 2004; Gimona et al., 2008; Linder et al., 2011;
Schachtner et al., 2013b). Indeed, degradation of ECM took place at protrusive podosome-like 
structures as apparent by the (~2-fold) local increased fluorescence intensity when the filters were
impregnated with double-quenched FITC-labeled collagen in gelatin (Fig. 4A,B), in agreement 
with previous results (Gawden-Bone et al., 2010). We observed by immunocytochemistry that 
MMP14 was present in the protrusive podosome-like structures (formed on 1-µm-sized pores) 
and this is a clear difference from the (non-protrusive) podosomes of cells cultured on glass, where
MMP14 was not enriched but rather seemed excluded from the actin-rich podosome cores 
(Wiesner et al., 2010) (Fig. 4C). MMP14-containing vesicles are known to traffic intracellularly 
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on microtubules in a kinesin-mediated manner (Wiesner et al., 2010; Cornfine et al., 2011) and 
to travel via microtubules to the tip of invadopodia of cancer cells (Schoumacher et al., 2010). 
Our data suggest that MMP14-containing vesicles could also traffic via microtubules to the tip of 
protrusive podosome-like structures, because microtubules clearly penetrated the F-actin ring of 
these structures and extended into the lumen of the filter pores (Fig. 4D). This tubulin protrusion 
again is different from podosomes of cells cultured on glass, where the extension of the tubules 
into the podosomal cores was not observed. 
^ Fig. 2: Podosome-like protrusive structures of dendritic cells. (A) Dendritic cells cultured on polycarbonate membrane 
filters impregnated with Alexa-Fluor-633-labeled gelatin (gray) with pore sizes of 1 µm. Cells were immunostained for 
vinculin (green) and actin was visualized with phalloidin (Phal, magenta) similar to in Fig. 1. Shown are confocal sections just 
above the surface of the filters. The yellow line indicates the position of the orthogonal views showing the protrusion of 
actin in the lumen of the pores. Yellow arrowheads depict randomly selected actin-rich cores. The red arrowhead indicates 
the approximate filter surface. The right-hand panel shows a schematic diagram of the protrusions (actin: magenta; vinculin: 
green). (B) Same as A, but now for filters with pore sizes of 2 µm and showing the protrusion of both the actin core and 
vinculin in the pores as indicated by the white arrows. The cells also formed podosomes that did not overlap with the pores 
as indicated by the yellow arrowheads. (C) Same as B, but now with pore sizes of 3 µm. (D) Quantification of the fraction of 
actin cores aligning with the filter pores from panels A–C (means ± s.d.). (E) Same as C, showing cell migration through the 
3-µm pores in the filter (white arrows) and the formation of podosomes on both sides of the filter (yellow arrowheads). 
Confocal sections above, through and underneath the filter are shown. Scale bars: 5 µm.
The substrate influences the lifetime of podosomes, and periodic undulations of the actin-
rich core are proposed to contribute to the protrusive and mechanosensitive properties of 
podosomes (Schachtner et al., 2013a; van den Dries et al., 2013a). Indeed, podosomes seem to 
become less dynamic and more stable when they become more invasive, because protrusive 
podosome-ike structures have lifetimes that exceeded several hours compared to less than 1 
h for podosomes on glass substrate. Moreover, the periodic undulations of the actin cores of 
protrusive podosome-like structures were reduced ~2-fold compared to podosomes of cells 
cultured on glass (supplementary material Fig. S2C–E; Movies 1, 2) (see also Labernadie et al., 2010; 
van den Dries et al., 2013a). Taken together, we conclude that when podosomes encounter spots 
of low physical resistance of the substrate (e.g. the filter pores), their morphology and protein 
composition change as they become increasingly more protrusive and less dynamic. We next 
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addressed the role of endocytosis at these protrusive podosome-like structures of dendritic cells.
^ Fig. 3: Characterization of protrusive podosome-like structures. (A) Confocal images of human dendritic cells cultured 
on membrane filters with pore sizes of 1 µm. Actin was stained with phalloidin–Alexa-Fluor-546 (Phal, magenta) and talin, 
paxillin, ITGAM and ITGB1 were labeled by specific monoclonal antibodies and secondary antibodies conjugated to Alexa 
Fluor 488 (AB, green). Yellow lines indicate the positions of the orthogonal views. Yellow arrowheads indicate randomly 
chosen actin cores. The red arrowhead indicates the approximate surfaces of the filter substrates. Bar graphs show 
quantifications of the percentage of AB-positive actin cores (means ± s.d.). (B) Confocal image of a dendritic cell on gelatin–
Alexa-Fluor-633-impregnated filters with pore sizes of 1 µm (Filter, magenta) and stained with phalloidin–Alexa-Fluor-488 
(green). The insets show magnifications of actin cores marked i–iv. The graphs show fluorescence intensity distributions 
through the cross-sections marked by the red boxes (y-averaging). The red arrowheads on the graph mark intensity peaks 
at the edges of the ring structures of some of the actin cores. (C) Staining of plasma membrane sheets of human dendritic 
cells similar to A, but instead of antibody staining, PIP2 was labeled with bacterially expressed PLCδ-PH. (D) Cells precultured 
for 1 h on glass or gelatin–Alexa-Fluor-633-impregnated filters with pore sizes of 1 µm (magenta) were treated for 1 h with 
5 µm of the WASP inhibitor wiskostatin or with carrier only (DMSO). Yellow arrowheads mark clusters of actin cores stained 
by phalloidin–Alexa-Fluor-488 (green). (E) The percentage of cells containing actin cores from the experiment described in 
D on glass (black) and filter (red) as a function of exposure time to wiskostatin (means ± s.d., three independent repeats).
Scale bars: 5 µm.
Protrusive podosome-like structures are involved in antigen sampling
In a previous study (Gawden-Bone et al., 2010), uptake of extracellular material at protrusive 
podosome-like structures of dendritic cells was shown by electron microscopy. In accordance 
with this observation, we found that the coat protein clathrin localized to these protrusive 
structures (Fig. 5A–C). Given that it is well-established that dendritic cells can sample for antigen
across epithelial membranes (Rescigno et al., 2001; Niess et al., 2005; Chieppa et al., 2006; 
137
Podosomes of dendritic cells facilitate antigen samPling 
6
Vallon-Eberhard et al., 2006; Lelouard et al., 2012; Thornton et al., 2012; Farache et al., 2013; Shan 
et al., 2013; Strisciuglio et al., 2013) and as confirmed by our observations with monolayers of 
the epithelial cell line Caco-2 (supplementary material Fig. S1E), we hypothesized that antigen 
recognition and uptake might occur at the protrusive podosome-derived structures. In order to 
test this possibility, we first determined whether PRRs involved in antigen uptake located to these 
protrusive structures. We cultured monocyte-derived dendritic cells on filters with 1-µm pore sizes 
for 1 hour and performed immunostaining for various PRRs [the C-type lectin family receptors DC-
SIGN (also known as CD209), DCIR (also known as CLEC4A), dectin-1 (also known as CLEC7A) and 
the mannose receptor CD206 (also known as MRC1)]. We also stained for the transferrin receptor 
CD71 (also known as TFRC) as a general endocytic receptor. All of these PRRs and CD71 localized 
to protrusive podosome-like structures, but not to non-protrusive podosomes on glass substrates 
(Fig. 5D–F). The presence of DC-SIGN and CD206 at these protrusive structures was confirmed by 
immunogold labeling followed by transmission electron microscopy (similar to Gawden-Bone et 
al., 2010), where we observed a ~3-fold (DC-SIGN) to ~9-fold (CD206) enrichment of gold beads 
at the protrusive structures compared to at the ventral membrane of the cells (i.e. membrane in 
contact with the filter surface) (Fig. 6). We subsequently determined the antigen sampling activity 
of these PRRs that localize to protrusive podosome-like structures.
^ Fig. 4. Podosome-like protrusive structures contain MMP14 and tubulin. (A) Confocal images of dendritic cells cultured 
on filters with 1-µm pore size that were impregnated with double-quenched FITC-labeled collagen in gelatin (DQ collagen, 
green). Actin was stained with phalloidin–Alexa-Fluor-633 (Phal, magenta). Collagen degradation results in loss of self-
quenching of the FITC fluorophore and an increase in fluorescence. (B) Fluorescence intensity profiles of the dashed lines 
marked in A. (C) Confocal images (left) and quantification (right) of dendritic cells cultured on glass and membrane filters 
with pore sizes of 1 µm. Actin was stained with phalloidin–Alexa-Fluor-546 (magenta), and the metalloproteinase MMP14 
was labeled by specific monoclonal antibodies and secondary antibodies conjugated to Alexa Fluor 488 (AB, green). The 
yellow line indicates the positions of the orthogonal view. The yellow arrowheads indicate randomly chosen actin cores. 
The red arrowhead indicates the approximate surface of the filter. (D) Same as C, but for tubulin. Error bars show the spread 
of data for multiple cells from at least two independent experiments. Scale bars: 5 µm.
We performed functional uptake experiments of quantum dots tethered to the HIV-1 envelope 
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glycoprotein gp120 as a prototype antigen (Cambi et al., 2007); gp120 is a ligand for DC-SIGN 
(Geijtenbeek et al., 2000) and these gp120-coated quantum dots have a particle size of about 
40 nm, which is comparable to the size of many viruses (Cambi et al., 2007). We also performed 
uptake experiments with OVA (ovalbumin), a well-characterized antigen and ligand for the 
mannose receptor CD206 (Burgdorf et al., 2006). Leakage experiments demonstrated that 
gelatin-impregnated filters were not or only poorly permeable to both OVA and gp120-quantum 
dots (Fig. 7A–C). We measured cellular uptake of gp120-quantum dots and of OVA through these 
gelatin-impregnated filters by fluorescence microscopy (Fig. 7D–F). Live-cell imaging showed 
that uptake of OVA through the filter occurred at the actin-rich protrusive structures (Fig. 7F). 
Uptake could be suppressed by the inhibitor of both clathrin-dependent (von Kleist et al., 2011) 
and independent (Dutta et al., 2012) endocytosis, Pitstop 2, indicating that uptake occurred via 
endocytosis (Fig. 7G). 
^ Fig. 5. Protrusive podosome-like structures contain pattern recognition receptors. (A,B) Confocal images of dendritic 
cells cultured on glass (A) and on filters with 1-µm pore size (B). Actin was labeled with phalloidin–Alexa-Fluor-546 (Phal, 
magenta) and clathrin was visualized by immunostaining (AB, green). The filters were impregnated with Alexa-Fluor-633-
labeled gelatin (Filter, gray). The yellow line indicates the position of the orthogonal view. Yellow arrowheads indicate 
randomly selected actin-rich cores. The red arrowhead indicates the approximate filter surface. (C) Quantification of the 
percentage of clathrin-positive actin cores from the experiments described in A and B. (D–F) Same as A–C, but now with 
immunostaining for DC-SIGN, DCIR, Dectin-1, CD206 and CD71. Error bars show the spread of data for multiple cells from at 
least two independent experiments. Scale bars: 2 µm
Importantly, uptake of both gp120-quantum dots and OVA through the filters was promoted 
by the presence of protrusive podosome-like structures, because uptake was strongly reduced 
(1) when the dendritic cells were cultured on filters with a 400-nm pore size (where podosomes 
form but cannot protrude; Fig. 1B) (Fig. 8A,B) and (2) when CHO cells heterogeneously expressing 
recombinant DC-SIGN were used instead of dendritic cells (Fig. 8A). These CHO–DC-SIGN cells 
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can take up gp120-quantum dots from the growth medium (Cambi et al., 2007), but do not form 
podosomes or podosome-like protrusions (supplementary material Fig. S3A). Moreover, uptake of 
OVA could be inhibited by the WASP inhibitor wiskostatin (Fig. 8C), which causes the disassembly 
of the protrusive structures (Fig. 3D,E). Although the rate of antigen uptake was decreased, uptake 
was not completely blocked in these control conditions, because of residual leakage of antigen 
through the filters and because the cells were still able to degrade gelatin. Uptake of gp120-
quantum dots and OVA was antigen specific, because (1) uptake could be blocked by competitive 
inhibition with the sugar mannan (which binds to DC-SIGN and CD206) and (2) biotintreated 
quantum dots (i.e. without gp120) were endocytosed substantially less effectively than gp120-
quantum dots (Fig. 8A,B). 
^ Fig. 6. Transmission electron microscopy of protrusive podosome-like structures. (A) Electron micrographs of a human 
dendritic cell cultured on a gelatin-impregnated filter with 1-µm pore size and immuno-gold labeled for DC-SIGN (an outline 
of the cell is shown to the upper-right of the micrograph). (B,C) Details of the ventral membrane (B, marked i in panel A) and 
of a protrusive structure (C, ii) from panel A. Yellow arrowheads mark positions of clusters of gold beads. (D) Quantification 
of the number of gold beads per µm in the ventral membrane (black) and the protrusions (red) for 10 different cells. Data 
points for individual cells and the means are shown ( ± s.e.m.). Bead density was increased 3-fold at the protrusions relative 
to ventral membrane (P=0.0005, two-tailed paired Student’s t-test). (E) Same as A, but now with immuno-gold labeling 
for CD206, and the outline shown at the bottom right. (F) Magnifications of E as indicated (i, ii). (G) Same as D, but now 
for CD206. Bead density was increased 9-fold at the protrusions relative to ventral membrane (P=0.002, two-tailed paired 
Student’s t-test). Scale bars: 1 µm.
The antigen was not only taken up by the dendritic cells through the filters, but also subsequently 
processed by proteases, as apparent from the increase in fluorescence of double-quenched OVA 
(Fig. 8D,E). Degradation of this double-quenched OVA by proteases in endosomal/lysosomal 
compartments results in loss of fluorescent quenching and an increased fluorescence intensity. 
Control experiments with bafilomycin demonstrated that this processing was dependent on the 
acidification of endosomal/ lysosomal compartments. Bafilomycin blocks the vesicular ATPase 
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and thereby prevents the acidification required for activation of proteases. We performed 
experiments with dendritic cells isolated from mouse bone marrow (BMDCs) to determine 
whether dendritic cells that took up OVA antigen via podosomes could activate T-cells. Similar 
to human dendritic cells, these mouse BMDCs were able to form protrusive podosome-like 
structures on filters with 1-µm pore sizes and these protrusive structures contained vinculin, 
MMP14 and CD206 (the receptor for OVA antigen (Burgdorf et al., 2006) (supplementary material 
Fig. S3B). Finally, BMDCs that were loaded with OVA antigen via the filters could activate mouse 
hybridoma DO11.10 T-cells (supplementary material Fig. S3C). DO11.10 T-cells recognize OVA 
(323–339 epitope) bound to MHC class II and this results in an increased secretion of interleukin 
(IL)-2 (Shimonkevitz et al., 1983). However, owing to (1) the great sensitivity of T-cells, (2) the 
limited amount of dendritic cells we could culture on the filters (~103 cells) and (3) the inability to 
completely wash OVA from the gelatin coated filters (because of non-specific binding), we were 
unable to exclude the possibilities that antigen was directly taken up from the medium during 
the prolonged T-cell incubation step or that antigen leaked out of the cells or was regurgitated to 
be presented to the T-cells in trans rather than in cis. Nevertheless, co-localization experiments 
indicated that the antigen at least partly reached compartments containing MHC class II in human 
dendritic cells (Fig. 8F). We conclude that antigen uptake can occur at the protrusive structures of 
dendritic cells that contain podosomal elements and this antigen can be subsequently processed 
by dendritic cells, which might eventually result in T-cell activation.
Discussion
In this study, we demonstrate that podosomes can evolve into protrusive structures that 
can contribute to antigen sampling of dendritic cells. It is increasingly well established that 
podosomes respond to and sense the stiffness and geometry of the cellular substrate (Collin 
et al., 2008; Labernadie et al., 2010; van den Dries et al., 2012). Podosomes localize to spots of 
low physical resistance in the substrate. At these soft spots, podosomes exert physical forces 
(Labernadie et al., 2010) and locally degrade extracellular matrix through the concentrated 
release of metalloproteinases, such as MMP14 (Buccione et al., 2004; Gimona et al., 2008; West 
et al., 2008; Gawden-Bone et al., 2010; Linder et al., 2011; Schachtner et al., 2013b). This can result 
in remodeling of the ECM, and when or if pores are formed of sufficiently large size (>1 µm), 
podosomes become progressively protrusive and less dynamic and the morphology and protein 
composition of podosomes change. These findings are in agreement with the role of invasive 
podosome-like structures in the formation of transcellular pores in the endothelium (Carman et 
al., 2007).
At least at the base of protrusive podosome-like structures, actin forms a ring-shaped structure 
that aligns with the edges of the pore. This differs from (non-protrusive) podosomes on glass 
substrates, which are generally considered to consist of solid cores of actin, although recent 
stochastic optical reconstruction microscopy (STORM) super-resolution microscopy data from our 
group also seems to suggest in this case that there is an uneven distribution of actin in podosome 
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cores that cannot be resolved by conventional diffraction-limited microscopy (van den Dries et 
al., 2013b). Microtubules penetrate the actin ring of the protrusive podosome-like structures and 
likely facilitate delivery of MMP14-containing vesicles to the protrusive tips (Wiesner et al., 2010; 
Cornfine et al., 2011), similar to in the invadopodia of cancer cells where this is well established 
(Schoumacher et al., 2010). This again differs from podosomes on glass substrates where MMP14-
containing vesicles do not seem to reach the core but only transiently contact the periphery of 
podosomes (Wiesner et al., 2010) and, there, perhaps the dense actin cores prevent the entry of 
microtubules 
^ Fig. 7. Antigen uptake by protrusive podosome-like structures. (A) Schematics of the control experiments for passive 
leakage of quantum dots or OVA–Alexa-Fluor-647 (OVA-647) through the filters. (B,C) Leakage assay of quantum dots (B) or 
OVA-647 (C) through filters with different pore sizes and with or without gelatin impregnation. (D) Scheme of the antigen 
uptake experiments. (E) Confocal images of dendritic cells cultured on gelatin-coated filters with 1-µm pore sizes. A 
suspension of quantum dots linked to gp120 (Qdot; left, magenta) or a solution of OVA-647 (right, magenta) was applied to 
the other side of the filter. The cells were stained with phalloidin–Alexa-Fluor-488 (Phal, green) and imaged after 1 h 
incubation (see Fig. 8A,B for quantification). (F) Live-cell imaging of dendritic cells transfected with LifeAct-GFP and cultured 
on filter. At time t=0, OVA-647 was applied to the other side of the filter. The inset shows the increase of OVA-647 fluorescence 
in time at the position of the three actin cores marked with orange arrowheads (i–iii). The full dataset is in supplementary 
material Movie 3. (G) Time course of OVA-647 uptake for dendritic cells on filter treated with 20 µM Pitstop 2 (black) or 
Pitstop 2 negative control (red) ( ± s.e.m. of three independent repeats). Scale bars: 10 µm (E), 2 µm (F).
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Eventually, the combined effects of the mechanical forces exerted by the podosomes and the 
protease-mediated degradation of extracellular material can allow for the complete cell to 
migrate through physical barriers. Here, pores in the substrate need to exceed a threshold size (~3 
µm) (Gawden-Bone et al., 2010), which is likely limited by the size of the nucleus (Wolf et al., 2013). 
Migration of dendritic cells and other leukocytes through ECM and across endothelial membranes 
of blood and lymph vessels is crucial for immune system function (Muller, 2011; Vestweber, 2012), 
and our data further support the well-established role of podosomes in this process (Zicha et al., 
1998; Burns et al., 2001; Jones et al., 2002; Matı´ as-Roma´n et al., 2005; Calle et al., 2006; Dovas et 
al., 2009). 
^ Fig. 8. Antigen uptake and processing by protrusive podosome-like structures. (A) Uptake assay as described in Fig. 7 for 
human dendritic cells and CHO cells stably expressing DC-SIGN cultured on gelatin-coated filters with 1-µm or 400-nm pore 
size and in the presence or absence of 25 µg ml-1 mannan. After 1 h of uptake, the percentage ( ± s.e.m.) of cells that took up 
gp120- or biotin-labeled quantum dots (gp120-Qdot and Biotin-Qdot, respectively) was determined by analysis of confocal 
images by two or three independent experts (>3 independent repeats; *P<0.02; **P<0.01). (B) Same as A, but now for OVA-
647. (C) Time course of OVA-647 uptake for dendritic cells on filter treated with 5 µM wiskostatin (black) or carrier only 
(DMSO; red) (mean±s.e.m. of three independent repeats). (D) Confocal images of dendritic cells cultured on gelatin-coated 
filters with 1-µm pore size and with uptake of double-quenched OVA (OVA-DQ, green) and OVA–Alexa-Fluor-647 (OVA-
647, magenta) through the filter. Actin was stained with phalloidin–Alexa-Fluor-564 (Phal, gray). OVA-DQ was dequenched, 
as apparent from the increased fluorescence compared to cells treated with bafilomycin A1. (E) Distribution of the OVA-
DQ fluorescence of OVA-647-positive compartments for the bafilomycin-treated and control cells from the experiment 
shown in D (at least five cells each). (F) Uptake of OVA-647 (magenta) by dendritic cells on a filter, immunostained for MHC-
class II (green). Actin was stained with phalloidin–Alexa-Fluor-546 (Phal, gray). Yellow arrowheads indicate intracellular 
compartments positive for MHC class II and OVA-647. The bar graphs show quantifications of compartments positive for 
MHC and OVA-647 (means ± s.d.). Scale bars: 10 µm.
In this study, we demonstrate a clear role of podosomes in antigen sampling of dendritic cells. We 
have shown that when podosomes become progressively protrusive, a variety of PRRs localize to 
these protrusive structures. These PRRs allow for receptor-mediated uptake of antigen from the 
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protrusive tips (Gawden-Bone et al., 2010) and thereby can help the cell to sample for antigens 
from deeper within the substrate (i.e. from the other side of the polycarbonate filter). Antigen 
cannot only be taken up, but can also be subsequently processed and trafficked to MHC class II 
compartments and, after antigen presentation, this might result in T-cell activation. Interestingly, 
it has recently been reported that T-cells also employ protrusive podosome-like structures that 
contain T-cell receptors to probe for peptides presented in MHC (Sage et al., 2012), in clear analogy 
to our findings of antigen recognition by podosomes of dendritic cells. 
A body of evidence suggests that dendritic cells can sample for antigen across lung, gut and 
small intestine epithelium (Rescigno et al., 2001; Niess et al., 2005; Chieppa et al., 2006; Vallon-
Eberhard et al., 2006; Lelouard et al., 2012; Thornton et al., 2012; Farache et al., 2013; Shan et al., 
2013; Strisciuglio et al., 2013). Here, dendritic cells can extend protrusive dendrites across the tight 
junctions of epithelial cells (Rescigno et al., 2001) or through trans-cellular pores in specialized 
microfold (M) cells (Lelouard et al., 2012); this facilitates the uptake of bacteria from the apical 
(lumen) side of the epithelial membrane. Our findings now suggest that these protrusive trans-
epithelial dendrites might have evolved from podosomes and thus could provide a mechanistic 
explanation for the capability of dendritic cells to phagocytose intra-epithelial bacteria. 
In summary, we have shown that podosomes can sample the extracellular environment for 
spots of low mechanical resistance and, once such a spot is identified, podosomes can become 
increasingly protrusive. These protrusive structures not only facilitate cellular migration through 
extracellular matrix and endothelial membranes but can also be engaged in receptor-mediated 
uptake of antigen. Thereby podosomes can effectively increase the search area that a dendritic 
cell samples for antigen. This localized uptake of antigen from podosome-derived protrusive 
structures constitutes a novel role for podosomes of dendritic cells. Understanding how dendritic 
cells and other monocytes sample for antigen in the complex physical environment of the human 
body is crucial for our understanding of immune function.
Material and Methods
Preparation of human dendritic cells
Dendritic cells were derived from peripheral blood monocytes isolated from a buffy coat (de Vries 
et al., 2002). Monocytes isolated from healthy blood donors (informed consent obtained) were 
cultured for 6 days in RPMI 1640 medium (Life Technologies) containing 10% fetal bovine serum 
(FBS, Greiner Bio-one), 1 mM ultra-glutamine (BioWhittaker), antibiotics (100 U ml-1 penicillin, 100 
µg ml-1 streptomycin and 0.25 µg ml-1 amphotericin B, Gibco), IL-4 (500 U ml-1) and GMCSF (800 U 
ml-1) in a humidified, 5% CO2-containing atmosphere.
Antibodies and reagents
The following primary antibodies were used for the immunofluorescence: mouse anti-vinculin 
(V9131, Sigma) at 1:200 dilution (v/v), mouse anti-talin (T3287, Sigma) at 1:100 (v/v), mouse anti-
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paxillin (349 | MAB3060, Sigma) at 1:100 (v/v), mouse anti-CD11b (ITGAM or Bear-1) (IM2581, 
Coulter) at 1:200 (v/v), mouse anti-CD29 (or ITGB1) (clone ts2/16) at 1:200 (v/v), mouse anti-MMP14 
(MAB3328, Bio Connect/MilliPore) at 1:100 (v/v), rat anti-tubulin (ab6161, Abcam) at 1:500 (v/v), 
mouse anti-human CD209 (or DC-SIGN) (551186, BD Bioscience) at 1:200 (v/v), mouse anti-human 
DCIR (DDX0180, Dendritics) at 1:200 (v/v), mouse anti-human dectin-1 (MAB1859, R&D Systems) at 
1:100 (v/v), mouse anti-human CD206 (555953, BD Biosciences) at 1:250 (v/v), mouse antihuman
CD71 (347510, SALK) at 1:50 (v/v), mouse anti-clathrin light chain (C1985, Sigma) at 1:100 (v/v) and 
mouse anti-human MHC class II (clone Q5/13; Quaranta et al., 1980) at 20 µg ml-1. The following
secondary antibodies were used: goat anti-mouse IgG (H+L) (A-11001), goat anti-rat IgG (H+L) (A-
11006) and goat anti-rabbit IgG (H+L) (A-11008), all labeled with Alexa Fluor 488 dye (Invitrogen). 
Alexa-Fluor-488-, -546- and -633-conjugated phalloidin (Invitrogen) was used at dilutions of 
1:200 (v/v) to stain F-actin. The quantum dot streptavidin conjugate (655 nm) was from Invitrogen 
(Q10121MP). Biotin rgp120 (HIV-1 III B) was purchased from ImmunoDiagnostics.
Gelatin impregnated filters
Gelatin was labeled with Alexa Fluor 633 by incubating 2% (w/v) gelatin from porcine skin in PBS 
with 100 µg ml-1 Alexa Fluor 633 succinimidyl ester (Invitrogen) for 30 min at room temperature. 
Unbound dye was removed by methanol precipitation of the gelatin. Hydrophilic polycarbonate 
membrane filters with different pore sizes (0.4, 1, 2 and 3 µm and 13 mm in diameter) (PCT0413100, 
PCT1025100, PCT2013100, PCT3013100; all from Sterlitech, Kent, WA) were washed first in 70% and
then in 96% ethanol at room temperature. A 5-µl droplet of 2.5% gelatin in PBS was placed on top 
of a parafilm sheet (sterilized with ethanol) and a filter together with a coverslip was positioned 
on top of the gelatin solution. After 10 min of incubation, the filters were detached from the 
coverslips and subsequently transferred into a 24-well plate and kept in PBS until needed for cell 
culturing.
DQ-FITC-conjugated collagen (Invitrogen) was used for detection of ECM degradation. Human 
immature dendritic cells were grown for 1 h on filters prepared with 2.5 µg ml-1 DQ-collagen 
(type I from bovine skin conjugated with fluorescein) in 1% gelatin in PBS. Degraded collagen was 
visualized after fixation and staining for F-actin with phalloidin–Alexa-Fluor-633.
Immunofluorescence
Cells were cultured on filters at , ~200,000 cells per filter (only several 1000 cells adhered) for 1 
to 4 h and fixed for 15 min in 4% PFA in PBS at room temperature. Cells were then permeabilized 
with 0.1% (v/v) Triton X-100 in PBS for 5 min and blocked with CLSM-buffer [PBS with 20 mM 
glycine and 3% (w/v) BSA] for 30 min. For immunostaining, the cells were incubated with primary 
antibodies diluted in CLSM overnight at room temperature. Subsequently, the cells were washed 
with PBS and incubated with Alexa-Fluor-488-labeled secondary antibodies and Alexa-Fluor-
546-conjugated phalloidin for 30 min. Finally, cells were washed with PBS prior to embedding 
in mounting medium containing 0.01% (v/v) Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-
carboxylic acid) and 68% (v/v) glycerol in 200 mM sodium phosphate buffer at pH 7.5. The cells 
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were imaged with an Olympus FV1000 confocal laser scanning microscope (Olympus, Tokyo, 
Japan) with a 60x1.35 NA oil immersion objective.
PIP2 labeling
Human monocyte derived dendritic cells were grown on filters with 1 µm pores coated with 2.5% 
gelatin. Cells were disrupted by a brief ultrasound pulse as described previously (van den Bogaart 
et al., 2011) with some modifications. In brief, the filters with cells were washed twice with PBS at 
room temperature and placed on the bottom of a large glass container with PBS. The tip of the 
sonicator (Branson Digital Sonifier) was placed 3 cm above the filter and three pulses (10% power, 
0.1 s pulse with 1 s interval) were given. Filters were then washed once with buffer containing 20 
mM Hepes-KOH, 120 mM K-gluconate, 20 mM Kacetate, 2 mM ATP-Mg and 0.5 mM DTT, pH 7.4, 
and incubated for 30 min with 1 µm PLCδ-PH in the same buffer (van den Bogaart et al., 2011). 
Finally, the filters were washed twice with PBS, fixed with 4% PFA and co-stained with phalloidin–
Alexa-Fluor-546.
Wiskostatin-mediated dissolution of podosomes
Dendritic cells were pre-cultured on glass or gelatin-impregnated filters for 1 h, followed by 
incubation for 15, 30, 60 and 120 min with 5 µm wiskostatin (40 mM stock in DMSO) and immediate 
fixation and immunostaining as described above.
OVA and gp120–quantum-dot uptake assay
For the conjugation of gp120 to quantum dots, 40 nM biotinylated gp120 was incubated with 
20 nM quantum dots-655 with coupled avidin by mixing for 30 min at 4 °C. The coupling was 
quenched by addition of a 10-fold molar excess of free biotin (to a final concentration of 200 nM)
(Cambi et al., 2007). 
To test the uptake of antigen via protrusive podosome-like structures, dendritic cells were pre-
cultured for 2 h on filters with 1 µm and 400 nm pore sizes that were impregnated with gelatin. 
Then, the filters were inverted and placed on top of plastic rings filled with culture medium 
such that the medium contacted the cells on the filter. The opposite (upper) side of the filter 
was covered with 50 µl of a suspension of 1 nM quantum dots-655 conjugated to gp120. After a 
30-minute incubation, the cells were fixed with 4% PFA and actin was stained with phalloidin– 
Alexa-Fluor-488. Cells were imaged by confocal microscopy. To test the uptake of OVA–Alexa-
Fluor-647 antigen we performed the same assay as for gp120-quantum dots, but now we placed 
50 µl of a 5 µg ml-1 OVA–Alexa-Fluor-647 on top of the filter.
Several control experiments were performed: (1) competitive inhibition of antigen uptake with 
25 µg ml-1 mannan, (2) using quantum dots conjugated to biotin instead of gp120, (3) using filters
with smaller pore sizes of 400 nm, (4) using CHO cells that stably expressed DC-SIGN (Cambi et 
al., 2007) instead of dendritic cells, and (5) using wiskostatin and (6) Pitstop 2 block of antigen 
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uptake. For the wiskostatin experiment, cells were preincubated for 30 min with 5 µm wiskostatin 
(40 mM stock in DMSO) and uptake experiments were performed in presence of wiskostatin. 
For the Pitstop 2 experiment, cells were preincubated for 15 min with 20 µM wiskostatin or the 
Pitstop 2 negative control (both from Abcam; 30 mM stock in DMSO) and uptake experiments 
were performed in presence of Pitstop 2 or negative control. All experiments were independently 
repeated at least three times with dendritic cells isolated from different donors and statistical 
significance (P values) was calculated with two-tailed Student’s t-test for paired samples.
Passive leakage of antigen through gelatin-coated filters
In order to measure passive diffusion of the quantum dots and OVA through the filters we used 
either uncoated or gelatin-impregnated filters with pore sizes of 400 nm and 1 µm (prepared as 
described above). These filters were placed on top of plastic rings filled with PBS. A 50-µl droplet 
of antigen suspension (0.2 nM for gp120-labeled quantum dots and 5 µg ml-1 of OVA-647) was 
then placed on top of the filter for 30 min. The remaining volume of antigen suspension (~20 
ml) was aspirated from the top of the filter and transferred to the MaxiSorp 96-well plate. The 
fluorescence intensity was measured with a CytoFluor ll fluorescence well plate reader (PerSeptive 
Biosystems) (quantum dots-655, excitation 360/40, emission 645/40 nm; OVA–Alexa-Fluor-647, 
excitation 590/20, emission 645/20 nm filters). Each experiment was repeated at least three times.
Live-cell imaging
Cells were transfected using the Neon Transfection system (Invitrogen) as described previously 
(van den Dries et al., 2013a). Briefly ~200,000 cells were washed with PBS and resuspended in 
100 ml resuspension buffer R (Invitrogen). These cells were subsequently mixed with 2 µg of a 
plasmid coding for LifeAct-GFP and electroporated (2 pulses of 40 ms, 1000 V). Transfected cells 
were plated in pre-warmed WillCo-dishes (WillCo Wells) containing antibiotic-free and serum-
free RPMI medium (Invitrogen). After 3 h of culturing, the medium was replaced by medium 
supplemented with 10% (v/v) FCS and antibiotics. Prior to live cell imaging, cells were washed 
with PBS and imaging was performed in RPMI without Phenol Red supplemented with 10 mM 
HEPES at pH 7.4. Transiently transfected cells were imaged at 37 °C on a Zeiss LSM 510 microscope 
equipped with a PlanApochromatic 636 1.4 NA oil immersion objective.
Transmission electron microscopy
For the immunogold labeling, dendritic cells were cultured on gelatinimpregnated filters with 1 
µm pore size for 1 h, washed once with 0.1 M phosphate buffer at pH 7.4 (PB) and fixed with 2% 
(w/v) PFA in PB for 2 h. Residual PFA was quenched with 20 mM glycine in PB for 20 min. Samples 
were blocked with 5% (w/v) BSA-c and 0.1% (w/v) cold water fish gelatin in PB for 20 min. The 
sample was incubated with the primary antibody (directed against DC-SIGN or CD206) overnight 
at 4 °C in 0.1% BSA-c in PB, followed by incubation with secondary rabbit-anti-mouse antibody for 
30 min at 20 µg ml-1. For visualization, cells were incubated with protein A labeled with 10-nm-
diameter gold particles (binds rabbit IgG) in 0.1% BSA-c in PB. A final fixation step was performed 
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with 2% glutaraldehyde in PB for 60 min at 4 °C. Samples were treated for 60 min with 1% (w/v) 
OsO4, 1% (w/v) potassium ferrocyanide in 0.1 M sodium cacodylate buffer at pH 7.4. Following 
dehydration with a graded ethanol series, the filters were embedded in Epon which was left to 
polymerize for 24 h at 60 °C. After polymerization, ~90-nm thin sections perpendicular to the 
surface of the filter surfaces were cut with a microtome and specimens were imaged with a JEOL 
1010 transmission electron microscope.
Transwell inserts with endothelial and epithelial monolayers
Costar Transwell 6.5-mm diameter inserts containing polycarbonate membrane filters with a 
5-µm pore size (catalogue number 3421; Corning Incorporated) and impregnated with gelatin 
were cultured with ~160,000 cells of the endothelial cell line EA.hy926 in DMEM with 4.5 g l-1 
glucose, 1 mM ultra-glutamine, antibiotics and 10% FBS on the outer side of the inserts. For the 
epithelial cell line Caco-2, ~5000 cells were cultured in DMEM with 25 mM glucose, 1% non-
essential amino acids, antibiotics and 20% FBS on the outer side of the inserts and without 
gelatin. Confluent monolayers were formed after 10 days (for EA.hy926) and 20 days (for Caco-
2) culturing time. Subsequently, ~20,000 to 100,000 dendritic cells were applied to the inner 
chamber of the transwell inserts and incubated for 24 h (for EA.hy926) or 5 h (for Caco-2). For the 
uptake experiments of Alexa-Fluor-647-labeled ovalbumin (OVA-647) through the monolayers of 
Caco-2 cells (supplementary material Fig. S1E), 5 µg ml-1 OVA-647 in RPMI was added to the outer 
chamber and incubated for 1 h. Finally, the samples were fixed and immunostained for DC-SIGN 
and CD206 (expressed by dendritic cells).
ELISA and DO11.10 activation assay
For measuring IL-2 production, as a readout of T-cell activation, we used the T-cell hybridoma line 
DO11.10. DO11.10 cells were grown in IMDM with 5% FCS, 1 mM ultra-glutamine, antibiotics and 
0.1% (v/v) β-mercaptoethanol. Immature mouse bone-marrow-derived dendritic cells (BMDCs) 
were isolated by culturing for 7 days with GM-CSF (20 ng ml-1). Animal studies were approved by 
the Animal Ethics Committee of the Nijmegen Animal Experiments Committee. The OVA antigen 
(concentration used 100 µg ml-1) uptake assay on filters (1 µm pores) was performed as described 
above for 1 h. The filters were washed three times with PBS, and DO11.10 cells in RPMI were added 
to the washed filters and incubated overnight. ~200,000 BMDCs and 1x106 DO11.10 cells were 
used, but the ratio of BMDC to T-cells was in the order of 1:20–1:200 given that only a fraction of 
the BMDCs adhered to the filter (1000–10,000 cells). After culturing for 6 days, IL-2 production was 
measured by using monoclonal capture and HRP-conjugated anti-IL-2 antibodies (554424 and 
554426, BD Biosciences) using standard ELISA procedures.
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Supplementary Figures
1
Supplementary Figure 1. Transmigration of dendritic cells through monolayers of 
endothelial and epithelial cells. (A) Confocal images of human dendritic cells cultured in 
inserts with gelatin impregnated polycarbonate filters with pore sizes of 5 µm. A monolayer 
of the endothelial cell line EA.hy926 (6 – 10 µm thick) was present on the opposite side of the 
filter. Dendritic cells were immunostained for DC-SIGN (green), actin was visualized by 
phalloidin-Alexa fluor 633 (magenta) and the nucleus by DAPI (cyan). The dotted outline 
indicates the position of a dendritic cell based on the DC-SIGN signal. Nuclei from 
endothelial cells are marked ‘E’. Nuclei from dendritic cells are marked ‘DC’. Several 
confocal sections underneath of the filter surface are shown (marked by the dashed yellow 
lines). (B) Same as A, but now for CD206 (green) instead of DC-SIGN. (C) Same as panel A, 
but now with a monolayer of the epithelial cell line Caco-2 (28 – 32 µm thick). (D) Schematic 
diagram of dendritic cell migration through the filter insert and through the endothelial or 
epithelial monolayer. (E) Uptake of Alexa fluor 647-labeled ovalbumin (OVA-647; magenta) 
through a monolayer of Caco-2 cells. Cells were immunostained for DC-SIGN (green); nuclei 
and actin were stained with DAPI and phalloidin-CruzFluor405 (Phal; Santa Cruz 
Biotechnology; both blue). Yellow arrow heads mark OVA-647 positive intracellular 
compartments. Scale bars, 10 µm.
^ Fig. S1: Transmigration of dendritic cells throu h monolayers of endothelial and epithelial cells. (A) Confocal images of 
human dendritic cells cultured in inserts with gelatin impregnated polycarbonate filters with pore sizes of 5 μm. A monolayer
of the endothelial cell line EA.hy926 (6 – 10 μm thick) was present on the opposite side of the filter. Dendritic cells were 
immunostained for DC-SIGN (g en), actin was visualized by phalloidin-Alexa fluor 633 (magenta) and the nucleus by DAPI 
(cyan). The dotted outline indicates the position of a dendritic cell based on the DC-SIGN signal. Nuclei from endothelial 
cells are marked ‘E’. Nuclei from dendritic cells are marked ‘DC’. Several confocal sections underneath of the filter surface 
are shown (marked by the dash d yellow li es). (B) Same as A, but now for CD206 (green) instead of DC-SIGN. (C) Same as 
panel A, but now with a monolayer of the epithelial cell line Caco-2 (28 – 32 μm thick). (D) Schematic diagram of dendritic cell 
migration through the filter insert and through the endothelial or epithelial monolayer. (E) Uptake of Alexa fluor 647-labeled 
ovalbumin (OVA-647; magenta) through a monolayer of Caco-2 cells. Cells were immunostained for DC-SIGN (green); nuclei
and actin were stained with DAPI and phalloidin-CruzFluor405 (Phal; Santa Cruz Biotechnology; both blue). Yellow arrow 
heads mark OVA-647 positive intracellular compartments. Scale bars, 10 μm.
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Supplementary Figure 2. Dynamics of podosome-like structures. (A) Live cell confocal
imaging of human dendritic cells transfected with the actin reporter LifeAct-GFP (green) and 
cultured on filter with 1 µm pore size impregnated with gelatin-Alexa fluor 633 (Filter; 
magenta). The filter was gently pressed towards the cover slip to achieve a higher imaging 
resolution and to allow visualization of the LifeAct-GFP distribution in rings (compare with 
figure 3B). Yellow arrow heads mark randomly selected actin cores. (B) Magnifications of 
actin rings from panel A (marked i–iii in panel A) and fluorescence intensity distributions 
through the cross-sections marked by the red boxes (y-averaging). Orange arrow heads mark 
intensity peaks at the edges of the actin rings. (C–D) Live cell imaging of dendritic cells 
expressing LifeAct-GFP (green) and cultured on glass (C) and filter with 1 µm pore size 
impregnated with gelatin-Alexa fluor 633 (magenta) (D). Shown are the fluorescence 
intensities over time of LifeAct-GFP at randomly selected actin-rich cores (yellow arrow 
heads). Original data is in Supplementary Movies 1 and 2. (E) Quantifications of the 
fluctuations of LifeAct-GFP fluorescence from panels C–D. The change was calculated as the 
difference of the maximum and the minimum fluorescence intensities (Fmax – Fmin; see panels 
C–D) divided over the average fluorescence intensity Faverage (**, P = 0.003; 2-tailed unpaired 
t-test; 50 podosomes from multiple cells of 3 independent preparations). Scale bars, 10 µm.
^ Fig. S2: Dynamics of podosome-like structures. (A) Live cell confocal imaging of human dendritic cells transfected with 
the actin reporter LifeAct-GFP (green) and cultured on filter with 1 μm pore size impregnated with gelatin-Alexa fluor 633 
(Filter; magenta). The filter was gently pressed towards the cover slip to achieve a higher imaging resolution and to allow 
visualization of the LifeAct-GFP distribution in rings (compare with figure 3B). Yellow arrow heads mark randomly selected 
actin cores. (B) Magnifications of actin rings from panel A (marked i–iii in panel A) and fluorescence intensity distributions 
through the cross-sections marked by the red boxes (y-averaging). Orange arrow heads mark intensity peaks at the edges 
of the actin ri gs. (C–D) Live cell imaging of dendritic cells expressing LifeAct-GFP (green) and cultured on glass (C) and filter 
with 1 μm pore size impregnated with gelatin-Alexa fluor 633 (magenta) (D). Shown are the fluorescence intensities over 
time of LifeAct-GFP at randomly selected actin-rich cores (yellow arrow heads). Original data is in Supplementary Movies 1 
and 2. (E) Quantifications of the fluctuations of LifeAct-GFP fluorescence from panels C–D. The change was calculated as the
difference of the maximum and the minimum fluorescence intensities (Fmax – Fmin; see panels C–D) divided over the average 
fluorescence intensity Faverage (**, P = 0.003; 2-tailed unpaired t-test; 50 podosomes from multiple cells of 3 independent 
preparations). Scale bars, 10 μm.
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Supplementary Figure 3. CHO cells, mouse bone marrow derived dendritic cells and T-
cell activation. (A) Confocal images of CHO cells heterogeneously expressing recombinant 
DC-SIGN and cultured on glass or filters with 1 µm pore size and impregnated with Alexa 
fluor 633-labeled gelatin (Filter; grey). Actin was labeled with phalloidin-Alexa fluor 546 
(Phal; magenta) and DC-SIGN was visualized by immunostaining (green). (B) Confocal 
images of mouse bone marrow derived dendritic cells (BMDCs) cultured on filters with 1 µm 
pore size and impregnated with Alexa fluor 633-labeled gelatin (Filter; grey). Actin was 
labeled with phalloidin-Alexa fluor 546 (magenta) and vinculin, MMP-14 and CD206 were 
visualized by immunostaining (AB; green). The yellow lines indicate the positions of the 
orthogonal views. The yellow arrows heads indicate randomly chosen actin cores. The red 
arrow head indicates the approximate filter surfaces. (C) IL-2 production by mouse 
hybridoma DO11.10 T-cells induced by BMDCs that were loaded with OVA-antigen through 
filters and measured after 6 days of T-cell activation. Due to (i) the great sensitivity of T-cells, 
(ii) the limited amount of dendritic cells we could culture on the filters (~103 cells) and (iii) 
the inability to completely wash OVA from the gelatin coated filters (due to non-specific
binding), we cannot exclude the possibility that antigen was directly taken up from the 
medium by the BMDCs during the prolonged T-cell incubation step or that antigen leaked out 
of the BMDCs or was regurgitated to be presented to the T-cells in trans rather than in cis.
Experiments were independently repeated at least 3 times. Data from a representative 
experiment is shown and error bars indicate the spread of data for at least 2 technical repeats. 
Scale bars, A: 10 µm; B: 2 µm.
^ Fig. S3: CHO cells, mouse bone marrow derived dendritic cells and Tcell activation. (A) Confocal images of CHO cells 
heterogeneously expressing recombinant DC-SIGN and cultured on glass or filters with 1 μm pore size and impregnated 
with Alexa fluor 633-labeled gelatin (Filter; grey). Actin was labeled with phalloidin-Alexa fluor 546 (Phal; magenta) and 
DC-SIGN was visualized by immunostaining (green). (B) Confocal images of mouse bone marrow derived dendritic cells 
(BMDCs) cultured on filters with 1 μm pore size and impregnated with Alexa fluor 633-labeled gelatin (Filter; grey). Actin was
labeled with phalloidin-Alexa fluor 546 (magenta) and vinculin, MMP-14 and CD206 were visualized by immunostaining 
(AB; green). The yellow lines indicate the positions of the orthogonal views. The yellow arrows heads indicate randomly 
chosen actin cores. The red arrow head indicates the approximate filter surfaces. (C) IL-2 production by mouse hybridoma 
DO11.10 T-cells induced by BMDCs that were loaded with OVA-antigen through filters and measured after 6 days of T-cell 
activation. Due to (i) the great sensitivity of T-cells, (ii) the limited amount of dendritic cells we could culture on the filters 
(~103 cells) and (iii) the inability to completely wash OVA from the gelatin coated filters (due to non-specific binding), we 
cannot exclude the possibility that antigen was directly taken up from the medium by the BMDCs during the prolonged 
T-cell incubation step or that antige  leaked out of the BMDCs or was regurgitated to be presented to the T-cells in trans 
rather than in cis. Experiments were independently repeated at least 3 times. Data from a representative experiment is 
shown and error bars indicate the spread of data for at least 2 technical repeats. Scale bars, A: 10 μm; B: 2 μm.
Communicative & Integrative Biology, 2014
Maksim Baranov
Martin ter Beest
Geert van den Bogaart
CHAPTER
Reaching for far-flung 
antigen: 
How solid-core
podosomes of 
dendritic cells 
transform into
protrusive structures
7
156
Chapter 7
7
Abstract
We recently identified a novel role for podosomes in antigen sampling. Podosomes are dynamic 
cellular structures that consist of point-like concentrations of actin surrounded by integrins 
and adaptor proteins such as vinculin and talin. Podosomes establish cellular contact with the 
extracellular matrix (ECM) and facilitate cell migration via ECM degradation. In our recent paper, 
we studied podosomes of human dendritic cells (DCs), major antigen presenting cells (APC) that 
take-up, process, and present foreign antigen to naive T-cells. We employed gelatin-impregnated 
porous polycarbonate filters to demonstrate that the mechanosensitive podosomes of DCs 
selectively localize to regions of low-physical resistance such as the filter pores. After degradation 
of the gelatin, podosomes increasingly protrude into the lumen of these pores. These protrusive 
podosome-derived structures contain several endocytic and early endosomal markers such 
as clathrin, Rab5, and VAMP3, and, surprisingly, also contain C-type lectins, a type of pathogen 
recognition receptors (PRRs). Finally, we performed functional uptake experiments to demonstrate 
that these PRRs facilitate uptake of antigen from the opposite side of the filter. Our data provide 
mechanistic insight in how dendritic cells sample for antigen across epithelial barriers for instance 
from the lumen of the lung and gut.
SHORT COMMUNICATION
Dendritic cells (DCs) are antigen-presenting cells (APCs) ubiquitously present in all parts of the 
human body and constantly sample for antigens via PRRs on their surface (1-3). DCs constitute the 
link between the innate and adaptive immune systems, because they are the only cells that can 
induce a primary immune response in naive T-lymphocytes (4). In order to perform this function, 
DCs have to migrate between their sites of origin (bone marrow), sites of sampling activity and 
lymph nodes where T-cells are activated by the antigens presented by major histocompatibility 
complex (MHC) molecules on the surface of the DCs. DCs are thus a very motile cell type, that 
travel inside the body not only passively within the blood stream, but can also “crawl” between 
cells thereby reaching almost any part of the body within a relatively short time. For this crawling, 
DCs need to adhere to the ECM and this adhesion is facilitated by podosomes (5-9).
Podosomes are cellular structures that consist of dense actin cores surrounded by adaptor 
proteins such as vinculin, talin, and paxillin that connect the actin cytoskeleton to the membrane, 
regulatory proteins WASP, and Arp2/3 as well as integrins that allow cellular adhesion to the ECM 
(10-13). Podosomes are also points of local degradation of ECM, which is achieved by concentrated
release of proteases such as MMP14 (also known as MT1-MMP) (7, 9, 14-16). Podosomes are well-
known to facilitate cell migration through endothelium, epithelium, and connective tissues (8, 17, 
18). A more recently discovered fact is that podosomes are mechanosensitive and can sense the 
local stiffness of the substrate (19, 20). 
In an elegant study, Gawden-Bone and coworkers demonstrated that when grown on porous 
polycarbonate filters, podosomes of dendritic cells can evolve into protrusive structures (16). 
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^ Fig. 1: Membrane trafficking at protrusive podosomes-derived structures. Human monocyte derived DCs transiently 
expressing MMP14, clathrin, Rab5, Rab8, and VAMP3 tagged with fluorescent proteins. Confocal imaging of cells co-
transfected with the Factin reporter either LifeAct-RFP or LifeAct-GFP (red) and plasmids carrying the genes of interest 
(either GFP or mCherry-tagged: green) cultured on polycarbonate filters with 1 μm pore size and impregnated with gelatin
labeled with Alexa fluor 633 (Filter; blue) at least for 1 h prior to imaging. (A) MMP14- mCherry and LifeAct-GFP. (B) 
Clathrin-GFP and LifeAct-RFP. (C) Rab5-GFP and LifeAct-RFP. (D) Rab8-GFP and LifeAct-RFP. (E) VAMP3-GFP and LifeAct-RFP. 
Transfections and imaging were performed as described (24). Scale bars represent 5 μm.
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Although these protrusive structures morphologically resemble invadopodia of cancer cells, 
they are more dynamic with shorter lifetimes and lower protrusion depths and, in contrast to 
invadopodia (7, 21), they still depend on the protein WASP for their formation. Very similar to 
invadopodia, these protrusive podosome-derived structures turned out to contain stretches of 
tubulin which likely mediate trafficking of metalloproteinases to the protrusive tips for degradation 
of ECM (22, 23). Indeed, in our recent paper (24) we showed the presence of the metalloproteinase 
MMP14 at the tips of protrusive podosome-like structures of human monocytederived DCs by 
immunofluorescence. We recently confirmed this finding by overexpression of MMP14 tagged 
with the fluorescent protein mCherry (25) (Fig. 1A). Here, we co-expressed the F-actin binding 
reporter protein LifeAct (26) tagged to GFP to visualize the protrusion of the actin cores into the 
filter pores. 
^ Fig. 2: C-type lectins locate to protrusive podosomes-derived structures. (A) Confocal images of human dendritic cells 
cultured on polycarbonate membrane filters with pore sizes of 1 μm. Actin was stained with phalloidin-Alexa-Fluor-546 
(Phalloidin, red), DC-SIGN was labeled by specific primary antibody and secondary antibody conjugated to Alexa-Fluor-488 
(DC-SIGN, green). Yellow arrow heads indicate the positioning of protrusion and filter pore. (B–D) Transmission electron 
microscopy of protrusive podosome-like structures. (B) Electron micrographs of human dendritic cells cultured on 
polycarbonate filter with 1 μm pore size, impregnated with gelatin and immunogold labeled for CD206. (C) An outline 
of part of the cell with the protrusion shown in the micrograph in panel (B) (yellow dashed box). (D) Magnification of the 
protrusion indicated by the yellow box in panel (B). Yellow arrowheads mark positions of clusters of gold-beads which 
indicate the localization of CD206. Scale bar represents 5 μm (A) and 1 μm (B–D).
Not only is MMP14 released at the tips of protrusive podosome-like structures, but endocytosis 
also occurs at these spots and Gawden-Bone et al. already demonstrated uptake of degraded 
gelatin (16). In agreement with this notion that when podosomes become invasive, membrane 
trafficking is increased at these sites, we showed the presence of several endocytic and 
endosomal markers at these protrusive structures. We first established the presence of clathrin 
at protrusive podosome-like structures by immunofluorescence (24) and recently confirmed this 
by overexpression of GFP-tagged clathrin (Fig. 1B). Several overexpressed GFP-tagged versions 
of other markers for endocytic activity also located to these protrusive podosome-evolved 
structures: Rab5, Rab8, and VAMP3 (Fig. 1C–E) (24). Localization was specific for these proteins, 
as free GFP and GFP-tagged VAMP7 did not or only little protrude into the filter pores. Rab5 
159
How solid-core podosomes of dendritic cells transform into protrusive structures 
7
and Rab8 are members of the Rab family of small GTPases, and are well-known regulators of 
intracellular membrane trafficking of early and recycling endosomes (27-29). VAMP3 is a soluble 
NSF attachment protein receptor (SNARE) that catalyzes membrane fusion of early endosomes 
(30,31) and is also involved in the extension of pseudopods in phagocytosis (32). Although Rab5, 
Rab8, and VAMP3 clearly localized in vesicles in the cytosol, our resolution was insufficient to 
discern a vesicular localization of these proteins in protrusive podosome-derived structures. 
Nevertheless, our results show that protrusions are sites of membrane trafficking and corroborate 
with the study of Gawden-Bone et al (16). 
Since Gawden-Bone et al. (16) and we (24) 
demonstrated that endocytosis occurs at 
protrusive podosome-like structures and 
since the main function of DCs is antigen 
presentation, it seemed logical to suggest 
that these protrusive structures might be 
involved in endocytosis of antigens. 
Indeed, protrusive podosome-evolved 
structures contain various PRRs that can 
recognize foreign antigens and our 
immunofluorescence data showed the 
localization of several members from the 
C-type lectin family: DC-SIGN (CD209; Fig. 2A), DCIR (CLEC4A), dectin-1 (CLEC7A), and the mannose 
receptor (CD206) (24). Further investigation by transmission electron microscopy and immunogold 
labeling confirmed that DCSIGN and CD206 were present on the protrusive structures (Fig. 2B–D 
for CD206).  
We then established that the PRRs residing at the protrusive podosome-like structures indeed 
were capable to sample for foreign antigen (24). We designed a functional assay where DCs were 
cultured on gelatin-impregnated filters and where fluorescently labeled mock antigen specific 
for either DC-SIGN or CD206 was present at the opposite side of the filter (24). With this assay, 
the ability of dendritic cells to endocytose antigens exclusively via protrusive podosome-like 
structures could be tested. Control experiments were performed: 1) without mock antigen, 2) with 
filters containing too narrow pores for podosome protrusion (< 1 μm), 3) competitive blockage 
of PRRs with mannose, 4) with the endocytic inhibitor Pitstop II, and 5) with the WASP inhibitor 
wiskostatin. These functional uptake experiments demonstrated the exclusive role of protrusive 
podosome-evolved structures for uptake of antigen through the filter pores (24). We were also 
able to show that antigen which was taken up via protrusive podosome-like structures could be 
< Fig. 3: Schematic representation of the protrusive 
podosome-derived structures of dendritic cells and 
their role in receptor-mediated antigen uptake by 
PRRs.
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actively processed in the cell and loaded onto MCH class II to finally be presented to T-cells (24).
Our study directly demonstrates a novel role for podosomes in antigen sampling (Fig. 3). 
Podosomes sense for spots of low physical resistance of the substrate where they exert mechanical 
forces and actively degrade the ECM. This process results in remodeling of the ECM and 
podosomes become increasingly invasive and start protruding in the extracellular environment 
(16, 19, 20, 24, 33).  At some point, when the pores in the extracellular environment reach beyond a 
threshold size of about 3 μm, these protrusive podosomes-derived structures facilitate migration 
of dendritic cells through ECM and across endo- and epithelial barriers (16, 17, 24, 34, 35). It is 
increasingly well established that podosomes thereby help DCs to rapidly migrate for instance 
to sites of infection in the body (36, 37). In our study, we showed that protrusive podosome-
derived structures are sampling stations that actively probe for antigen which would otherwise 
not be accessible because of its deeper localization within the substrate or across epithelial/
endothelial membranes (24). In these cases, PRRs locating to the protrusive tips of podosomes-
derived structures can trigger receptor-mediated uptake and this propels subsequent antigen 
degradation, MHC class II presentation and finally T-cell activation (24). Our findings provide a 
mechanistic understanding for the well-known capability of DCs to probe for antigens across 
epithelial barriers, for instance in the lumen of the gut, lungs and small intestine (34, 35, 38-44). 
Thereby, our data constitute a novel way of how DCs sample for antigen in the human body and 
this aids our understanding of the immune system.
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Dendritic cell subsets
Dendritic cells (DCs) and macrophages contribute to innate immunity via uptake and killing of 
cancerous cells, apoptotic cells and pathogens. Adaptive immunity is fulfilled when DCs and 
macrophages communicate information about encountered antigens to other cells, mainly T cells. 
Both DCs and macrophages can degrade ingested material to 18-20 amino acid long peptides 
and present them in the context of MHC type II to CD4+ “helper” T-cells. 
Why do we still use monocyte derived DCs (moDCs) in our experiments and what is the 
physiological relevance of these cells? Monocytes are abundant in blood and can be easily cultured 
from the blood of human donors in comparison to blood-circulating DC subsets, plasmacytoid 
pDCs (which are morphologically close to plasma cells) and myeloid mDCs. When placed in a 
setting consisting of pro-inflammatory GM-CSF with homeostatic IL-4, monocytes differentiate 
into moDCs. Phenotypically, moDCs have a larger cell size than pDCs and cDCs and can ingest 
many particles of 3-5 μm in size. This feature of moDCs makes them a more useful model system 
for phagocytosis research. Moreover, moDCs can sustain electroporation for transfection with 
DNA expression constructs or siRNA for knock down, in contrast to primary DC subsets [1-3]. 
MoDCs can be easily derived from the blood of patients carrying mutations affecting phagosomal 
physiology and be directly used for studies in vitro, as was shown in our lab for DCs derived from 
patients with chronic granulomatous disease (CGD) [4]. Unlike macrophages, moDCs are strong 
antigen presenters and can be used both in MHC-class II and MHC-class I (cross)-presentation 
studies [2, 4]. In the past moDCs were used in anti-cancer therapy and still present an interest in 
translational research [5]. MoDCs can be linked to intestinal DCs for their ability to form protrusive 
structures through endo/epithelial barriers, meaning that our findings on protrusive podosome 
sampling for antigens [2, 6] can be directly linked to relevant situations present in the gut [7, 8]. 
Historically DCs, macrophages and monocytes were grouped together as mononuclear 
phagocytes due to eliciting comparable immune responses, similarity in produced cytokines, 
ability of migrating to sites of infection and strong phagocytocytic specialization [9, 10]. 
However, this classification no longer holds and it is increasingly clear that primary DC subsets 
are professional antigen-presenting cells that orchestrate immune responses [11] via activating 
naïve T-cells [12, 13], constituting only 1% of peripheral white blood cells in humans and animals 
[14]. These primary subsets are less heterogeneous, elicit better ability to migrate to lymph nodes 
and exhibit better T-cell priming functions than monocyte-derived cells [15]. Through lineage-
tracing analysis it is well-established that macrophages and blood monocytes are different and 
maintained independently from DCs [15]. Naturally occurring DCs consist of pDCs and conventional 
cDC1 and cDC1 subsets [15, 16]. Before entering the blood stream these subsets originate in 
bone marrow from haematopoietic stem cell (HSC)-derived precursors (pre-DC). Interestingly, 
precursors of pDCs separate quite early from pre-DC committed to cDC1 and 2 phenotypes. The 
origin and differentiation of these subset is a matter of continuous research and debate [17], but 
it is clear that mononuclear phagocytes can be divided into naturally occurring DCs derived from 
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common pre-DCs of HSC origin, embryonic-derived and self-renewing macrophages and (HSC)-
derived common monocyte progenitors (cMoPs) cells, giving rise to moDCs [15]. Nevertheless, DC 
nomenclature remains to be a dynamic, debated and still rapidly changing subject. 
There is a general lack of consensus in the literature on defining particular cell types as DCs. 
Monocyte-derived cells of the intestine are defined as DCs by some researches based on a CD11c+ 
signature [18, 19] and presence of transepithelial dendrites [7, 8], while others have reasons to 
classify these cells as macrophages [20]. Mouse mononuclear phagocytes undergo phenotypical 
changes in inflammatory environments making them different from steady state and some 
researchers define them as tumour necrosis factor (TNF)- and inducible nitric oxide synthase 
(iNOS)-producing DCs (TIP-DCs) [21-23]. This highlights the remarkable quality of monocytes as 
transient accessory cells capable of changing their steady state phenotype and acquire an array 
of different functions in changing micro-environments [7, 24, 25]. It is certain from transcriptomic 
analysis that human and mouse monocytes are precursors for dermal CD14+ DCs and intestinal 
mouse CD103−CD172a+ DCs [26, 27], as well as inflammatory DCs hallmarked by CD1c, CD1a and 
CD14 [28, 29].
Another difficulty is the comparison between murine and human subsets of mononuclear 
phagocytes. Mouse monocyte-derived cells exhibit similarities to cDCs by expressing CD11c 
and MHC class II, presenting antigens for activation of naïve T-cells [30-32]. At the same time, 
mouse monocyte-derived cells have strong similarities to macrophages which is highlighted by 
expression of F4/80, MER kinase and CD64 [23, 24, 30, 33], making them efficient phagocytes. 
Mouse monocytes are highly plastic and making a clear distinction between mouse monocytes 
and macrophages or mouse monocytes and cDCs is a challenging task [15]. Thorough 
transcriptomic analysis it has been shown that non-classical CD14lowCD16+ human monocytes 
are comparable to the LY6Clow non-classical mouse monocytes, while CD14+CD16 are more 
comparable to LY6C+ classical mouse monocytes [34, 35]. In this work we also use mouse-derived 
DCs generated from mouse bone marrow applying the murine cytokine GM-CSF. As reported for 
mouse bone-marrow-derived mononucleocytes, the GM-CSF and IL-4 stimulation method leads 
to high purity of mouse DCs based on CD11c, CD40, CD80, CD86, and MHC-II expression markers 
[14]. However, more recent studies show that mouse bone-marrow cells treated with GM-CSF will 
result in production of heterogeneous population of CD11c+MHCII+ macrophages and DCs [36]. 
Comparing mouse and human DCs might be complicated by the finding that some functional 
specializations of DCs between species may not be necessarily conserved, as shown by IL12p70 
secretion and cross-presentation by cDC1s [37, 38].
Thus, our understanding of DC subsets and the development of a nomenclature is still work 
in progress [15, 17]. In our work we focused on studying phagocytosis in moDCs, mainly for 
experimental reasons (higher cell counts and ease of handling). Given the role of monocytes 
as precursor of moDCs and M1 and M2 macrophages, it would be of interest to compare the 
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molecular machinery driving phagocytosis in moDCs with monocytes as well as pro-inflammatory 
M1 and anti-inflammatory M2 macrophages. Human monocytes, unlike mouse monocytes, also 
exhibit strong phagocytic properties [39]. We have not investigated what signaling mechanisms 
are activated in these cell types in response to pathogenic and non-pathogenic stimuli triggering 
phagocytosis, and how this relates to phagosomal maturation properties. The complete picture 
of why monocytes reserve the ability to differentiate into different types of phagocytes and what 
cues control that process remains to be investigated.
Phagosomal shape
In our work we identified novel roles of SWAP70 in phagosomal uptake and the PIKfyve kinase in
phagosomal maturation, but several questions concerning their roles remain. In all of our studies 
we used spherical zymosan particles or spherical latex beads as model cargo for phagocytosis. This 
approach is commonly used due to uniformity and easy accessibility of the material, as well as for 
availability of standard protocols and quantification methods [1, 40]. However, not all pathogens 
are round and they may adopt different shapes and forms. Interestingly, not only the pathogen’s 
ligands and opsonization can drive phagocytic efficiency, but also the shape and roughness of 
the particle is a key defining point in antigen uptake as shown by theoretical simulations [41-43] 
and experimental data [44-52]. Fungi developed a protective mechanism impeding uptake by 
switching from short and round shape to elongated hyphae (reviewed in [53-56]) which is further 
described in recent studies [57]. Interestingly, theoretical and experimental studies reveal that 
smaller sized particles can be engulfed without involvement of F-actin [41], suggesting SWAP70 
might be dispensable for this process. It would be of value to investigate how the results from 
our work could be translated into a situation where the pathogen would be capable to change 
its form within the phagosome. Proteins (integrins, ERM, BAR, etc.) and lipids (phosphoinositides, 
PtfEtn, PA, DAG, etc.) involved in cytoskeletal anchoring, are sensitive to the curvatures of the 
particle shape [58-60]. It has been reported that after uptake, phagocytes can rotate particles 
to adjust to its shape [61, 62] and a number of protocols and probes were created for imaging of 
such rotation [63]. Particle shape can trigger different immune activation programs in phagocytes 
such as the type of cytokines produced [51, 64] or activation of the inflammasome pathway [65]. It 
would be of interest to investigate how phagocytes would employ SWAP70 and PIKfyve to adjust 
to different shapes or dynamic alterations in the shapes of the ingested pathogens and how loss 
of these proteins may affect antigen degradation, presentation and cytokine production.
Routes of F-actin polymerization
The specific mechanisms of phagosomal F-actin polymerization depend on the type of pathogen,
phagocytic cargo shape and size, ligands, receptors involved, presence of co-stimulatory or co-
inhibitory signals and the type of phagocyte [45, 48, 66-74]. These aspects add a significant level 
of complexity to our understanding of phagocytosis. 
In our studies we confirmed that SWAP70 localization to phagosomes was not affected by the 
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type of ligand on the phagosomal surface [1, 3]. In both DCs and macrophages, SWAP70 was 
excluded from other F-actin rich compartments such as podosomes and the immunological 
synapse [1, 3]. It was also reported that SWAP70 can be found on macropinosomes [75]. It would 
be of value to visualize how SWAP70 is recruited to the phagocytic cup. Experimental setups 
involving frustrated phagocytosis on coated glass surfaces [76] and our newly developed Förster 
resonance energy transfer (FRET) employing fluorescence lifetime imaging microscopy (FLIM) 
imaging protocols [77, 78] could help to answer these questions, as it will allow to resolve with 
a far higher temporal resolution the recruitment of SWAP70 in relation to different gradients 
of phosphoinositides at the phagocytic cup. This would also help to determine in what order 
SWAP70 is recruited to the phagocytic cup in comparison to other F-actin adaptors or GEFs for 
GTPases. With these approaches, we could investigate if SWAP70 knock-down would cause some 
changes in recruitment stoichiometries of other F-actin stabilizing proteins such as Rho and 
Cdc42 GTPases, vinculin, talin, paxilin and integrins to compensate for SWAP70 loss. Since topical 
localization of these proteins is sometimes difficult to observe by conventional microscopy at 
phagocytic cups formed by phagocytosis of regular size particles of 3-5 μm, it would be much 
easier to define such localization patterns on the flat phagocytic cup formed during frustrated 
phagocytosis. This approach also makes it easier to employ super resolution microscopy for 
resolving protein clustering or F-actin bundling. 
How do individual F-actin filaments anchor themselves on the surface of the phagosome? F-actin 
anchoring differs depending on the intracellular niche such as lamellopodia, pseudopodia and 
phagosomes [66, 79-81]. From personal communication (Grinstein Lab) we know that solid 
core podosome-like structures were observed in phagocytic cups in frustrated phagocytosis. 
Since SWAP70 was practically absent from the classical podosomes formed on the ventral side 
of moDCs, it would be interesting to test how SWAP70 is positioned in relation to podosomes 
observed in phagocytic cups. We believe that powerful imaging approaches such as super-
resolution microscopy imaging will be able to answer this question, as it would allow to resolve 
these structures with sufficient spatial resolution to discern individual F-actin filaments. 
SWAP70 can directly bind to PI(3,4,5)P3 and PI(3,4)P2 at the phagocytic cup as was shown by us [1]. 
It is also well-described that phagocytic cup closure cannot be accomplished in the absence of 
these phosphoinositides, due to their role in Ca2+ signaling and F-actin polymerization [82]. Mass 
spectrometry analysis of phosphoinositide-binding proteins revealed quite a limited number of 
binders for PI(3,4)P2 [83]. Interestingly, SWAP70 harbors an EF-hand domain which might sense 
Ca2+ [84, 85] and we showed in our studies that SWAP70 mutants lacking this domain are less 
efficiently recruited to the phagosome [1]. Since the role of calcium signaling in phagocytosis 
is profound [86], it will be interesting to further decipher the input of the EF-hand domain in 
SWAP70 functions at the phagosome. 
Another point of interest is the concentric rings of SWAP70 formed on the surface of the 
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phagosome. Mammalian septins couple GTP or GDP, interact with F-actin and can self-organize 
in higher order structures such as filaments and rings [87-89]. In RAW264.7 and J774 mouse 
macrophage cell lines, septins SEPT2 and SEPT11 are co-localized with sub-membranous actin-
rich structures during the early stages of FcγR-mediated phagocytosis. SEPT2 and SEPT11 knock-
down may inhibit phagocytosis. Since similar structures are described for septins, it would be 
interesting to investigate a possible connection of these septin structures with SWAP70.
Phagosomal pH
According to the canonical model of phagocytosis, early endo/phagosome with neutral pH 
gradually convert into acidic late endo/lysosomes by exchanging PI(3)P to PI(3,5)P2 and increased 
activity of the v-ATPase [66, 90]. A recent study using elongated bacteria as phagocytic model 
showed that direct manipulation of pH can control acquisition of phagocytic markers [91]. This 
suggests an inside-out sensing, where cytosolic proteins are capable of sensing luminal pH 
in tubular phagocytic cups (tPCs). The suggested mechanism for such sensing could be pH-
dependent conformational changes of the transmembrane region of the protein, or proton 
leakage (also suggested by our lab [4]) from the lumen of the phagosome into the cytosol. The 
latter mechanism might generate a potential signaling-response coming from pH-sensitive 
proteins in the cytosol of alter Ca2+ signaling since some cation channels release Ca2+ in response 
to local pH changes [92]. In addition, the v-ATPase itself can sense pH [93] and can transmit signals 
to mTOR with can sense and regulate the luminal concentration of amino acids in lysosomes [94].
Cathepsin expression levels and activity
Cathepsins are a class of proteases with remarkable roles in antigen degradation and presentation 
in endo-/lysosomes. Cathepsins selectively recognize specific substrates for degradation. 
Cathepsin S is expressed in professional antigen-presenting cells (APCs) and is crucial for the 
processing of the invariant chain in bone-marrow derived antigen-presenting cells thereby 
controlling MHC-II presentation [95]. The different cathepsin activation states at different stages 
of endo-/phagosomal maturation are still discussed and the reported pH optima for different 
cathepsins may differ depending on the literature source [40, 95, 96]. Cathepsins can also be 
active in non-endosomal settings, for example extracellulary for degrading extacellular matrix.
The mechanism of cathepsin trafficking to the phagosome is still under discussion. Cathepsin H, 
D, S, L and B are commonly referred to as lysosomal [90, 96, 97], but several pieces of evidence 
suggest they may already be present at phagosomes earlier during maturation. In FcR-mediated 
phagocytosis, the treatment of cells with PIKfyve antagonists (MF4, YM201636, apilimod) inhibited 
recruitment of LAMP1+ and lysosomal aspartic cathepsin D [90]. In contrast, the overexpression 
of a kinase-defective dominant-negative form PIKfyveK1831E did not affect lysosomal targeting of 
newly synthesized pro-cathepsin D [97]. In another study, inhibition of PIKfyve or manipulation 
with PIKfyve downstream targets (such as TFEB; master transcriptional regulator of lysosomal 
biogenesis) caused an increase in the levels of inactive pro-cathepsins A and D in B-cell lymphoma 
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cell lines [98]. A similar increase of the inactive version of pro-cathepsin D expression by a factor 
of 20 and of the active version of cathepsin B by factor of ~3 was observed in PIKfyvefl/fl Pf4-Cre 
platelets from mice [99]. Similar results on accumulation of an immature form of cathepsin D were 
obtained in MNT-1 melanoma cells upon apilimod treatment [100]. Accumulation of the immature 
form of cathepsin D was observed in podocytes upon overexpression of a dominant negative 
mutant of PIKfyve-dependent Vac14 (L156R) [101]. In contrast, apilimod treatment of the prostate 
cancer epithelial cell line PC-3 had no effect on cathepsin D activity [102]. In our work we focused 
on cystein cathepsins (S, B) and not aspartic cathepsins, such as cathepsin D. We did not detect 
significant differences in total protein levels of cathepsin X, B and S while the effect of PIKfyve 
inhibition had the strongest effect on cathepsin S activity. It is of note that PIKfyve inhibition with 
YM201636 caused an enlargement of lysosomal compartments, but these remained acidic and 
retained cathepsin B activity, as shown with a membrane permeable substrate for cathepsin B 
[103]. 
The activity-based probe we used in our work is also designed to detect cathepsin L [104]. It is 
reported that cathepsin L is only active in steady state DCs and becomes inactive in matured DCs 
[96]. It is remarkable that activity of cathepsin L in our moDC lysates is almost undetectable, likely 
because down regulation of cathepsin L expression is a common feature for moDCs. It is believed 
that cathepsin S and L have similar functions at li-processing leading to MHC-II-driven activation 
of CD4+, but cathepsin L is mainly expressed in thymus, for example by cortical thymic epithelial 
cells generating cues for CD4+-T cell selection [105]. 
Literature data linking PIKfyve perturbation to cathepsin B activity shows that inhibition of PIKfyve 
results in an upregulation of cathepsin B expression in platelets [99] or retention of function in 
enlarged lysosomes in HeLa cells [103]. This partially correlates with our observations were we 
do not detect a strong effect of our PIKfyve inhibitors on cathepsin B activity in moDCs. We also 
could not detect any significant differences in total cathepsin expression differences, possibly 
due to a limited length of our standard experiments for cathepsin activity which we measured for 
3 hours in cell lysates after addition of inhibitors.
NOX2 activity and cathepsin activity
Phagosomal maturation is largely shaped by a redox microenvironment in the phagosomal lumen 
created by the activity of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 
2 (NOX2) complex. Unlike macrophages, DCs adopt the strategy of slowing down phagosomal 
maturation to prevent the engulfed cells or pathogens from too fast degradation [106, 107]. This 
is particularly important because DCs have to migrate to lymph nodes and communicate the 
information about phagocytosed material to helper and effector T-cells. This migration may take 
days and reduction of antigen degradation speed allows for sustained surface presentation of the 
ingested antigen within MHC-I and II [4, 40, 108-114]. NOX2 is recruited early to the phagosomes 
already at the stages before phagocytic cup sealing and the fully functional complex resides on 
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the phagosome carrying early markers for hours after uptake [115, 116]. Self-produced ROS can 
partially damage NOX2 and it needs to be replenished from the lysosomal LAMP1+ compartment 
for sustained NOX2 activity [40, 117]. NOX2 complex produces the free radical superoxide (O2•−), 
that can dismutate to hydrogen peroxide (H2O2) leading to the generation of hydroxyl radicals 
(•OH) in the presence of transition metals [4, 111]. Sustained presence of NOX2 at the phagosome 
may facilitate reactive oxygen species (ROS)-mediated pathogen killing [118-120]. At the same 
time NOX2 can inhibit proteases such as cathepsins through either a direct effect of ROS on 
cysteines located in their active sites (reported in this thesis and in [112, 113]) or through a higher 
pH due to alkalization of the phagosomal lumen [40, 108, 110].
Lysosomal cysteine cathepsins (such as B, S, L and Z) constitute a major basis for proteolytic activity 
within phagosomes [95, 121]. Our data show that pharmacological inhibition of PIKfyve caused an 
increased ROS production and a remarkable decrease of cathepsin S activity, which is in line with 
reported ROS effects on cathepsin activity [121]. Additionally, it would be of value to demonstrate 
how the cathepsin content changes in the phagosome lumen over time after uptake. As reported, 
cathepsin S has a higher pH optimum than cathepsins B and L [40], suggesting that cathepsin S 
might already be active in early phagosomes before reaching complete maturation. We observed 
the strongest effects of PIKfyve inhibition on cathepsin S activity, compared to other cathepsins, 
allowing us to conclude that inhibitors acting on PIKfyve caused not only a maturation defect 
and prolonged NOX2 presence, accompanied by an increase in ROS, but also might already affect 
the activity of proteases present in early phagosomes. In our studies we primarily used zymosan, 
which is a potent activator of NOX2 activity [4, 117]. Since it is known that FcR-stimulation and 
LPS also stimulate ROS production by NOX2 [114, 122, 123], it seems likely that ligands for those 
receptors elicit a similar NOX2-mediated reduction of cathepsins S activity. As NOX2 activity can 
inhibit phagosomal cysteine cathepsins, but not aspartic cathepsins [112, 114, 124], we do not 
expect aspartic cathepsins to be affected by NOX2 activity, but their trafficking to phagosomes 
might be disrupted upon PIKfyve inhibition.
NOX2 activity does not only affect proteolysis of ingested antigens by lysosomal cysteine 
cathepsins, but also ROS produced by NOX2 can result in disulfide reduction of protein antigens 
as was recently reviewed [121]. It is of note that only linear peptide/protein stretches are accessible 
to proteases for cleavage, hence all inter- and intra- disulfide bonds have to be reduced before 
antigen processing [125], as has been also demonstrated for MHC-II with model antigens [126, 
127]. GILT (γ-interferon-inducible lysosomal thiol reductase) activity can be inhibited by ROS and 
this may cause different antigen processing patterns leading to altered repertoires of peptides for 
presentation, because some of the proteins cannot be unfolded and are therefore not accessible 
to proteinases for degradation [121].
MHCII loading depends from its dissociation from the li-chaperon, which is degraded by cathepsin 
S. MHCII-li complexes reside in endo-lysosmal compartments and on the cell surface where MHC-
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II can be internalized into the phagosomal lumen. As our Western blot data shows that cathepsin 
S and li degradation were affected upon PIKfyve inhibition, it would be of value to resolve the 
compartment of Ii degradation and determine whether MHCII-li and cathepsin S co-localize to 
early phagosomes with confocal or super-resolution microscopy. A current culprit for solving this 
issue is the lack of suitable antibodies or expression constructs. 
SWAP70 was shown to de able to directly binding RhoA and through that interaction, SWAP70 
can affect MHCII trafficking to the surface [128]. Although we studied MHCII presentation in the 
context of PIKfyve, we did not address this role of SWAP70. This could be studied using our novel 
biorthogonal labeling of MHCII-presented peptides.
PIKfyve and downstream effectors
The mechanism underlying PIKfyve control of phagosomal maturation is not completely 
understood. Taken into account the redundancy of many PIP-kinases [129-131], the non-redundant 
role of PIKfyve in this process is remarkable but the precise trafficking role of its product (PI(3,5)P2) 
is not understood. PI(3,5)P2 may be involved in vesicular trafficking along tubules towards their 
“-” end. Evidence in support for this comes from our live imaging experiments with PIKfyve fused 
to GFP which is present on zymosan-containing phagosomes but also on tubular structures that 
move from the cell periphery towards the nucleus (unpublished data). It would be interesting 
to study if phagosomal PIKfyve causes a TRPML1-dependent calcium release from phagosomes, 
thereby activating dynein adaptor ALG2 as it is described for endolysosomal transport towards 
“-” ends in the direction of the microtubule-organizing center (MTOC) [132, 133]. However, of 
course, we cannot exclude that phagosomes as very large structures rely on other mediators of 
directional vesicle transport.
Other potential PIKfyve effectors are D-repeat proteins interacting with phosphoinositides (WIPI), 
WIPI1 and WIPI2 can bind specifically to PI(3,5)P2, but the function of this binding remains to be 
understood [134]. WIPI2 has been recently reported in linking of a Rab11a+ recycling endosomal 
compartment to PI(3)P2-enriched membranes, creating a platform for autophagy LC3-conjugation 
[135]. Rab11a+ is also known to recruit MHC-I to the phagosomes from the endosomal recycling 
compartment (ERC) [136], but the relationship between these roles is unclear. MHCII is assembled 
in the ER and eventually resides in late endosomal compartment from where it can be recruited 
to the maturing endo-/phagosomes [137]. Since PIKfyve facilitates fusion with lysosomes as we 
extensively discussed above, it would be of particular interest to study the role of PIKfyve in both 
MHC-class I and II trafficking to the phagosome.
The role of PIKfyve in autophagy is well-established, disruption of PIKfyve leads to accumulation 
of autophagic proteins such as NBR1, p62, LC3, WIPI2, which is sometimes explained by an 
inactivity of proteases, dysregulation of fusion with lysosomes, dysfunctional formation of 
multivesicular bodies (MVBs), or problems the with ESCRT machinery [102, 138-140]. It would be 
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interesting to investigate how this involvement of PIKfyve in autophagy might be linked to MHC-II 
antigen loading, since it has been shown that phagosomal LC3-II facilitates presentation of fungal 
antigens within MHC-II [141]. A possible mechanism underlying this process is LC3-II dependent 
recruitment of FYCO1, an effector of Rab which is necessary for fusion with lysosomes [142-144]. 
Contrary to this, TLR2-ligand cargo phagosomes require LC3-II to prevent them from fusion 
with lysosomes and stabilize NOX2 production of ROS for prolonged MHC-II presentation [145]. 
Interestingly, TLR4-ligands such as LPS-coated beads stimulated lysosomal marker recruitment 
and cargo degradation [146]. It would be interesting to compare the rates of PIKfyve recruitment 
and PI(3,5)P2 abundance with phagosomes carrying different stimuli.
Mechanism of phagosomal escape by pathogens
In our study we used very simple model particles for phagocytosis, that do not take into account 
the possible alternative mechanisms that pathogens can employ for avoiding classical route 
phagosomal maturation. Even though host cells developed profound mechanisms of defense, 
many parasites still can escape phagocytosis. Bacterial avoidance strategies are reviewed 
extensively, showing that bacterial shape [147, 148], filamentation [149-152] or virulence factors 
can be utilized by bacteria to avoid phagocytosis [153] or to perturb phagosomal maturation 
[154, 155]. Fungal filamentous structure can also impede phagocytosis [91, 156, 157]. It would be 
interesting to study the characteristics of SWAP70 and PIKfyve following uptake or infection with 
pathogens employing such unconventional avoidance strategies.
Phagocytosis and cancer
How does our work contribute to the understanding of immune defense mechanisms in 
cancer clearance? We found that a SWAP70 deficiency may lead to a reduced phagocytosis and 
pinocytosis. At the same time, SWAP70 is described as an oncogen promoting cancer spreading in 
prostate cancer (CaP) cell lines [158] and ovarian cancers [159], promoting invasiveness of human 
malignant glioma cells [160] and formation of larger tumors formed by SWAP70 transformed 
cells in nude mice [161]. Since the role of SWAP70 in cancer spreading is emerging, it would be 
interesting to study how SWAP70 deficiency in animal models affects the clearance of tumors.
In our studies we employed drugs (apilimod) that were used in clinical trials targeting Crohn´s 
disease [162, 163], rheumatoid arthritis [164], psoriasis [165, 166] . Clinical development of these 
drugs was stopped due to unforeseen side effects [162-166]. We show that apilimod can lead 
to inhibition of crucial mechanisms of antigen degradation and presentation in DCs, leading to 
suppression of immune responses. This is a potential explanation for the observed toxicity of 
apilimod in the clinical trials.
Podosomal protrusions and medical conditions
Shortly after protrusive podosomes were described by Gawden-Bone et al. [167], we discovered 
a role of these structures in antigen sampling by DCs and a possible role in diapedesis. How this 
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can be linked to anti-cancer therapy? Interestingly, cell spreading cancers use invadopodia, which 
in some ways are similar to protrusive podosomes because both are F-actin based, dymamic 
protrusions capable of degrading extracellular matrix and share similar molecular signaling 
mechanisms for maintaining their structure [168]. Our results suggest that therapies targeting 
invadopodia in cancer spreading [169] may potentially affect the immune cell ability to sample 
antigens and migrate to sites of infections.
Conclusion and future perspectives
The summary models outlined in Fig. 1 and 2 showed that DCs can resort to different mechanisms 
of antigen uptake (phagocytosis and endocytic uptake via podosome protrusions are the focus 
of this thesis). The mode of uptake depends on the type of antigen, shape and size, as well as 
the niche where antigen sampling is performed. Our findings explain how F-actin is anchored 
and stabilized at large phagosomes via the adaptor protein SWAP70 which facilitates particle 
uptake. This contributes a new role for SWAP70’s in immunity [128] and cancer development [158-
161]. Our findings further provide a new mechanism for antigen processing and degradation, as 
we show that blockage of PIKfyve activity results in endo-/phagosomal defects of maturation 
leading to prolonged presence of NOX2 on the phagosome. New aspects of the role of NOX2 
in antigen processing and presentation are still being uncovered [4, 108-113, 117, 121, 124, 145] 
and these explain the antigen presentation defects observable in patients suffering from chronic 
granulomatous disease (CGD) [4]. Although knock-out of PIKfyve in mice is embryonically lethal 
[170], PIKfyve mutations in humans result in François-Neetens fleck corneal dystrophy (CFD) which 
manifests in white flecks scattered in all layers of the stroma of the eye [171].
Thus, our data showed the involvement of PIKfyve in immunity by controlling endo-/phagosomal 
maturation, antigen processing and MHC-II loading and presentation. This important function of 
PIKfyve might explain the reason why clinical trials targeting PIKfyve to prevent cancer viability 
and spreading [162-166] have had a negative effect on immune functions of DCs and possibly 
other phagocytes. Our data clearly shows that phagocytes rely on PIKfyve to assure pathogen 
clearance and for triggering of adaptive immunity via MHCII-dependent antigen presentation 
to T-cells. Overall, our findings add to our understanding of antigen uptake, degradation and 
presentation mechanisms by DCs, that can be utilized in clinical target design for combating 
autoimmune-diseases, cancers or infections.
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Figure 1-2. Model of all findings described in this thesis showing different routes of antigen uptake 
via phagocytosis or (Fig 1) protrusive podosomes (Fig. 2).  
Figure 1 A. Pathogen uptake by phagocytic cup formation. (1) Larger antigen particles (>0,5 µm) are 
internalized via phagocytosis, which is initiated by receptor clustering and PI(4,5)P2 accumulation at 
the site of particle-cell contact. (2) PI(3,4,5)P3 is dephosphorylated by SHIP1 and 2 producing 
PI(3,4)P2. Surface expressed MHCII-li might be internalized, facing the phagosomal lumen. (3) The 
initial phagocytic cup is decorated by SWAP70 utilizing its pleckstrin homology (PH-)domain for 
binding to PI(3,4)P2. (4) Via its Dbl-homology domain, SWAP70 participates in recruitment and 
stabilization of an active (GTP-bound) version of Rac1. (5) Rac1 triggers downstream events resulting 
in F-actin polymerization at the phagocytic cup. (6) This, in turn, triggers further recruitment of 
SWAP70 binding more F-actin via its F-actin binding domain. (7) F-actin is anchored at the 
phagosome and completes phagocytic cup closure and particle uptake. (8) After closure, PI(3,4)P2 is 
converted to PI(3)P triggering recruitment of early endo/phagosomal markers such as Rab5 and 
EEA1. (9) NOX2 completes its assembly on emerging phagosomes and initiates ROS production in the 
phagosomal lumen. Early phagosomes might already contain cathepsin S becoming active at 
alkalinized pH and initiating proteolytic degradation of the li-chaperon, thereby releasing the 
antigen-loading site of MHCII. (10) Approximately 10 min after phagocytic cup closure, the PIKfyve 
kinase converts PI(3)P into PI(3,5)P2. (11) PI(3,5)P2 initiates TRPML-1 activation and Ca2+ release, 
^ Fig. 1: Model of all findings described in this thesis showing different routes of antigen uptake via phagocytosis. 
(A) Pathogen uptake by phagocytic cup formation. (1) Larger antigen particles (>0,5 μm) are internalized via phagocytosis, 
which is initiated by receptor clustering and PI(4,5)P2 accumulation at the site of particle-cell contact. (2) PI(3,4,5)P3 is 
dephosphorylated by SHIP1 and 2 producing PI(3,4)P2. Surface expressed MHCII-li might be internalized, facing the 
phagosomal lumen. (3) The initial phagocytic cup is decorated by SWAP70 utilizing its pleckstrin homology (PH-)domain 
for binding to PI(3,4)P2. (4) Via its Dbl-homology domain, SWAP70 participates in recruitment and stabilization of an active 
(GTP-bound) version of Rac1. (5) Rac1 triggers downstream events resulting in F-actin polymerization at the phagocytic 
cup. (6) This, in turn, triggers further recruitment of SWAP70 binding more F-actin via its F-actin binding domain. (7) F-actin 
is anchored at the phagosome and completes phagocytic cup closure and particle uptake. (8) After closure, PI(3,4)P2 is 
converted to PI(3)P triggering recruitment of early endo/phagosomal markers such as Rab5 and EEA1. (9) NOX2 completes 
its assembly on emerging phagosomes and initiates ROS production in the phagosomal lumen. Early phagosomes might 
already contain cathepsin S becoming active at alkalinized pH and initiating proteolytic degradation of the li-chaperon, 
thereby releasing the antigen-loading site of MHCII. (10) Approximately 10 min after phagocytic cup cl sure, the PIKfyve 
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kinase converts PI(3)P into PI(3,5)P2. (11) PI(3,5)P2 initiates TRPML-1 activation and Ca
2+ release, initiating ALG2 dynein adaptor 
recruitment which might execute transport towards the “-”of microtubules towards the MTOC and perinuclear region. 
(12) PI(3,5)P2 containing phagosomes fuse with endolysosomal compartments hallmarked by LAMP1 and the V-ATPase, 
triggering phagosomal lumen acidification to low pH. (13) Endolysosomal cathepsins such as B and D may become active at 
this point facilitating further antigen degradation for loading to MHCII. Additional MHCII might be recruited to phagosomes 
from endolysosomal compartments. Cathepsin S has a wide range of pH optima therefore it will likely continue degrading 
the li-chaperon. (14) Antigen peptides of 18-20 amino-acids in length are loaded onto MHCII with the help of HLA-DM in 
endolysosomal compartments and will be trafficked to the surface of the cell to initiate CD4+ T-cell responses. (15) Novel 
assay for measuring MHC-II presentation: non-natural amino acid L-C-propargylglycine of MHCII-loaded antigen can be bio-
orthogonally labeled with CalFluor dyes to quantitatively access levels of antigen presentation. 
< Fig. 2: Model of all findings described in this thesis showing different routes of antigen uptake via protrusive podosomes. 
Protrusive podosomes for antigen sampling. (1) Podosomes can protrude and dissolve their solid F-actin cores. (2) Tubulin 
microfilaments penetrate into the lumen of protrusive podosomes and facilitate kinesin-dependent delivery of MT1-MMP 
proteinase for further matrix degradation at the protrusive tip. (3) Pattern recognition receptors are also delivered at the 
tip of protrusive podosomes along microtubules, likely via kinesins. (4) Sample antigens are internalized through epithelial 
barriers via such protrusive structures.
  
Figure 1-2. Model of all findings described in this thesis showing different routes of antigen uptake 
via phagocytosis or (Fig 1) protrusive podosomes (Fig. 2).  
Figure 1 A. Pathogen uptake by phagocytic cup formation. (1) Larger antigen particles (>0,5 µm) are 
internalized via phagocytosis, which is initiated by receptor clustering and PI(4,5)P2 accumulation at 
the site of particle-cell contact. (2) PI(3,4,5)P3 is dephosphorylated by SHIP1 and 2 producing 
PI(3,4)P2. Surface expressed MHCII-li might be internalized, facing the phagosomal lumen. (3) The 
initial phagocytic cup is decorated by SWAP70 utilizing its pleckstrin homology (PH-)domain for 
binding to PI(3,4)P2. (4) Via its Dbl-homology domain, SWAP70 participates in recruitment and 
stabilization of an active (GTP-bound) version of Rac1. (5) Rac1 triggers downstream events resulting 
in F-actin polymerization at the phagocytic cup. (6) This, in turn, triggers further recruitment of 
SWAP70 binding more F-actin via its F-actin binding domain. (7) F-actin is anchored at the 
phagosome and completes phagocytic cup closure and particle uptake. (8) After closure, PI(3,4)P2 is 
converted to PI(3)P triggering recruitment of early endo/phagosomal markers such as Rab5 and 
EEA1. (9) NOX2 completes its assembly on emerging phagosomes and initiates ROS production in the 
phagosomal lumen. Early phagosomes might already contain cathepsin S becoming active at 
alkalinized pH and initiating proteolytic degradation of the li-chaperon, thereby releasing the 
antigen-loading site of MHCII. (10) Approximately 10 min after phagocytic cup closure, the PIKfyve 
kinase converts PI(3)P into PI(3,5)P2. (11) PI(3,5)P2 initiates TRPML-1 activation and Ca2+ release, 
< Fig. 1(B): Situation in the absence of SWAP70 or PIKfyve 
deficiency. F-actin fibers cannot be efficiently anchored 
to phagosomes due to lower levels of Rac1 upon lack of 
SWAP70. F-actin filaments cannot bundle or anchor to 
the phagosomal surface. This leads to lower phagocytosis 
levels. PIKfyve deficiency causes prolonged NOX2 
recruitment due to overproduction of PI(3)P, which leads 
to more ROS production. ROS inhibit cathepsin S activity 
thereby blocking the proteolytic uncoupling of MHCII from 
its chaperon li, leading to lower antigen presentation. Large 
endosomes do not fuse with lysosomal compartments 
further delaying antigen presentation, because cathepsin 
B cannot reach phagosomes. Overall, MHCII-li and MHCII-
antigen cannot reach the cell surface due to trafficking 
defects caused by PIKfyve inhibition..
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APPENDIX
A
Het immuunsysteem
Schadelijke pathogenen (d.w.z. organismen of virussen die ziekte kunnen veroorzaken) en 
kankercellen kunnen beschermende afweermechanismen van ons lichaam tegenkomen – het 
zogenaamde immuunsysteem. Het proces van het herkennen en elimineren van pathogenen 
of kankercellen wordt een immuunreactie genoemd. Aanvankelijk worden pathogenen of 
kankercellen aangevallen en zonder onderscheid opgeslokt door bepaalde cellen van ons 
immuunsysteem. Deze eerste verdedigingslijn wordt “innate” immuunsysteem genoemd. De 
tweede verdedigingslinie wordt “adaptieve” immuunsysteem genoemd. Adaptieve immuniteit 
heeft enige tijd nodig om zich te ontwikkelen, maar resulteert in een zeer specifieke reactie tegen 
bepaalde soorten pathogenen, en een “geheugen” om sneller op te treden bij terugkerende 
infecties.
Dendritische cellen (DC) spelen een belangrijke rol in het adaptieve immuunsysteem. Ze 
kunnen actief pathogenen van de infectieplaats (zoals een wond) of kwaadaardige cellen (bij 
kanker) overspoelen. Daarna kunnen DCs ongewenste pathogenen of cellen verteren tot 
kleinere fragmenten en later een deel van deze resterende fragmenten van slechte indringers 
terugsturen op het celoppervlak van de DC. Blootstelling van fragmenten van ziekteverwekkers 
aan het oppervlak van DCs wordt "antigeenpresentatie" genoemd. Fragmenten van afgebroken 
pathogenen worden gepresenteerd binnen eiwitcomplex genaamd MHCI of MHCII (major 
histocompatibility complex).
Daarna kunnen DCs migreren of kruipen van de infectie- of kankerplaats naar lymfeklieren. Hier 
"vertonen" de DCs slechte deeltjes op MHCI of MHCII op hun celoppervlak aan andere cellen van 
het "adaptieve" immuunsysteem zoals T- en B-cellen. Geïnstrueerde T- en B-cellen kunnen zich 
zeer snel vermenigvuldigen en terugreizen naar de plaats van infectie/kanker en pathogenen 
of kankercellen aanvallen. Op deze manier creëren DCs een verbinding tussen de “innate” en 
“adaptieve” immuniteiten.
Fagocytose / Endocytose
Simpel gezegd, opname van deeltjes of moleculen kleiner dan 0.5 µm (0.0005 mm) kan 
endocytose worden genoemd, en deeltjes groter dan 0.5 µm worden meestal door de cellen 
opgegeten door het proces genaamd fagocytose. Cellen kunnen ook vloeistoffen "drinken" via 
een mechanisme genaamd micropinocytose. Alle cellen worden beschermd door membranen 
die bestaan uit lipiden. Al het materiaal dat van buiten komt moet de celmembraanbarrière 
passeren. Elke opname / drinkgedrag door cellen wordt gedaan door membraanstructuren die 
vouwen kunnen vormen (een zogenaamde fagocytische “cup”) en pathogene deeltjes kunnen 
vangen in een lipide-envelop. Deze envelop blijft op het endo / phagosomale oppervlak, zelfs 
nadat deeltjes zich in de cel bevinden en de "spijsvertering" van de opgenome deeltjes vindt 
binnen in deze envelop plaats. De lipide samenstelling van de membraanomwikkeling bepaalt 
de efficiëntie van fagocytose of endocytose. Een interessant type lipiden zijn de zogenaamde 
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fosfatidyl inositolfosfaten (phosphoinositide, PI). Deze PIs worden in een lipide-membraan 
ingebracht door een vet staart, maar de zuikerhoofden van deze lipiden steken uit. Deze 
suikerkop (inositolring) kan op meerdere plaatsen worden gefosforyleerd, wat resulteert in 7 
verschillende soorten PIs. Wat interessanter is, is dat één soort fosfoinositide in een andere soort 
kan worden omgezet, dit gebeurt na endocytose, pinocytose en fagocytose en dit kan optreden 
op het oppervlak van de lipide-envelop van het pinosoom, fagosoom of endosoom in de cel. 
Vanwege de unieke structuren van verschillende PIs kunnen ze specifieke eiwitten die vrij in de 
cel ronddrijven binden. Als één type PI op één plek (bijv. op het fagosoom) in overvloed aanwezig 
is, kunnen al deze eiwitten in grote aantallen binden en een bepaalde plek op bijvoorbeeld het 
fagosome binden die een verandering van fagosomale eigenschappen veroorzaakt.
Alle stadia van de vorming van endo- / fagosomen kunnen worden gevolgd: van vroege stappen 
tot late stappen. In de vroege stadia van endo- / fagosomale opname moet het celmembraan 
zich uitstrekken tot "armachtige" verlengingen om een pathogeen te "omhelzen". Interacties 
tussen eiwitten van the cytoskelet en PI-lipiden stimuleert de vorming van deze uitbreidingen. 
Vervolgens wordt de membraanenvelop gevormd en worden fagosomen in een binnenruimte 
van de cellen opgenomen. Nu is het cytoskelet niet langer nodig en beginnen andere eiwitten 
met the verteren in het vroege fagosoom.
Andere soorten PIs zullen later eiwitten rekruteren die het vroege fagosoom omzetten naar 
een laat fagosoom. Dit late fagosoom zal uiteindelijk fuseren met lysosomen. Lysosomen zitten 
vol met componenten die klaar staan om een pathogen of kankercel die gevangen zitten in de 
fagosomale membraanomhulling te "verteren" en "vernietigen".
Nieuwe biologische inzichten in de uitwisseling tussen organellen door 
superresolutiemicroscopie
Processen van endo / fagosomale conversies berusten op fusie van de membraanvesicles 
en organellen in de cellen. Fagosomen en andere organellen zijn erg klein, dus deze 
conversies zijn op submicroscopische schaal en daarom moeten zeer krachtige methodes 
zoals microscopie met superresolutie worden gebruikt. In Hoofdstuk 2 bespreek ik 
de snel ontwikkelende superresolutie benaderingen (zoals STED, PALM, STORM) die 
worden gebruikt voor het bestuderen van membraanfusie. Ik bespreek de gepubliceerde 
studies die zich richten op cytoskelet re-arrangementen en dynamica in endocytose en 
fagocytose. Ik onderzocht ook de interacties van DCs met T- en B-cellen doormiddel van 
immunologische synapsvorming en probeerde het belang van superresolutie in dergelijk 
onderzoek te demonstreren. Ik heb ook sleutelgebieden in het subcellulaire organelverkeer 
geidentificeerd waar superresolutiemicroscopie vereist is om belangrijke vragen aan te pakken.
PIs in vroege stadia van fagocytose
In Hoofdstuk 3 bestudeerde ik de rol van een zeldzaam soort PI genaamd PI(3,4)P2 in 
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antigeenopname via fagocytose door DCs. In eerste instantie heb ik gekeken naar gebubliceerde 
screens om nieuwe eiwitten die binden aan PI(3,4)P2 te identificeren. Van de slechts een paar 
voorspelde interactoren, heb ik besloten om me te concentreren op het eiwit SWAP70. Ik 
bevestigde met verschillende soorten microcopie dat SWAP70 een sterk binding heeft aan 
PI(3,4)P2 in fagocytische cups tijdens vroege stadia van fagocytose. Ik kon SWAP70 niet vinden 
in andere cytoskeletrijke structuren zoals podosomen, wat eerdere waarnemingen bevestigt. 
Superresolutie microscopie onthulde dat SWAP70 langs parallelle bogen of ringen van het 
celskelet uit F-actine "kabels" uitlijnt. SWAP70 is ook uitgelijnd met kabels van Rac1 GTPase op de 
fagocytische cup. Ik heb ook SWAP70 gemuteerd en SWAP70 uit de cellen verwijderd met behulp 
van zogenaamde siRNA knock-down. Ik gebruikte specifieke medicijnen om de productie van 
PI(3,4)P2 in humane immuuncellen te remmen. Alles werd gedaan om te bewijzen hoe belangrijk 
SWAP70 is in Rac1-activering, F-actinevorming en fagocytose. Dus, ik heb een nieuw PI(3,4)
P2 bindend eiwit SWAP70 geïdentificeerd dat in grote hoeveelheden op vroege fagosomen te 
vinden is. SWAP70 bindt tegelijkertijd aan PI(3,4)P2, F-actine en Rac1, hetgeen noodzakelijk is voor 
een succesvolle antigeenopname.
In Hoofdstuk 4 heb ik mijn onderzoek over SWAP70 uitgebreid en zijn rol getest niet alleen in 
menselijke monocyt-afgeleide DCs, maar ook in andere DC-subsets zoals pDCs en mDCs. Ik 
bevestig in dit hoofdstuk de belangrijke rol van SWAP70 bij fagocytose in beenmergafgeleide 
DCs (BMDCs) van de muis gegenereerd met de groeifactoren FLT3 en GM-CSF en in de 
muizenmacrofaagcellijn RAW264.7. Ik presenteer aanvullende gegevens die de rol van SWAP70 
in het controleren van F-actine in het fagosoom aantonen, maar niet op de immunologische 
synaps waarbij DCs in contact komen met T-cellen. Ik bevestigde verder de rol van SWAP70 
door zijn functie te remmen met het molecuul sanguinarine. De bevindingen van dit hoofdstuk 
ondersteunen onze bevindingen met SWAP70 knock-down en mutatie-analyse in Hoofdstuk 3. 
Bovendien heb ik waargenomen dat actieve SWAP70 niet alleen F-actinevorming ondersteunt, 
maar ook activering het de F-actine verstorende eiwit coffiline blokkeert
PIs in latere stadia van fagocytose
In Hoofdstuk 5 heb ik gekeken naar de fagosoomovergang van het vroege naar late stadium en 
heb ik de rol van de fosfoinositide kinase PIKfyve in dit proces besproken. PIKfyve is het eiwit in de 
cel dat het PI type PI(3,5)P2 kan produceren. Dit is weer een onderbestudeerd type PI dat cruciaal 
is voor membraanfusie van fagosomen met lysosomen. Deze fusie wordt gekenmerkt door 
lage pH en verhoogde protease-activiteit van cathepsines, dat zijn eiwitten die andere eiwitten 
kunnen "verteren" of "vernietigen". We toonden aan dat remming van PIKfyve met specifieke 
geneesmiddelen (apilimod of YM201636) een stop veroorzaakte van fagosomale rijping en leidde 
tot de verlengde aanwezigheid en verhoogde activiteit van een ander eiwitcomplex - NOX2. 
NOX2 produceert reactieve zuurstofradicalen (ROS), wat resulteert in verminderde activiteit 
van cysteïnecathepsines. Ik heb onderzocht hoe blokkering van PIKfyve en lagere niveaus van 
cathepsine-activiteit afbraak en presentatie van antigeen in MHC II beïnvloeden. Daarnaast heb 
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ik samen met collega's een alternatieve bioorthogonale MHCII-presentatietest ontwikkeld om 
presentatie van het griepvirus op MHCII op het celoppervlak te traceren. Mijn experimenten 
onthullen een belangrijke rol van PIKfyve bij antigeenafbraak in fago / endo-lysosomen, wat 
leidde tot antigeenpresentatie binnen MCH II die adaptieve immuniteit teweegbrengt.
Nieuwe routes van antigeenopname door uitstekende structurent
In Hoofdstuk 6 identificeerde ik een nieuwe rol van podosomen bij de opname van pathogenen. 
Podosomen zijn structuren die uit de cel steken en in verschillende celtypen kunnen worden 
gevonden. Podosomen kunnen celmigratie begeleiden door de extracellulaire matrix en door 
endo / epiteel barrières (zoals huid, bloedvaten, ingewanden, enz.). Mijn studie is geïnspireerd door 
waarnemingen dat de dichte en ronde kernen van podosomen kunnen worden omgezet in lange 
en uitstekende structuren wanneer ze zachte plekken op substraten tegenkomen. Dit verhoogde 
de mogelijkheid van een rol van podosomen bij het vangen van pathogenen. Inderdaad, in mijn 
experimenten onthulde ik dat DCs met podosomen, als een soort van armen, kunnen doordringen 
in de dichte lagen gevormd door andere cellen (die darm of vaten nabootsen) om pathogenen aan 
de andere kant van de laag te vangen. Dit betekent dat DCs deze lange "armen" kunnen gebruiken 
om pathogenen te vangen zonder helemaal door de laag te hoeven migreren.
In een korte studie gepresenteerd in hoofdstuk 7, bespreek ik verder de lange en doordringende 
aard van podosomen. Ik heb de aanwezigheid van verschillende endocytische en exocytische 
eiwitten aangetoond op uitstekende podosomen.
Ten slotte bespreek ik in hoofdstuk 8 onze resultaten en relateer onze observaties aan de 
momenteel beschikbare gegevens in de literatuur. Ik bespreek mogelijke nieuwe richtingen in 
fosfoinositide-onderzoek met een focus op superresolutie microscopie en nieuwe bioorthogonale 
labelingstechnieken.
De bevindingen in dit proefschrift zijn samengevat in een overzichtsfiguur die ons in staat stelt 
de unieke en complexe mechanismen van antigeenopname en antigeenverwerking door 
antigeenpresenterende cellen te traceren vóór presentatie aan T-cellen. Deze fundamentele 
ontdekkingen leiden tot een beter begrip van welke routes van fosfoinositidemetabolisme cruciaal 
zijn voor endo / fagocytische functies van DCs. Daarnaast bieden de bevindingen een mechanische 
verklaring voor de bevindingen van verschillende klinische onderzoeken dat remmers van 
fosfoinositide-gerelateerde eiwitten zoals apilimod of YM201636 een algeheel toxisch effect 
hebben.
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